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Summary 
I 
SUMMARY 
Retinal degenerations including age-related macular degeneration (AMD) have devastating 
consequences for patients. AMD primarily affects the cone-rich macular region of the retina that is 
responsible for central, high-acuity vision. With the rise in life expectancy, the prevalence of AMD 
continues to increase. Adequate treatment options are urgently needed, especially since available 
therapies are restricted to the less frequent neovascular form of the disease. The development of 
novel therapies, however, requires detailed understanding of disease mechanisms, a knowledge 
that is still limited in the case of AMD mostly due to the lack of suitable experimental models with a 
cone-rich macula.  
Numerous factors have been proposed and/or validated to contribute to AMD disease development 
and progression. One such pathological factor might be reduced retinal oxygenation leading to local 
hypoxia. Age-related changes such as reduction of choroidal blood flow, accumulation of drusen and 
thickening of the Bruch’s membrane may limit oxygen supply from the choroidal vasculature to 
photoreceptors and thereby activate a chronic hypoxic response. Hypoxia induces several cellular 
mechanisms orchestrated by hypoxia-inducible factors (HIFs). Considering the importance of high 
oxygen levels for normal photoreceptor metabolism it is highly likely that chronic hypoxia in 
senescent eyes might play an important role in AMD pathology.  
In this work, we employed several mouse models to study cone degeneration and the contribution 
of hypoxia. First, we used Rpe65R91W;Nrl-/- (R91W;Nrl-/-) double-mutant mice to mimic the central 
cone-exclusive region of the human macula. R91W;Nrl-/- mice express only cone photoreceptors in 
a functional, well-layered retina and can be used to study cone photoreceptor pathologies. To test 
the potential involvement of chronic hypoxia in AMD, we triggered a chronic hypoxia-like response 
in cone photoreceptors of R91W;Nrl-/- and rod photoreceptors of wild-type mice. Then, to understand 
the mechanisms of cone degeneration, we analyzed retinal degenerative processes in the all-cone 
R91W;Nrl-/- mouse model which was subjected to damaging blue light.  
In the first part, we show that early stabilization of HIFs in cone photoreceptors of the all-cone retina 
led to subretinal neovascularization and cone degeneration, features that are central to a distinct 
form of AMD known as retinal angiomatous proliferation (RAP). Additionally, we present evidence 
that inactivation of Hif1a rescued the observed phenotype, which clearly identifies Hif1a as the 
pathological isoform. In the rod-dominant retina, long-term activation of the hypoxic response caused 
age-dependent retinal degeneration and retinal pigment epithelium defects, without inducing blood 
vessel growth into the subretinal space. Although photoreceptor degeneration was evident in both 
models, the progression of the degenerative process differed. While cones in the all-cone retina 
degenerated already at early time points, rod cell death in rod-dominant retinas was milder and 
progressed more slowly. To interfere with these hypoxia-related mechanisms that led to cell death, 
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we tested a gene therapy approach using adeno-associated virus (AAV)-mediated expression of 
anti-Hif1a shRNA. Our approach ameliorated the degenerative pathology and encourages further 
research to evaluate a potential translation of anti-Hif1a therapy to the clinics.  
In the second part, we analyzed retinal degenerative processes in R91W;Nrl-/- mice which were 
exposed to blue light. Our data revealed essential differences between wild-type (rod-dominant 
retina) and R91W;Nrl-/- (all-cone retina) mice: the all-cone retina was more resistant to blue light 
damage in terms of photoreceptor degeneration. However, while in wild-type mice blue light damage 
affected the outer blood-retina barrier maintained by the retinal pigment epithelium, the inner blood-
retinal barrier formed by tight junctions between retinal capillary endothelial cells was additionally 
impaired in R91W;Nrl-/- mice, resulting in vascular leakage and edema. 
Investigating molecular pathways involved in retinal degeneration is essential to develop successful 
treatment approaches. This work contributes to the better understanding of the retinal response to 
chronic hypoxia-like conditions and toxic levels of light, two important features implicated in retinal 
degenerative diseases. Our findings support the concept that targeting HIFs might serve as a 
therapeutic strategy for hypoxia-mediated degenerative diseases.  
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ZUSAMMENFASSUNG 
Sehbehinderungen und Erkrankungen der Netzhaut (Retina) beeinträchtigen die Lebensqualität der 
Betroffenen erheblich. Zu den häufigsten degenerativen Augenkrankheiten zählt die altersbedingte 
Makuladegeneration (AMD), bei welcher das Zentrum der Netzhaut, die sogenannte Makula, 
geschädigt wird. Das Absterben der dort in hoher Dichte vorkommenden Zapfen führt zu einer 
fortschreitenden Verschlechterung der zentralen Sehschärfe. Mit der steigenden Lebenserwartung 
wird die Anzahl der von AMD Betroffenen in Zukunft weiter zunehmen. Es werden deshalb dringend 
Behandlungsmöglichkeiten benötigt, zumal sich diese momentan auf die seltenere, feuchte Form 
der AMD beschränken. Im Gegensatz dazu steht für die trockene AMD bisher keine wirksame 
Therapie zur Verfügung. Die Erforschung der Ursachen und des Verlaufs der AMD gestaltet sich 
jedoch schwierig, da den meisten Tiermodellen eine Makula mit hoher Zapfendichte fehlt.  
Zur Entstehung und zum Verlauf der AMD können zahlreiche Faktoren beitragen. Eine wichtige 
Rolle spielt möglicherweise auch ein Sauerstoffmangel (Hypoxie), der durch alterungsbedingte 
Prozesse entstehen kann. Im Laufe der Alterung kann die Sauerstoffzufuhr zu den Photorezeptoren 
durch den verminderten Blutfluss in der Choroidea (Aderhaut), die Zunahme der Ablagerungen unter 
der Netzhaut (sogenannte Drusen) und die Verdickung der Bruch-Membran eingeschränkt werden. 
Als Antwort auf den Sauerstoffmangel werden heterodimere hypoxie-induzierte Faktoren (HIF) 
aktiviert. In Anbetracht des hohen Sauerstoffbedarfs der Photorezeptoren für den Zellstoffwechsel 
kann eine chronisch aktivierte hypoxische Antwort eine wichtige Rolle bei der Pathogenese der AMD 
spielen.  
In dieser Arbeit haben wir mit mehreren Mausmodellen Zapfendegenerationen und die 
Auswirkungen einer hypoxischen Antwort studiert. Hierfür haben wir Rpe65R91W;Nrl-/- Mäuse 
(R91W;Nrl-/-; ʺZapfenmäuseʺ) analysiert, deren morphologisch normale Netzhaut ausschliesslich 
aus funktionstüchtigen Zapfen besteht und somit der Makula beim Menschen ähnlich ist. Diese 
Zapfenmaus ist ein ideales Modell, um die molekularen Mechanismen bei Zapfendegenerationen zu 
studieren. Um den Einfluss einer chronisch-hypoxischen Antwort zu analysieren, haben wir 
ausserdem lokale Hypoxie in zwei Mausmodellen simuliert. Einerseits haben wir die chronisch-
hypoxische Zellantwort in den Stäbchen einer normalen, von Stäbchen dominierten Netzhaut und 
andererseits in den Zapfen der Zapfenmaus aktiviert. Um zusätzlich die Mechanismen der 
Zapfendegeneration besser zu verstehen, haben wir die durch Bestrahlung mit Licht im blauen 
Wellenlängenbereich ausgelöste Degeneration der Netzhaut in der Zapfenmaus studiert.  
Im ersten Teil dieser Dissertation zeigen wir, dass die Aktivierung der hypoxischen Zellantwort in 
der Zapfenmaus zu subretinaler Neovaskularisation und Degeneration führte, und somit zu 
Merkmalen, die den zentralen Eigenschaften einer als retinale angiomatöse Proliferation (RAP) 
bezeichneten Form der feuchten AMD entsprechen. Ausserdem zeigen wir, dass die zusätzliche 
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Inaktivierung von Hif1a die Netzhaut vollständig schützte, womit wir in diesem Modell eindeutig Hif1a 
als pathologische Isoform identifizieren konnten. In der von Stäbchen dominierten Netzhaut 
verursachte die chronisch aktivierte Hypoxieantwort einen Verlust der Photorezeptoren sowie 
Veränderungen des retinalen Pigmentepithels, ohne subretinale Neovaskularisation anzuregen. 
Obwohl die Photorezeptoren in beiden Mausmodellen degenerierten, unterschied sich der Verlauf 
des degenerativen Prozesses. Während die Zapfen in der Zapfenmaus bereits früh starben, schritt 
der Verlust der Stäbchen in der von Stäbchen dominierten Netzhaut langsamer voran. Mittels 
Gentherapie haben wir versucht, den durch HIF1A ausgelösten Zelltod therapeutisch zu behandeln. 
Um Hif1a künstlich stillzulegen, haben wir eine shRNA-Sequenz in adeno-assoziierte Viren (AAV) 
verpackt und durch subretinale Injektionen in die Photorezeptoren eingeschleust. Dadurch konnten 
wir die Degeneration der Sehzellen vermindern. Weitere Untersuchungen mit dem Endziel einer 
möglichen klinischen Anwendung scheinen deshalb sinnvoll. 
Im zweiten Teil haben wir mit dem Ziel, die Mechanismen der Zapfendegeneration besser zu 
verstehen, die durch Bestrahlung mit Licht im blauen Wellenlängenbereich ausgelöste 
Netzhautdegeneration in Wildtyp- und Zapfenmäusen studiert. Unsere Analysen zeigen deutliche 
Unterschiede zwischen den beiden Modellen: Die Netzhaut der Zapfenmaus scheint bezüglich der 
Degeneration resistenter zu sein. Während jedoch bei den Wildtypmäusen die äussere, durch das 
retinale Pigmentepithel gebildete Blut-Retina-Schranke geschädigt wurde, wurde bei den 
Zapfenmäusen auch die innere, durch die retinalen Endothelzellen gebildete Blut-Retina-Schranke 
beeinträchtigt. Aufgrund der undichten Blutgefässe kam es zu einer Flüssigkeitsansammlung, die 
eine Schwellung der Netzhaut verursachte (Netzhautödem). 
Für die Entwicklung der therapeutischen Behandlungen ist es erforderlich, die molekularen 
Signalwege im Laufe der Degeneration zu kennen und zu verstehen. Diese Dissertation trägt zu 
einem besseren Verständnis der molekularen Auswirkungen einer chronisch aktivierten 
Hypoxieantwort und der Einwirkung von Licht auf Netzhautzellen bei, zwei wichtigen Faktoren im 
Zusammenhang mit degenerativen Netzhauterkrankungen. Unsere Forschungsergebnisse 
unterstützen insbesondere die Theorie, dass die gezielte Ausschaltung von Hif1a zur Behandlung 
der AMD und anderer mit einer hypoxischen Komponente assoziierten Netzhautdegenerationen in 
Betracht gezogen werden kann.  
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1 INTRODUCTION 
Our visual system is confronted with a large amount of different inputs – every second. Humans and 
non-human primates largely rely on sensory input by the visual system and any disturbance or 
malfunctioning of the visual system has devastating consequences for the patient’s daily life. Over 
a broad range of light intensities, vision conveys signals about objects, their movements, speed and 
distance. Handling of this large amount of information is efficient both in terms of quantity and quality 
thanks to extensive parallel processing and sorting of visual data. Before the information is sent to 
the visual cortex in our brain, our eyes take the first step in visual processing at the level of the retina.  
1.1 Retinal Structure and Function 
1.1.1 Retina and retinal pigment epithelium 
The retina is the innermost layer of the eye (Figure 1A) and is derived from the optic vesicle, an 
outpocketing of the diencephalon (Purves 2012). Upon light reception, the multilayered neuronal 
tissue processes the image and transmits electrical signals via the optic nerve to the brain. Six 
classes of cell types (photoreceptors, bipolar cells, horizontal cells, amacrine cells, Müller glia cells 
and ganglion cells) are structured into three layers, namely the outer nuclear layer (ONL), inner 
nuclear layer (INL) and the ganglion cell layer (GCL, Figure 1B,C). The ONL consists of two types 
of photoreceptors – the rods and cones – that are composed of membrane disks containing light-
sensitive photopigments. Light absorption by the photopigments in the outer segments of the 
photoreceptors initiates a process called phototransduction (see 1.1.3). Signals are then transmitted 
from the photoreceptors to bipolar cells in the INL and to ganglion cells in the GCL. Synaptic contacts 
are made in the outer (photoreceptors and bipolar/horizontal cells) and inner plexiform layer (bipolar 
and ganglion/amacrine cells). The axons of ganglion cells form the optic nerve and transmit 
information to the visual centers in the brain (Purves 2012, Reid et al. 2013). 
Horizontal cells establish lateral connections between photoreceptors and modulate the input to 
bipolar cells, while amacrine cells mediate lateral inhibition by interacting with bipolar and ganglion 
cells. Additionally, the retina has three glial cell types that support and protect retinal neurons: 
astrocytes, microglia and Müller cells. Astrocytes play important roles in neurovascular coupling and 
during development of the retinal vasculature (see 1.2.3; 1.3.1; (Kur et al. 2012)). Microglia cells are 
active sensors of the retinal microenvironment and are involved in immune defense (reviewed in 
(Karlstetter et al. 2015)). The main glial cells of the retina, Müller cells, provide metabolic support 
and protection of retinal neurons. Müller cell nuclei are located in the INL and their radial processes 
span the entire retina to mediate structural stabilization (Lewis et al. 1995, Reichenbach et al. 2013). 
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Figure 1. Structure of the eye and anatomy of the retina. (A) Diagram of the human eye. The retina forms 
the innermost layer, adjacent to the RPE. Enlarged box shows the central region of the macula called fovea, 
which has the highest visual acuity compared to other parts of the retina and is characteristic for humans and 
higher primates (i.e. haplorhines (Kirk et al. 2004)). (B) The different cell types of the retina are organized into 
three layers: ONL, INL and GCL. (C) Morphological section of the mouse retina. RPE: retinal pigment 
epithelium, OS: outer segments, IS: inner segments, ONL: outer nuclear layer, INL: inner nuclear layer, GCL: 
ganglion cell layer. Scale bar: 50 μm. Images in (A) and (B) adapted from (Dyer et al. 2001, Sung et al. 2010). 
The retinal pigment epithelium (RPE) is a monolayer of cells located at the back of the eye between 
the photoreceptors and the choroidal blood vessels (see 1.2.1). The RPE fulfills diverse tasks to 
support photoreceptors and maintain visual function. For example, the RPE is essential for the 
regeneration of the visual chromophore 11-cis retinal, a photosensitive derivative of vitamin A 
(see 1.1.4). Beside its critical role in the visual cycle, the RPE ingests shed membrane disks of 
photoreceptors by circadian-regulated phagocytosis. This process called disk shedding is crucial for 
photoreceptor function, since outer segments have a limited life span and therefore require a 
constant renewal process. Additionally, the RPE establishes the outer blood-retinal barrier (BRB) 
through tight junctions between RPE cells, prevents reflection of light by absorbing scattered light 
through dark melanin granules and is involved in epithelial transport, spatial ion buffering, secretion 
and immune modulation (reviewed in (Strauss 2005)). 
Interestingly, the vertebrate retina has an inverted design: light passes through all retinal layers 
before being captured by the photopigments in the photoreceptor outer segments. Although this 
seems counterintuitive, the chromophore provided by the RPE as well as the high oxygen and 
nutrient demand of the photoreceptors (see following sections) explain the need for close proximity 
to the choriocapillaris and the RPE (Kolb 2003).  
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1.1.2 Photoreceptors: rods and cones  
The retina has two types of photoreceptors: rods and cones. Although they differ in size and shape, 
both have similar structures: outer segments with membrane disks containing light-sensitive 
photopigments, mitochondria-rich inner segments and cell bodies with synaptic terminals (Figure 
2A). Photopigments consist of the visual chromophore 11-cis retinal and opsin, a protein component 
that determines the wavelength sensitivity. The visual pigment of rods, rhodopsin, has a peak 
sensitivity at ~500 nm (Berg et al. 2002). Opsin is synthetized in the rod inner segment, transported 
to the outer segment via vesicles and finally inserted into membranes of the rod outer segment 
(Papermaster et al. 1985). Several rods can contact the same rod bipolar cell. Consequently, the 
rod circuitry is highly convergent, but has a low spatial resolution. Due to this convergence, the rod 
system is specialized for sensitivity: a single photon of light may induce a functional response (Baylor 
et al. 1979). 
 
Figure 2. Two photoreceptor types: rods and cones. (A) Illustration of rod and cone structure including 
functions connected to different photoreceptor compartments. OS: outer segments, IS: inner segments, CB: 
cell body, Syn: synaptic terminals. (B) Distribution of cone photoreceptors in the human and mouse retina.  
S-, M- and L-opsin expressing cones in the human retina are organized in a mosaic-like pattern, whereas in 
mice the two cone types (S- and M-cones) are distributed along a dorso-ventral gradient. (C) Densities of rod 
and cone photoreceptors in the human retina. Cone density is highest in the fovea. Adapted from (Mustafi et 
al. 2009, Swaroop et al. 2010).  
Whereas the highly light-sensitive rods function under dim light-conditions and allow night vision, 
cones mediate color perception and central, fine acuity vision. Even though rods outnumber cones 
by a ratio of 97:3, our vision largely depends on the cone system (Carter-Dawson et al. 1979, 
Swaroop et al. 2009). In the human retina, three different cone types expressing either S-, M- and 
L-opsin (peak sensitivity to short (blue), medium (green) and long (red) wavelength light, 
respectively), are arranged in a mosaic-like pattern (Roorda et al. 1999) (Figure 2B). In mice, S- and 
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M-opsin expressing cones are distributed along a dorso-ventral gradient and L-opsin cones are 
completely absent (Szel et al. 1992, Swaroop et al. 2010). In contrast to other animals like mice, 
humans and other higher primates (i.e. haplorhines (Kirk et al. 2004)) have a specialized central 
region called macula (Figure 2C). The central part of the macula, the fovea, primarily consists of 
cones and each cone is connected to only one bipolar and one ganglion cell. Thus, the cone system 
is far less convergent compared to rods and allows high-resolution vision, however at the expense 
of sensitivity (Sung et al. 2010, Purves 2012). 
1.1.3 Phototransduction 
The process by which photoreceptors absorb and convert light into electrical signals is called 
phototransduction. Typically, neurons respond to stimuli by depolarization of the cell membrane, 
leading to an action potential and release of neurotransmitters. In the retina, however, photon 
absorption by photopigments leads to hyperpolarization of photoreceptors, whereas dark-adapted 
photoreceptors are depolarized and have increased neurotransmitter release (Purves 2012). In the 
dark, cyclic guanosine monophosphate (cGMP) concentration is high and cGMP-gated ion channels 
are open, allowing sodium and calcium to enter the outer segment (Figure 3). Thereby the cell is 
depolarized and the neurotransmitter glutamate is released. In response to light, 11-cis retinal 
isomerizes to all-trans retinal. This activates the heterotrimeric G protein transducin, which is 
composed of α-, β-, and γ-subunits. On the α-subunit of transducin, guanosine diphosphate (GDP) 
is exchanged for guanosine triphosphate (GTP). As a consequence, the α-subunit dissociates and 
activates a phosphodiesterase (PDE) that hydrolyzes cGMP. Lower cytoplasmic concentration of 
cGMP leads to closure of cGMP-gated cation channels on the plasma membrane. Hence, 
photoreceptors hyperpolarize and release less of their neurotransmitter glutamate upon light 
stimulation (Arshavsky et al. 2002, Sung et al. 2010, Reid et al. 2013).  
An important feature of phototransduction is the high degree of signal amplification, which is 
achieved on three levels: (1) conformational change of 11-cis to all-trans retinal activates many 
transducins; (2) every activated PDE subunit hydrolyzes many cGMP molecules; (3) numerous 
channels close in response to lower cGMP concentration (Burns et al. 2001).  
Glutamate is the brain’s major excitatory amino acid neurotransmitter (Deutch 2013). In the retina, 
however, glutamate released by photoreceptors elicits opposite responses on the two types of 
bipolar cells known as ON and OFF bipolar cells. While glutamate is inhibitory for ON bipolar cells 
which express a G protein-coupled metabotropic glutamate receptor (mGluR6), it has excitatory 
effects on OFF bipolar cells which express ionotropic receptors (kainate and α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA)). The mammalian retina consists of at least 13 types of 
cone bipolar cells and one type of rod bipolar cell (Ghosh et al. 2004, Wassle et al. 2009, 
Helmstaedter et al. 2013). Rod photoreceptors make connections with the ON rod bipolar cell only. 
In contrast, cone photoreceptors synapse with various types of ON and OFF cone bipolar cells 
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(reviewed in (Euler et al. 2014)). Signals are then further transmitted to either ON or OFF retinal 
ganglion cells and to the visual centers in the brain. ON and OFF pathways are important in terms 
of luminance contrast and light adaptation (Kuffler 1953, Reid et al. 2013).  
 
Figure 3. Phototransduction in vertebrate photoreceptors. (A) In darkness, open cGMP-gated ion 
channels lead to photoreceptor depolarization and release of the neurotransmitter glutamate. (B) Upon 
stimulation by light, 11-cis retinal changes its conformation to all-trans retinal. Transducin activates PDE, which 
lowers cGMP concentration and thereby leads to closure of cGMP-gated ion channels. Consequently, 
photoreceptors hyperpolarize and discontinue the release of glutamate. OS: outer segments, T: transducin, 
PDE: phosphodiesterase, cGMP: cyclic guanosine monophosphate, IS: inner segments, Glu: glutamate. 
From (Klapper et al. 2016). 
Importantly, the proteins of the phototransduction cascade need to be returned to their inactivated 
state after light stimulation. Rhodopsin kinase (G protein-coupled receptor kinase 1, GRK1) 
phosphorylates activated rhodopsin and allows binding of arrestin, which blocks the interaction with 
transducin (Wilden et al. 1986, Kuhn et al. 1987). Guanylate cyclase, whose activity is regulated by 
Ca2+-mediated inhibition, restores cGMP-levels and thereby permits reopening of cation channels 
(Kawamura et al. 1989). 
1.1.4 The visual cycle 
After intense stimulation, it can take around ten minutes until the visual sensitivity returns to baseline 
levels (Lamb et al. 2004). A significant amount of visual pigment is “bleached” and needs to be 
regenerated. The chromophore is recycled through a series of enzymatic steps called the visual 
cycle (Figure 4) (Baehr et al. 2003). First, all-trans retinal is transported from the intradiscal space 
to the cytosol of the rod outer segment, facilitated by ATP-binding cassette transporter 4 (ABCA4, 
also known as ATP-binding cassette transporter Retina (ABCR)). After modification from all-trans 
retinal to all-trans retinol by all-trans retinol dehydrogenase, it is removed from the photoreceptor 
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outer segments and transported to the RPE via the chaperone protein interphotoreceptor retinol 
binding protein (IRBP) (Strauss 2005). In the RPE, it binds to cellular retinol binding protein (CRBP) 
and is then esterified by lecithin retinol acyltransferase (LRAT) to all-trans retinyl ester. 
Subsequently, RPE65 (RPE-specific 65kDa protein) uses all-trans retinyl ester as a substrate to form 
11-cis retinol (Redmond et al. 1998). 11-cis retinol dehydrogenase oxidizes 11-cis retinol to 11-cis 
retinal, which is supported by cellular retinaldehyde-binding protein (CRALBP). Subsequently, 11-cis 
retinal is transported back to photoreceptor outer segments, where it recombines with rod opsin 
(reviewed in (Strauss 2005, von Lintig et al. 2010, Kiser et al. 2014)).  
In contrast to rods in which trans-cis isomerization of the chromophore takes place in the RPE, 
evidence suggests that cones additionally use a faster Müller cell-dependent alternative pathway for 
recycling of the chromophore (Mata et al. 2002, Schonthaler et al. 2007, Wang et al. 2011). 
 
Figure 4. The visual cycle in rod photoreceptors and retinal diseases associated with mutations in key 
enzymes. Light stimulation converts 11-cis retinal to all-trans retinal and all-trans retinol in the photoreceptor 
outer segments. All-trans retinol is transported to the RPE, where it is converted to 11-cis retinal. After being 
transported back to the photoreceptor outer segments, it binds to rhodopsin. Several retinal diseases have 
been associated with mutations in visual cycle components (blue boxes). 11-cis-Rol: 11-cis retinol, 11-cis-Ral: 
11-cis retinal, at-Ral: all-trans retinal, at-Rol: all-trans retinol, ABCR: ATP-binding cassette transporter Retina 
(also known as ABCA4), AMD: age-related macular degeneration, CSNB: congenital stationary night 
blindness, IPM: interphotoreceptor matrix, IRBP: interphotoreceptor retinol binding protein, LCA: Leber 
congenital amaurosis, LRAT: lecithin retinol acyltransferase, RDH: retinal dehydrogenase, ROS: rod outer 
segment, RP: retinitis pigmentosa, RPE: retinal pigment epithelium, RPE65: RPE-specific 65kDa protein. From 
(Kiser et al. 2012).  
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Mutations in visual cycle components may impair the regeneration of the visual chromophore and 
thus affect vision (reviewed in (Travis et al. 2007)). Several retinal disorders have been associated 
with mutations in key enzymes (indicated in Figure 4, blue boxes), such as Leber congenital 
amaurosis, age-related macular degeneration, congenital stationary night blindness, retinitis 
pigmentosa and Stargardt’s disease. As outlined above, the isomerohydrolase RPE65 plays a key 
role in the regeneration of 11-cis retinal and is essential for rod and cone function (Redmond et al. 
1998, Moiseyev et al. 2005, Wenzel et al. 2007). Mutations in human RPE65 lead to severe retinal 
dysfunction and blindness, accounting for a significant percentage (11.4%) of early-onset retinal 
degenerations. Various diagnostic designations are used for patients suffering from RPE65-
associated mutations, such as Leber congenital amaurosis type 2, early severe retinitis pigmentosa, 
autosomal recessive retinal dystrophy and early-onset severe retinal dystrophy (Thompson et al. 
2000).  
1.2 Oxygen Homeostasis in the Retina 
As one of the most metabolically active tissues in the body, the retina – and especially the high-
energy demanding photoreceptors – require appropriate oxygen levels to generate ATP (Niven et 
al. 2008, Okawa et al. 2008). In general, cells produce energy by oxidative phosphorylation in 
mitochondria and glycolysis in the cytosol, providing about 30 or 2 molecules of ATP per molecule 
glucose, respectively (Alberts et al. 2002). Whereas glutamate neurotransmission in the retina is 
mainly supported by glycolysis, phototransduction depends on oxidative metabolism (Ames et al. 
1992, Xu et al. 2007).  
1.2.1 Retinal vasculature 
To ensure appropriate oxygen levels for normal retinal function, oxygen is delivered by two vascular 
systems: the retinal vasculature nourishes the inner retina and the choroidal vasculature at the 
basolateral side of the RPE supplies photoreceptors in the outer retina (Figure 5). Besides the 
different functions, the systems also differ in their properties. While the retinal vasculature has barrier 
properties and is part of the inner blood-retinal barrier, the choroidal vasculature has fenestrated 
capillaries (Saint-Geniez et al. 2004). Additionally, blood flow in the retinal vasculature is auto-
regulated through the release of vasoactive substances in response to changes in oxygen levels 
(reviewed in (Pournaras et al. 2008)). The mature retinal vasculature consists of three vascular plexi: 
the superficial primary plexus spreads in the nerve fiber layer across the inner surface of the retina. 
The two other plexi – the intermediate and the deep plexus – are located in the inner and the outer 
plexiform layer where neuronal synaptic connections are made.  
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Figure 5. The vascular network in the mouse retina. (A) Schematic illustration of the three vascular plexi. 
The primary (blue), intermediate (green) and deep plexus (red) of the retinal vasculature. The choroidal 
vasculature (brown) is located at the basolateral side of the RPE. Ch: choroid, RPE: retinal pigment epithelium, 
OS: outer segments, IS: inner segments, ONL: outer nuclear layer, OPL: outer plexiform layer, INL: inner 
nuclear layer, IPL: inner plexiform layer, GCL: ganglion cell layer, NFL: nerve fiber layer (from (Caprara et al. 
2012)). (B) Immunostaining of vessels stained with isolectin IB4 on a retinal flat mount showing the superficial 
primary plexus (BPCre;R91W;Nrl-/-;Vhlf/f;Hif1af/f mouse, see section results). Scale bar: 1 mm.  
1.2.2 Hypoxia-inducible factors 
The retina is highly vulnerable to any disturbances in oxygen saturation (Ames et al. 1992, Arjamaa 
et al. 2009). In response to reduced oxygen levels (hypoxia), regulatory systems in the body are 
activated, with hypoxia inducible factors (HIFs) playing a central role. In the retina, hypoxic conditions 
may occur due to different reasons (see following chapters: 1.2.3, 1.2.5). 
HIF proteins are composed of an oxygen-labile α-subunit (HIFA) and a constitutively expressed β-
subunit (aryl hydrocarbon receptor nuclear translocator (ARNT), alias HIF1B) (Wang et al. 2011). 
Each subunit contains a basic-helix-loop-helix (bHLH) and a Per/ARNT/Sim (PAS) domain (Wang 
et al. 1995) that mediate heterodimerization and DNA binding (Semenza 2004). Three structurally 
homologous α-chains were identified (Figure 6A): HIF1A (Semenza et al. 1992, Wang et al. 1995), 
HIF2A (alias, endothelial PAS domain protein 1 (EPAS1), (Ema et al. 1997, Flamme et al. 1997, 
Tian et al. 1997)) and HIF3A (Gu et al. 1998, Heidbreder et al. 2003).  
In contrast to HIF1A that is ubiquitously expressed, HIF2A expression is more restricted. Hypoxic 
induction of HIF2A has been observed in brain, heart, lung, kidney, liver, pancreas, and intestine 
(Wiesener et al. 2003). While HIF1A and HIF2A have been studied extensively, the role of HIF3A is 
less well understood. Possibly, HIF3 modulates the hypoxic response by acting as a negative 
regulator of HIF1A function (Makino et al. 2001).  
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Both HIF1A and HIF2A can form a functional transcriptional complex with ARNT (HIF1B) (Tian et al. 
1997). Three isoforms of HIF-β chains are known: ARNT (alias HIF1B), ARNT2, ARNT-like (ARNTL) 
(Hirose et al. 1996, Ikeda et al. 1997, Hogenesch et al. 1998, Hogenesch et al. 2000). Although they 
share homologous structures, not all isoforms promote responses to hypoxia. ARNT2 shares 
overlapping functions with ARNT (HIF1B) but is primarily involved in neural development (Keith et 
al. 2001). ARNTL, also known as brain and muscle ARNT-like protein 1 (BMAL1) (Ikeda et al. 1997), 
is an important regulator of circadian rhythm (Reppert et al. 2001).  
 
Figure 6. HIF isoforms and HIF pathway. (A) Illustration of the three HIFA subunits and HIF1B (alias, ARNT) 
structure. Specific domains on HIF1A, HIF2A and HIF3A mediate DNA binding, specificity and dimerization 
with HIF1B (bHLH/PAS), protein stability (ODDD/N-TAD), transcriptional activity (N-TAD/C-TAD) and nuclear 
localization (NLS). HIF1B lacks an ODDD and is thus not oxygen-dependently regulated. NLS: nuclear 
localization signal, bHLH: basic-helix-loop-helix, PAS: Per-ARNT-Sim motif, ODDD: oxygen-dependent 
degradation domain, N-TAD: N-terminal transactivation domain, C-TAD: C-terminal transactivation domain. 
(B) Under normoxic conditions, PHDs use oxygen to hydroxylate HIF1A on proline residues (Pro402 and 
Pro564). Subsequently, pVHL binds to HIF1A and recruits an ubiquitin E3 ligase. Consequently, HIF1A is 
degraded via the proteosomal pathway. Under hypoxic conditions, however, hydroxylation does not occur. 
HIF1A accumulates and enters the nucleus, where it dimerizes with HIF1B, interacts with co-activators 
Cbp/p300 and drives the transcription of target genes. PHD: prolyl hydroxylase, HIF-1α: hypoxia-inducible 
factor 1α, HIF-1β: hypoxia-inducible factor 1β (alias, ARNT), pVHL: von Hippel Lindau protein, HRE: hypoxia 
response element, VEGF: vascular endothelial growth factor. From (Krock et al. 2011, Maes et al. 2012). 
Under normal oxygen levels (normoxia), HIFA is hydroxylated on proline residues (402 and 564 for 
HIF1A, 405 and 531 for HIF2A) by prolyl hydroxylases (PHDs). Three PHDs were identified in 
mammalian cells: PHD1, PHD2, PHD3 (Epstein et al. 2001). They contain Fe(II) in their active site 
and require 2-oxoglutarate (α-ketoglutarate) as a substrate as well as ascorbate as a cofactor. 
Proline hydroxylation promotes the interaction with the von-Hippel-Lindau (VHL) ubiquitin E3 ligase 
complex (Figure 6B), which leads to ubiquitination and degradation via the proteosomal pathway. 
Oxygen is rate-limiting for the enzymatic activity of hydroxylases. Thus, under conditions of reduced 
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oxygen availability (hypoxia), HIFA is less hydroxylated. Hence, HIFA proteins accumulate and enter 
the nucleus (Semenza 2004, Patel et al. 2008, Webb et al. 2009, Semenza 2011). 
After translocation into the nucleus, HIF1A or HIF2A proteins dimerize with HIF1B and recruit co-
activators, such as p300/CBP (CREB(cAMP-response element-binding protein)-binding protein) in 
the case of HIF1A (Arany et al. 1996, Semenza 2004). Other co-activators for HIF1A and HIF2A are 
summarized in (Loboda et al. 2010). Regulation of the interaction of HIFA with the co-activators 
p300/CBP is mediated by a second oxygen-sensitive hydroxylation event. Under normoxic 
conditions, factor inhibiting HIF1 (FIH) hydroxylates HIFA at an asparagine residue in the C-terminal 
transactivation domain (C-TAD) (Asn-803 for human HIF1A, Asn-851 for human HIF2A) and 
prevents the interaction with p300/CBP (Arany et al. 1996, Mahon et al. 2001, Lando et al. 2002, 
McNeill et al. 2002, Schofield et al. 2004). Under hypoxic conditions, however, hydroxylation is 
diminished. Consequently, HIF dimers and co-activators bind to hypoxia response elements (HREs) 
on HIF target gene promoters and drive the transcription of a multitude of target genes involved in 
angiogenesis, cell metabolism, survival, cytoskeletal structure and apoptosis (Semenza 2004).  
HIF1A and HIF2A have both shared and unique transcriptional target genes: under hypoxia, HIF1A 
and HIF2A both stimulate expression of for example glucose transporter 1 (Glut1), adrenomedullin 
(Adm) and vascular endothelial growth factor (Vegf) (Hu et al. 2003). Glycolytic enzymes (such as 
lactate dehydrogenase A (Ldha)) and BCL2/adenovirus E1B interacting protein 3 (Bnip3) are 
targeted by HIF1A and erythropoietin (Epo) has been shown to be a HIF2A-target (Hu et al. 2003, 
Warnecke et al. 2004). HIF2A-target genes are more restricted and little is known about its targets 
in the retina. However, several candidate genes such as HtrA serine peptidase 1 (Htra1), tissue 
inhibitor of metallopreinase 3 (Timp3) and heme oxygenase (decycling) 1 (Hmox1) have been 
suggested to be HIF2A-regulated in rod photoreceptors (Kast et al. 2016).  
1.2.3 Hypoxia during development of the retinal vasculature 
During retinal development, photoreceptors are functional before the retinal vasculature has 
completely been formed (Graymore et al. 1959). Therefore, it has been proposed that the retina 
suffers from ‘physiological hypoxia’ which stimulates retinal angiogenesis (Chan-Ling et al. 1995).  
Initially, an arterial network in the vitreous called hyaloid vasculature provides blood supply from the 
central hyaloid artery in the optic nerve to the retina and lens during early development (Saint-Geniez 
et al. 2004). The hyaloid vasculature usually regresses before or around birth, depending on the 
species. It is replaced by the retinal vasculature, which contains both arteries and veins (Fruttiger 
2007). In the mouse retina, the primary plexus develops along a gradient from the center to the 
periphery and reaches the periphery at around postnatal day (PND) 8. At the same time, vessels 
start sprouting and penetrate the retina. They turn laterally when they reach the inner and outer 
boundary of the INL to first form the deep and consequently the intermediate plexus (Fruttiger 2007). 
The deep plexus in the retinal periphery is generated at around PND12, followed by the intermediate 
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plexus between PND12 and 15. By the end of the third postnatal week, all vascular plexi are fully 
mature (Stahl et al. 2010).  
Hypoxia induces expression of Vegf, a potent angiogenic factor (Shweiki et al. 1992, Carmeliet 
2003). It has been suggested that hypoxia-induced Vegf expression by astrocytes in the GCL 
regulates the formation of the primary plexus (Stone et al. 1995). Additionally, transient Vegf 
expression in the INL precedes the formation of the deep plexus (Stone et al. 1995). However, the 
study by Weidemann et al. shows that astrocyte-derived VEGF is not essential for primary plexus 
development (Weidemann et al. 2010). Although the role of VEGF (and other angiogenic factors) in 
formation of the primary plexus still needs to be clarified, the hypoxic response clearly plays a central 
role in retinal angiogenesis. Inactivation of Vhl in the retinal periphery during development leads to 
vessel growth into the ONL (Kurihara et al. 2010, Lange et al. 2011). Additionally, knockdown of 
Hif1a in the retinal periphery prevents the formation of the intermediate plexus (Caprara et al. 2011). 
Therefore, neurovascular crosstalk and a tight regulation of angiogenic factors such as VEGF 
(Okabe et al. 2014) seems to be essential to direct and guide appropriate retinal vascularization.  
1.2.4 Hypoxia and retinal protection: hypoxic preconditioning 
Besides being an important regulator of vascular development, hypoxia has also distinct roles in the 
adult retina. A period of acute hypoxia (6 hours) induces pro-survival factors and protects 
photoreceptors against light-induced degeneration in mice (Grimm et al. 2002). Additionally, hypoxic 
preconditioning has been shown to be protective in models for retinal ischemia (Whitlock et al. 2005, 
Zhu et al. 2007) and glaucoma (Zhu et al. 2013). Erythropoietin, an oxygen- and HIF2-regulated 
protein that stimulates the production of red blood cells, has been suggested as candidate factor 
mediating photoreceptor survival (Grimm et al. 2002). Interestingly, the protective response is neither 
HIF1- nor HIF2-dependent: rods lacking HIF1A, HIF2A or both factors are still protected against light-
induced damage (Thiersch et al. 2009, Kast et al. 2016). Identification of the molecular mechanisms 
that activate these protective signaling events might further help in understanding neuroprotective 
pathways in the retina and other tissues. 
1.2.5 Hypoxia and retinal diseases 
In contrast to acute hypoxia that supports photoreceptor survival, long-term (chronic) hypoxia during 
aging may contribute to disease development. Photoreceptors receive their oxygen largely from the 
choroidal vasculature (see 1.2.1). During aging, reduced choroidal blood flow (Dallinger et al. 1998, 
Lam et al. 2003) and accumulation of extracellular deposits known as drusen (Grunwald et al. 2005) 
may impair oxygen supply to photoreceptors. Consequently, photoreceptors in the old human retina 
may suffer from reduced oxygen availability. Accumulating evidence proposes that chronic hypoxia 
may contribute to development and progression of degenerative diseases such as age-related 
macular degeneration (AMD). Choroidal ischemia in dry AMD (Ciulla et al. 1999, Coleman et al. 
2013) suggests reduced oxygen transport from the choroid to the inner retina (Kim et al. 2013). 
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Decreased choroidal blood volume in AMD as well as the correlation of drusen density and 
decreased choroidal blood flow (Berenberg et al. 2012) support the hypothesis that hypoxia might 
play an important role in retinal pathologies by affecting hypoxic target genes involved in lipid 
handling, energy metabolism and cell survival. 
Additionally, reduced tissue oxygenation may trigger neovascularization. As outlined above (see 
1.2.3), hypoxic target genes modulate retinal angiogenesis. Increased concentration of VEGF 
stimulates vessel growth along the inner retinal surface and/or into the vitreous in retinal neovascular 
diseases, such as diabetic retinopathy (see 1.3.1), central retinal vein occlusion and retinopathy of 
prematurity (Aiello et al. 1994, Lashkari et al. 2000). Similarly, elevated VEGF levels cause 
pathological vessel growth from the choroid to the subretinal space in choroidal neovascular 
diseases (see 1.3.2). Hypoxia-related mechanisms may therefore be relevant for numerous retinal 
diseases in humans. 
1.3 Macular Degenerations and Therapies 
Loss of vision dramatically affects the patient’s quality of life and represents a major burden for health 
and social systems (Chakravarthy et al. 2017). Global causes for blindness are cataract (i.e. clouding 
of the lens), glaucoma (i.e. vision loss due to damage to the optic nerve), age-related macular 
degeneration (AMD), corneal opacities, childhood blindness (a group of diseases occurring in 
childhood which, if left untreated, result in blindness), uncorrected refractive errors, trachoma (a 
bacterial infection) and diabetic retinopathy (DR) (Pascolini et al. 2012). Most of these causes, 
except AMD, are at least partially preventable or treatable, although access to care still strongly 
limits treatment in developing countries. In industrialized countries, AMD and other age-related 
diseases will become even more important with the increasing life expectancy of our population. 
With regard to the main projects of this thesis, I will briefly address DR and discuss AMD in more 
detail, since AMD is a major research focus in our lab. 
1.3.1 Diabetic retinopathy (DR) 
Chronically high blood sugar in patients suffering from diabetes may damage retinal blood vessels 
and lead to visual impairment known as DR. During disease progression, microaneurysms may leak 
blood into the retina and swelling of the retina known as macular edema may occur. As the disease 
progresses, dysfunctional blood vessels may cause vessel growth along the inner retina and into the 
vitreous. DR is separated into early, non-proliferative and proliferative DR. In contrast to non-
proliferative DR, a hallmark of proliferative DR is neovascularization. Additionally, in advanced 
stages retinal detachment may affect visual acuity (reviewed in (Cheung et al. 2010, Antonetti et al. 
2012); Figure 7). 
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Although improvements in glycemic control reduced the prevalence and incidence of DR (Klein et 
al. 2010), DR still affects up to 20% of patients after 30 years of disease, despite intensive insulin 
therapy (Nathan et al. 2009).  
 
Figure 7. Diabetic Retinopathy: Clinical features and macular edema. (A) Proliferative DR with macular 
edema in a 57-year-old patient. AN: arteriolar narrowing, NFH: nerve-fiber hemorrhage, HE: hard exudates, 
CWS: cotton-wool spots, VB: venous beading, PRH: preretinal hemorrhage. (B) An optical coherence 
tomography (OCT) scan through the central fovea (marked with horizontal line in A) shows thickening and 
macular edema. C: cysts, SRF: subretinal fluid. Reproduced with permission from (Antonetti et al. 2012), 
Copyright Massachusetts Medical Society.  
As outlined above, the molecular pathophysiology of DR is associated with a dysfunctional blood 
vessels and impaired BRB. VEGF-targeting therapies provide benefit for DR patients (Michaelides 
et al. 2010, Nguyen et al. 2010, Sultan et al. 2011), underlining a role for VEGF in vascular 
permeability and disease pathology. Several mouse models support the suggested key role of the 
neurovascular unit (i.e. neurons, glia cells and vasculature, Figure 8) in DR pathology. Loss of 
pericytes caused by platelet-derived growth factor (PDGF) ablation may cause retinopathy and 
mimics DR in mice (Enge et al. 2002). Additionally, inflammation including activation of microglial 
cells (Zeng et al. 2008) and increased levels of interleukin-1β and TNF-α (Schram et al. 2003, 
Demircan et al. 2006) contribute to disease development and progression. Further research focusing 
on the molecular changes may assist in understanding and treating DR pathology.  
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Figure 8. Dysfunction of the neurovascular unit in DR. (A) Neurovascular unit of the retina with pericytes, 
astrocytes and microglial cells. (B) In DR, increased levels of VEGF and inflammatory cytokines as well as the 
loss of PDGF signaling in pericytes impair the BRB and stimulate angiogenesis. PDGF: platelet-derived growth 
factor. Reproduced with permission from (Antonetti et al. 2012), Copyright Massachusetts Medical Society. 
1.3.2 Age-related macular degeneration (AMD) 
AMD is a highly prevalent blinding disease and a leading cause of visual impairment in the elderly 
population in industrialized nations (Klein et al. 1999, Buch et al. 2004, Wong et al. 2014). Due to 
the degeneration of photoreceptors and RPE in the macular region, patients lose the ability for 
central, high acuity vision (Green 1999, Swaroop et al. 2009). AMD is a multifactorial disease and 
numerous risk factors have been identified. Major genetic contributors include complement pathway 
genes (complement factor H (CFH) (Edwards et al. 2005, Hageman et al. 2005, Haines et al. 2005, 
Klein et al. 2005), complement 3 (C3) (Yates et al. 2007), complement factor B (CFB), complement 
component 2 (C2) (Gold et al. 2006)) and other genes such as age-related maculopathy 
susceptibility 2/HtrA serine peptidase 1 (ARMS2/HTRA1) (Rivera et al. 2005, Dewan et al. 2006). 
Additionally, many other candidate genes such as tissue inhibitor of metalloproteinase 3 (TIMP3) 
(Chen et al. 2010, Vierkotten et al. 2011, Ardeljan et al. 2013, Fritsche et al. 2016) and SLC16A8 
(Fritsche et al. 2016) have been related to AMD (Figure 9).  
Besides genetic factors, numerous environmental risk factors have been reported. Elevated risk of 
AMD is associated with increasing age, cigarette smoking, cardiovascular disease, hypertension and 
obesity (Chakravarthy et al. 2010).  
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Figure 9. Genome-wide single variant association analysis in advanced AMD patients. Shown are novel 
(green) and known (blue) AMD loci. From (Fritsche et al. 2016).  
Clinically, AMD is separated into early, intermediate and late AMD based on fundus inspection 
(Figure 10). Late AMD can further be divided into dry and neovascular (wet) AMD. Although the dry 
form of AMD is more frequent, neovascular AMD is responsible for the vast majority of cases of 
severe visual loss or blindness (Ferris et al. 1984, Ferris et al. 2013).  
Apart from drusen (i.e. deposits between the basal lamina of the RPE and the Bruch’s membrane), 
a hallmark of dry AMD is geographic atrophy, i.e. the cell death of photoreceptors and RPE within 
the macular region (Sarks 1976, Bird et al. 1995, Green 1999, Lim et al. 2012). Although drusen are 
part of the normal aging process (Sarks et al. 1999), excess amount and size of drusen may interfere 
with the functional photoreceptor/RPE unit. Similar to drusen, autofluorescent lipid and protein 
aggregates known as lipofuscin granules accumulate with increasing age in the RPE (Wing et al. 
1978, Kennedy et al. 1995). Lipofuscin granules represent non-degraded debris from phagocytosed 
photoreceptor disks. A2E, a component of lipofuscin (Eldred 1995), inhibits the ATP-driven proton 
pump in lysosomes, leads to lysosomal dysfunction and thereby contributes to AMD pathogenesis 
(Bergmann et al. 2004). Thickness of the Bruch’s membrane increases with age (Hogan et al. 1967, 
Ramrattan et al. 1994), which may affect fluid/nutrient transport (Starita et al. 1996) and initiate cell 
death of adjacent cells due to inappropriate cell adhesion known as anoikis (Gilmore 2005). As a 
consequence of the above mentioned factors, tissue hypoxia may occur, which has been implicated 
in the etiology of AMD (see 1.2.5 and (Remsch et al. 2000, Arjamaa et al. 2009, Sheridan et al. 2009, 
Boltz et al. 2010, Stefánsson et al. 2011, Kent 2014)). 
In contrast to retinal neovascularization in DR where vessels grow along the inner retinal surface, 
new blood vessels in neovascular AMD grow from the choroid, penetrate the Bruch’s membrane and 
extend into the subretinal space (Bressler et al. 1988, Spaide 2013). This process is known as 
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choroidal neovascularization (CNV). Retinal angiomatous proliferation (RAP), also known as deep 
retinal vascular anomalous complexes, represents an additional, distinct form of neovascular AMD 
(Yannuzzi et al. 2001). In contrast to the typical choroidal neovascular form of AMD, pathological 
vessels observed in RAP originate from the deep retinal plexus in the inner retina and extend into 
the photoreceptor layer and subretinal space (Hartnett et al. 1996, Yannuzzi et al. 2008). RAP 
accounts for 15-20% of neovascular AMD (Cohen et al. 2007, Massacesi et al. 2008). 
 
Figure 10. Fundus images and histology of different stages of AMD. Early AMD (A) with medium size 
drusen (arrows) and intermediate AMD (B) with large drusen (arrows) are shown. In advanced dry AMD (C), 
geographic atrophy (white arrow) with loss of Bruch’s membrane (black arrow) is present. Advanced 
neovascular AMD (D) is characterized by subretinal hemorrhages (blue arrow) and choroidal 
neovascularization (white and black arrow). Shown are fundus (top) and histopathological images (middle) as 
well as a description of clinical features (bottom). Reproduced with permission from (Jager et al. 2008). 
Copyright Massachusetts Medical Society.  
1.3.3 Current treatment of AMD 
With an aging population, the number of people with age-related retinal diseases such as AMD is 
predicted to rise over the coming years. 196 million people are expected to suffer from AMD in 2020, 
increasing to 288 million in 2040 (Wong et al. 2014). These data highlight the urgent need for efficient 
therapeutic approaches. Current management of dry AMD includes cessation of smoking, 
maintenance of a healthy weight, regulation of blood pressure and antioxidant supplementation 
(vitamin C, E, beta-carotene, zinc oxide, cupric oxide). Such daily supplementation may reduce the 
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risk of progression from intermediate to advanced AMD (Age-Related Eye Disease Study Research 
2001, Jager et al. 2008). In contrast to dry AMD, neovascular AMD can be treated by intravitreal 
anti-VEGF therapies (e.g. pegabtanib (Macugen) (Gragoudas et al. 2004), ranibizumab (Lucentis) 
(Rosenfeld et al. 2006), aflibercept (Eylea, VEGF trap-eye) (Holash et al. 2002, Heier et al. 2012), 
bevacizumab (avastin, off-label use (Maguire et al. 2016)). Although frequent intraocular injections 
may slow disease progression of neovascular AMD, no cure is available until now. 
1.3.4 Stem cell therapy as a new therapeutic approach for degenerative diseases 
New fields of research emerge and include, among others, stem cell transplantation and gene 
therapy. In advanced stages of retinal degeneration, stem cell therapy can replace lost 
photoreceptors and RPE. Several studies are ongoing (reviewed in (Scholl et al. 2016)) and first 
human studies of human embryonic stem cell(hESC)-derived RPE demonstrated not only feasibility 
but also challenges and risks. Studies by Dr. Schwartz and colleagues reported long-term safety in 
nine patients suffering from dry AMD and nine patients suffering from Stargardt’s disease. In eight 
of 18 patients, visual acuity improved during the first year after surgery. Clearly, however, the low 
number of enrolled patients limits a conclusive interpretation of the results and subsequent clinical 
trials will be needed (Schwartz et al. 2015, Schwartz et al. 2016). Although no adverse events related 
to hESC-derived RPE cells were reported, some patients had adverse events due to surgical 
procedure and concomitant systemic immunosuppression (Schwartz et al. 2012, Schwartz et al. 
2015, Song et al. 2015, Schwartz et al. 2016). Rejection and ethical concerns on using cells derived 
from human embryos favor the use of induced pluripotent stem cells (iPSCs), which can be derived 
from differentiated adult cells (Takahashi et al. 2006) and make the use of concomitant 
immunosuppressive therapy unnecessary. The first human trial on iPSCs that included only one 
patient was suspended in 2015 due to regulatory changes in Japan (Garber 2015), although the 
treatment was reported to be safe (Mandai et al. 2017). In this study, iPSCs were generated from 
skin fibroblasts, differentiated into an RPE cell sheet and transplanted in a patient with wet AMD 
(Mandai et al. 2017). Research focuses now on a change of strategy by using partially matched 
(human leukocyte antigen (HLA)-matched) allogenic iPSC-derived RPE cells, which is expected to 
tremendously reduce the cost and increase the number of patients that could be treated with the 
same therapy (Garber 2015).  
1.3.5 Gene therapy for retinal disorders: adeno-associated viruses (AAV) 
Another major research interest is gene therapy. The non-pathogenic, helper-dependent adeno-
associated virus (AAV) has become the vector of choice in retinal gene therapy due to safety reasons 
and the availability of several serotypes conferring tropism to different tissues (Lisowski et al. 2015, 
Sengillo et al. 2016, Moore et al. 2017) and, most notably, different retinal cell types across species 
(Boye et al. 2013).  
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The wild-type AAV genome is about 4.7 kilobases long and consists of linear single-stranded DNA 
with two genes (replication (rep) and capsid (cap), Figure 11A) and two inverted terminal repeats 
(ITR) (Koczot et al. 1973). The four rep proteins (rep78, rep68, rep52, rep40) are required for the 
AAV life cycle and the three cap proteins (VP1, VP2, VP3) together assemble the icosahedral capsid. 
Upon binding to receptors on the outer cellular surface, the AAV enters the cell via endocytosis 
through clathrin-coated vesicles (reviewed in (Goncalves 2005, Kotterman et al. 2014, Samulski et 
al. 2014)).  
To produce recombinant AAV for research purposes, different plasmids are co-transfected into AAV 
packaging cells: i) a pAAV-transgene plasmid (the gene of interest flanked by ITRs), and ii) 
packaging constructs (i.e. a plasmid with rep/cap and a helper plasmid (Figure 11B) (Samulski et al. 
2014)). One of the most studied AAVs, AAV serotype 2, can be cross-packed into capsids of other 
serotypes (Rabinowitz et al. 2002). Capsid engineering can further increase flexibility and specificity 
of the AAV. It was discovered that phosphorylation of tyrosine residues on AAV capsids leads to 
ubiquitination and proteosomal degradation by the host cells (Zhong et al. 2008a, Zhong et al. 
2008b). This finding prompted the development of tyrosine-to-phenylalanine mutated AAV capsids 
to escape host defense and increase target gene expression (Zhong et al. 2008b). Additionally, 
further efficiency increase can be achieved by using self-complementary AAVs, which have two 
complementary parts that anneal after uncoating without the need of prior DNA synthesis (McCarty 
2008). 
AAVs can be delivered to the retina by subretinal or intravitreal injections (Figure 11C). While 
intravitreal injections are only minimally invasive, subretinal injections deliver the vector between the 
photoreceptors and the RPE and thereby create a temporary retinal detachment. Currently, 
subretinal delivery is the method of choice to target cells of the outer retina but AAV variants are 
being engineered that allow efficient transduction of the outer retina via intravitreal injections, e.g. 
AAVs with tyrosine-to-phenylalanine mutations (Zhong et al. 2008b, Petrs-Silva et al. 2011, Kay et 
al. 2013) or AAV2-7m8 with a 10-amino acid peptide insertion (Dalkara et al. 2013, Khabou et al. 
2016). 
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Figure 11. AAV biology and vector delivery routes. (A) The rep ORF encodes four non-structural proteins 
(rep78, rep68, rep52, rep40) needed for viral replication, transcriptional regulation, genome integration and 
virion assembly. The cap ORF encodes the structural proteins VP1, VP2 and VP3 and the assembly-activating 
protein (AAP, encoded by alternative ORF) that promotes capsid assembly (Sonntag et al. 2011). ORF: open 
reading frame. (B) rAAV production by triple-plasmid transfection. HEK293 cells (already expressing 
adenoviral genome fragments E1a/E1b) are co-transfected with a helper (pHelper, containing adenoviral 
helper genes E2A/E4/VA RNA), a rep/cap plasmid (pAAVrep2cap8) and the transgene plasmid (pAAV-
transgene). (C) Schematic illustration of subretinal and intravitreal injections in the primate eye. RPE: retinal 
pigment epithelium, RGC: retinal ganglion cells. Adapted from (Dalkara et al. 2014, Kotterman et al. 2014, 
Samulski et al. 2014). 
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Gene therapy to treat retinal disorders is a major research topic, especially since the famous 
experiments with RPE65-associated Leber congenital amaurosis, an inherited congenital retinal 
dystrophy resulting in early vision loss. In these studies, an AAV serotype 2 expressing human 
RPE65 was injected subretinally to prove safety and efficacy (Bainbridge et al. 2008, Cideciyan et 
al. 2008, Maguire et al. 2008). Subsequent clinical studies confirmed these findings (Cideciyan 2010, 
Jacobson et al. 2012, Testa et al. 2013, Bainbridge et al. 2015, Weleber et al. 2016) and phase 3 
(clinicaltrials.gov Identifier: NCT00999609) as well as phase 1 trials on optimized vectors are 
ongoing (NCT02781480).  
For neovascular AMD, one of the earliest clinical trials using intraocular gene therapy involved 
intravitreal delivery of anti-angiogenic pigment epithelium-derived factor (PEDF) (NCT00109499). 
The phase I trial was generally safe but due to the lack of a randomized control group, no conclusions 
could be made regarding efficiency (Campochiaro et al. 2006).  
Recent trials (NCT01024998, NCT01494805) used recombinant AAV2 expressing fms related 
tyrosine kinase 1 (sFLT1), a soluble form of VEGF receptor 1. sFLT1 is a potent antagonist of VEGF 
(Kendall et al. 1993) and it is important for photoreceptor avascular privilege (Luo et al. 2013). 
Studies in animals showed that AAV2-sFLT1 is well-tolerated and capable of long-term expression 
in cynomolgus monkeys (Maclachlan et al. 2011). In humans, both intravitreal (Heier et al. 2017) 
and subretinal (Rakoczy et al. 2015, Constable et al. 2016, Constable et al. 2017) delivery of AAV2-
sFLT1 seemed to be safe. However, the results did not meet expectations in vision improvement, 
as both the control and gene therapy groups performed poor in terms of visual acuity (Constable et 
al. 2016, Moore et al. 2017) compared to standard anti-VEGF trials (MARINA (Rosenfeld et al. 2006) 
and ANCHOR (Brown et al. 2009)). Heier and colleagues suggested that pre-existing antibodies 
against AAV2 before treatment start may limit therapeutical benefit of intravitreal delivered AAV2-
sFLT1 (Heier et al. 2017). However, more data to support this conclusion are needed. Recently, 
another anti-VEGF gene therapy approach has been initiated. This clinical trial uses an AAV8 vector 
expressing a monoclonal antibody fragment to bind and neutralize VEGF (NCT03066258).  
In contrast to AAVs which have a limited packaging capacity (4.7 kilobases), lentiviral vectors have 
a larger capacity of up to 10 kilobases (Kumar et al. 2001). However, while recombinant AAVs mostly 
persist extra-chromosomally as episomes, lentiviruses integrate into the host genome with the 
potential for insertional mutagenesis (Kotterman et al. 2015, Moore et al. 2017). The only clinical trial 
using lentiviral vectors for visual disorders (Carvalho et al. 2015), NCT01301443, uses the non-
primate-derived lentiviral Equine Infectious Anemia Virus (EIAV) vector (Mitrophanous et al. 1999, 
Wong et al. 2004) expressing endostatin and angiostatin (RetinoStat) to inhibit angiogenesis in 
advanced neovascular AMD. RetinoStat has been proven to be well-tolerated in non-human 
primates and rabbits (Binley et al. 2012). Although the clinical study demonstrated that subretinal 
injection of RetinoStat into humans is safe, data failed to prove a therapeutic benefit for the treatment 
of neovascular AMD (Campochiaro et al. 2017). 
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As outlined above, most AAV-based clinical trials have been initiated to treat neovascular AMD. For 
dry AMD, gene therapy is less advanced. Recently, a clinical trial using intravitreally delivered AAV2-
sCD59 (AAVCAGsCD59, NCT03144999) has started. AAV2-sCD59 is believed to cause retinal cells 
to increase expression of a soluble form of CD59, which should inhibit the formation of the membrane 
attack complex, the final step of complement-mediated cell lysis (Cashman et al. 2011).  
Future gene therapy approaches should consider combination therapies, use of improved vectors 
and targeting of broad antiangiogenic agents to further increase treatment success. 
1.4 Mouse Models to Study Retinal Degeneration 
To study retinal diseases, the choice of an adequate animal model is crucial. Due to the close 
evolutionary relationship, non-human primates would be best suited to study human diseases (Gwon 
2008), but ethical and financial reasons as well as the available genetic tools favor the choice of 
mice as model organism.  
1.4.1 Vision in mice 
Similar to the human retina, the mouse retina is rod-dominant and consists of 97% rods and only 3% 
cones (Carter-Dawson et al. 1979). However, in contrast to humans and other higher primates, mice 
lack a cone-rich macula and have a low visual acuity (Prusky et al. 2004). Furthermore, mice are 
dichromats: they lack the L-opsin expressing cones (peak sensitivity to long wavelength, red light, 
see 1.1.2). However, the similarities (e.g. structure of the visual system) outnumber the differences 
(Huberman et al. 2011) and thus, the mouse has become the first choice for studying retinal 
degenerative diseases.  
1.4.2 Models for induced retinal degeneration 
Retinal degeneration is mostly studied by using genetically engineered mouse models (see 1.4.3) 
or by applying toxic stimuli. Photoreceptor damage can be induced by using chemical and physical 
stimuli, such as pharmacological agents (e.g. N-methyl-N-nitrosourea, MNU (Yuge et al. 1996, 
Nambu et al. 1997), digoxin (Hinshaw et al. 2016, Landfried et al. 2017)) or light exposure (Noell et 
al. 1966, Wenzel et al. 2005, Organisciak et al. 2010). Light is a natural stimulus that has been 
suggested to be a co-factor contributing to retinal diseases such as AMD (Taylor et al. 1990, 
Margrain et al. 2004). Upon light damage, photoreceptor apoptosis occurs in a relatively fast, 
synchronized process. The severity of damage can be modified by adjusting light intensities (Wenzel 
et al. 2005). The process of light-induced photoreceptor degeneration can be separated into four 
phases: induction, death signal transduction, execution and clearance (Wenzel et al. 2005). The 
peak of apoptosis is reached 36 hours after bright light exposure, and 10 days following light 
exposure almost no photoreceptors are left in the ONL (Wenzel et al. 2005). It has been shown that 
the process of light-induced retinal degeneration depends on the visual cycle and is mediated by 
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rhodopsin (Grimm et al. 2000). In addition to the described bright light exposure model, another 
model that uses continuous low light exposure and involves transducin-dependent apoptosis has 
been described (Hao et al. 2002). 
1.4.3 Models for inherited retinal degeneration 
Many genes that cause retinal degeneration have been identified (see section 1.4.4 and 
https://sph.uth.edu/retnet) and numerous mouse lines with naturally occurring mutations or 
genetically engineered mice have been described, e.g. retinal degeneration 1 (rd1), retinal 
degeneration 10 (rd10) and cone photoreceptor function loss 1 (cpfl1) (reviewed in (Chang et al. 
2002, Samardzija et al. 2010)). Using these different models, researches aim to understand the 
particular genetic defect and its consequences. However, for non-monogenic diseases that have 
multifactorial causes such as AMD, generation of an appropriate mouse model is challenging. 
1.4.4 Models for AMD 
Although many mouse models for AMD exist, none can recapitulate all the different aspects of the 
disease (reviewed in (Rakoczy et al. 2006, Ramkumar et al. 2010, Pennesi et al. 2012)). 
Nevertheless, they help in understanding the pathological mechanisms and in developing treatment 
options.  
Several mouse models have been described to study neovascular AMD including RAP (reviewed in 
(Grossniklaus et al. 2010)). In the model of laser-induced CNV, laser injury creates local breaks in 
the Bruch’s membrane resulting in vessel recruitment from the choroid (Tobe et al. 1998b). In a 
transgenic mouse model with VEGF expression driven by the rhodopsin promoter (rho/VEGF mice), 
neovascularization originates in the deep plexus and extends into the photoreceptor layer/subretinal 
space, a phenotype that resembles RAP lesions (Okamoto et al. 1997, Tobe et al. 1998a, Ohno-
Matsui et al. 2002). Vldlr-/- mice with a partial deletion of exon 5 of the very low density lipoprotein 
receptor (Vldlr) gene (Frykman et al. 1995) show a similar neovascular RAP-like phenotype due to 
increased VEGF levels (Heckenlively et al. 2003, Joyal et al. 2016). 
To study non-vascular forms of macular degenerations, several models such as Abcr-/- (Weng et al. 
1999) (Mata et al. 2000), Elovl4-mutant (Karan et al. 2005, Vasireddy et al. 2006) and 
Timp3S156C/S156C mice (Weber et al. 2002) are used, in which targeted genes were shown to play a 
key role in disease pathogenesis of AMD, Stargardt’s disease and Sorsby’s fundus dystrophy (an 
autosomal dominant, late-onset retinal dystrophy (Sorsby et al. 1949)), respectively. Certain murine 
models focus on the different pathways involved in pathology of dry AMD, e.g. inflammation and the 
complement pathway. In Cfh-/- mice with complement C3 accumulation, disorganized photoreceptor 
outer segments and RPE organelles were observed (Coffey et al. 2007). Ccl2-/- and Ccr2-/- mice that 
were generated to analyze the role of macrophage dysfunction were found to mimic some features 
of AMD (Ambati et al. 2003), including photoreceptor atrophy and accumulation of lipofuscin and 
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drusen-like deposits (later shown to be swollen macrophages (Luhmann et al. 2009)). Accumulation 
of microglia observed in Cx3cr1-/- mice has also been suggested to be a driving force in AMD 
(Combadiere et al. 2007). Increased levels of carboxyethylpyrrole (CEP)-adducted proteins in AMD 
patients (Crabb et al. 2002, Gu et al. 2003) and some features of AMD observed in CEP-immunized 
mice led to the hypothesis that oxidative damage could be an initiating event in AMD (Hollyfield et 
al. 2008, Hollyfield 2010). Sod1-/- mice with drusen-like deposits and thickening of Bruch’s membrane 
(Imamura et al. 2006) and Sod2 knockdown mice with RPE degeneration and atrophy of 
photoreceptors (Justilien et al. 2007) further underline the importance of oxidative stress in AMD 
disease development. Disturbances in cell metabolism were studied in ApoE-/- mice (Dithmar et al. 
2000) and APOE4/E2 transgenic mice on a high fat diet (Malek et al. 2005). Histological analyses 
showed thickening of Bruch’s membrane, membrane-bound material and RPE changes. 
Additionally, hypoxia has been suggested to be involved in AMD pathogenesis (see 1.2.5), and a 
recent report shows degeneration of RPE cells in a chronic hypoxia-like model (Kurihara et al. 2016). 
1.4.5 The all-cone R91W;Nrl-/- mouse 
Wild-type mice have a rod-dominant retina (see 1.4.1; (Carter-Dawson et al. 1979)), which hinders 
the study of cone degeneration. In contrast, Nrl-/- knockout mice express only cone photoreceptors 
in their retinas (Mears et al. 2001). Neural retina leucine zipper (NRL) is a transcription factor 
required for rod photoreceptor development and plays an important role in rod homeostasis in the 
mature retina. In the absence of NRL, photoreceptor precursor cells follow the default pathway and 
become S-opsin expressing cones (Mears et al. 2001, Swaroop et al. 2010). However, disturbed 
cone layering with rosette formation in Nrl-/- mice impairs the analysis of cone degeneration. It has 
been shown that rosette formation in Nrl-/- is dependent on 11-cis-retinal (Wenzel et al. 2007, 
Kunchithapautham et al. 2009). However, combination of Nrl-/- and Rpe65-/- mice (RPE65 is essential 
for the regeneration of the visual chromophore 11-cis-retinal, see 1.1.4) results in Rpe65-/-;Nrl-/- mice 
with complete chromophore absence and thus non-functional retinas (Feathers et al. 2008).  
A mutation in RPE65 (RPE65R91W) has been identified in three consanguineous families with 
prevalent early-onset retinal dystrophy. Affected family members were homozygous for the mutation 
(Lorenz et al. 2000, El Matri et al. 2006). To model the disease and analyze the pathology, Rpe65R91W 
knock-in mice were generated. In these mice, reduced amounts of the visual chromophore 11-cis-
retinal and progressive loss of photoreceptor cells were observed (Samardzija et al. 2008). Under 
these conditions, rods and cones compete for 11-cis-retinal. Rods seem to take up the vast majority 
and consequently, cones suffer from chromophore deficiency. This leads to cone opsin 
mislocalization and cell death (Samardzija et al. 2009). Based on the hypothesis that reduced levels 
of 11-cis-retinal in Rpe65R91W mice may still be high enough to support vision but prevent rosette 
formation, Rpe65R91W mice were bred to Nrl-/- mice. Indeed, retinas of the resulting Rpe65R91W;Nrl-/- 
(R91W;Nrl-/-) mice are functional and well-layered. Similar to Nrl-/- mice, R91W;Nrl-/- express 
predominantly blue-light sensitive S-cones (Mears et al. 2001, Samardzija et al. 2014). Retinas of 
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R91W;Nrl-/- mice are quite stable with only slow, age-related degeneration (Samardzija et al. 2014). 
Thus, R91W;Nrl-/- mice provide an ideal model to study cone-related mechanisms and cone 
degenerative diseases.  
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2 AIMS OF THE THESIS 
Patients suffering from cone degenerative diseases including age-related macular degeneration 
(AMD) lose the ability for central, high acuity vision. Despite the ongoing strong research efforts 
worldwide, our knowledge about the mechanisms leading to cone cell death is very limited – partially 
due to the lack of suitable animal models. Rpe65R91W;Nrl-/- (R91W;Nrl-/-) mice express only cone 
photoreceptors in a functional and well-layered retina and therefore provide a suitable model to 
investigate cone cell death (Samardzija et al. 2014). We used the all-cone R91W;Nrl-/- mouse model 
to analyze the response of cones to hypoxia, an important feature of AMD. To further understand 
the underlying mechanisms of cone cell death, we analyzed retinal degenerative processes in 
R91W;Nrl-/- mice which were exposed to damaging blue light. 
I. The effects of a chronic hypoxia-like response on photoreceptors 
Risk factors for cone degenerative diseases such as AMD are manifold and include age, gene 
mutations and environmental influences. Hypoxia activates regulatory systems in the body with 
hypoxia-inducible factors (HIFs) playing a central role (see 1.2.2). It has been shown previously that 
the knockdown of Vhl in rod photoreceptors (OpsinCre;Vhlf/f = rodΔVhl mice) causes long-term HIF1A 
stabilization and slow, age-dependent retinal degeneration (Lange et al. 2011). Here, I employed the 
all-cone R91W;Nrl-/- mice and aimed to specifically analyze the response of cones to hypoxia. To 
analyze the effect of a chronic activation of the molecular response to hypoxia, we generated mice 
lacking von Hippel Lindau (VHL) protein specifically in cones (BPCre;R91W;Nrl-/-;Vhlf/f = coneΔVhl 
mice). 
 Characterization of coneΔVhl mice   
The main focus was to analyze all-cone mice with cone-specific Vhl ablation (coneΔVhl) and to 
investigate the influence of HIF1A on cone photoreceptors and retinal vasculature. 
 Anti-Hif1a gene therapy in rodΔVhl mice  
We hypothesized that genetic inactivation of HIF1A could rescue the observed phenotype in 
rodΔVhl mice. Therefore, we tested a gene therapy approach using an AAV-mediated expression 
of an shRNA directed against Hif1a in photoreceptors. 
II. Blue light-induced retinal degeneration in the all-cone R91W;Nrl-/- mouse 
Bright light exposure is a well-described model to induce degeneration in the rod-dominant wild-type 
mouse (Wenzel et al. 2005) and lifetime light exposure has been implicated as a co-factor in the 
etiology of AMD (Taylor et al. 1990, Margrain et al. 2004). Additionally, constant production of 
reactive oxygen species within photoreceptors upon light absorption may lead to substantial 
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molecular damage and microglia infiltration (Margrain et al. 2004, Joly et al. 2009). Due to the high 
resistance of cones to bright light-induced damage (Okano et al. 2012), we used blue light exposure 
as a model to study cone cell death in all-cone R91W;Nrl-/- mice. The aim of this part of the thesis 
was to analyze and compare mechanisms of retinal degeneration in all-cone R91W;Nrl-/- and rod-
dominant wild-type (129S6) mice in response to toxic levels of blue light. 
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Abstract 
Degeneration of cone photoreceptors leads to loss of vision in patients suffering from age-related 
macular degeneration (AMD) and other cone dystrophies. Evidence implicates reduced tissue 
oxygenation in AMD pathology and suggests a role of the cellular response to hypoxia for disease 
onset and progression. To investigate the consequence of a chronic activation of the molecular 
response to hypoxia in cones, we ablated the von Hippel Lindau protein (VHL) specifically in cones 
of the all-cone Rpe65R91W;Nrl-/- mouse. The resulting stabilization and activation of hypoxia-inducible 
factor 1A (HIF1A) led to increased expression of genes associated with hypoxia and retinal stress, 
as well as to severe cone degeneration and pathologic vessel growth, features that are central to 
AMD pathology. Additional deletion of Hif1a protected cone cells, prevented pathological vessel 
growth and preserved vision. Our results identify HIF1A as a potential therapeutic target to rescue 
hypoxia-related vision loss in patients. 
 
Significance statement 
Despite the identification of several risk factors for age-related macular degeneration (AMD), a 
therapy is still an unmet medical need. Chronic hypoxia has been postulated to be important in AMD 
etiology. It induces several cellular responses including the accumulation of hypoxia-inducible 
factors that control expression of a multitude of target genes. We demonstrate that a chronic hypoxia-
like response triggered specifically in cone photoreceptors (coneΔVhl mice) leads to severe cone 
degeneration and pathological vessel growth into the photoreceptor layer. The observed vision loss 
in coneΔVhl mice is rescued by selective inactivation of Hif1a in coneΔVhlHif1a mice. Our findings provide 
evidence for a HIF1A-mediated mechanism and identify HIF1A as potential target for a therapeutic 
intervention in hypoxia-mediated cone degenerative diseases.  
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Introduction 
Age-related macular degeneration (AMD) is the leading cause of visual impairment in the elderly 
population in industrialized nations (Klein et al. 1999, Buch et al. 2004, Wong et al. 2014). Due to 
the degeneration of photoreceptors in the cone-rich macula and/or the ingrowth of blood vessels, 
patients suffering from AMD lose central, high acuity vision (Green 1999, Swaroop et al. 2009, 
Spaide 2013). While there is no therapy available for geographic atrophy (dry AMD), the neovascular 
(wet) form of AMD is treated by vascular endothelial growth factor (VEGF)-targeting therapies to 
slow disease progression (Gragoudas et al. 2004, Rosenfeld et al. 2006, Maguire et al. 2016). 
Choroidal neovascularization (CNV) defines the classic form of neovascular AMD and is 
characterized by the ingrowth of blood vessels from the choroid to the subretinal space (Bressler et 
al. 1988, Spaide 2013). Retinal angiomatous proliferation (RAP) has been described as an 
additional, distinct form of neovascular AMD (Yannuzzi et al. 2001). In RAP, also known as deep 
retinal vascular anomalous complexes, vessels originate not from the choroid but from the deep 
retinal plexus in the inner retina and extend into the photoreceptor layer and the subretinal space 
(Hartnett et al. 1996, Yannuzzi et al. 2008).  
AMD is a multifactorial disease. Besides genetic and environmental risk factors (Swaroop et al. 2009, 
Chakravarthy et al. 2010, Fritsche et al. 2016), tissue hypoxia and changes in retinal blood flow have 
been implicated in its etiology (Remsch et al. 2000, Arjamaa et al. 2009, Boltz et al. 2010, Stefánsson 
et al. 2011, Kent 2014). Oxygen supply to photoreceptors in the eyes of elderly people may be 
impaired due to an age-dependent reduction of choroidal blood flow (Dallinger et al. 1998, Lam et 
al. 2003) and accumulation of drusen (Grunwald et al. 2005). Choroidal ischemia in dry AMD (Ciulla 
et al. 1999, Coleman et al. 2013) and decreased choroidal blood volume in AMD (Berenberg et al. 
2012) further support the hypothesis that hypoxia might be implicated in disease development and 
progression. The retina is considered as one of the most metabolically active tissues and is therefore 
highly vulnerable to changes in oxygen tension (Ames et al. 1992, Arjamaa et al. 2009). In conditions 
of reduced oxygen supply (hypoxia), molecular responses are activated with hypoxia-inducible factor 
1 (HIF1) playing a key regulatory role for adapting the cell/tissue to the new condition. Heterodimeric 
HIF1 proteins are composed of an oxygen-labile α-subunit and a constitutively expressed β-subunit 
(Wang et al. 1995). Under normoxic conditions, HIF1A is hydroxylated by prolyl hydroxylase domain 
(PHD) proteins. This promotes the interaction with the von Hippel-Lindau (VHL) ubiquitin E3 ligase 
complex leading to ubiquitination and rapid degradation of hydroxylated HIF1A by proteasomes. 
Under hypoxic conditions, hydroxylation of HIF1A is reduced. Hence, HIF1A accumulates, enters 
the nucleus and drives transcription of a multitude of target genes (Jaakkola et al. 2001, Semenza 
2004, Semenza 2011). 
In this study, we investigated the consequences of a chronic hypoxia-like response triggered in cone 
photoreceptors to elucidate the mechanisms of cell death in cone degenerative diseases such as 
AMD. To this end, we used Rpe65R91W;Nrl-/- (R91W;Nrl-/-) double-mutant mice which express only 
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cone photoreceptors in a well-layered, functional retina (Samardzija et al. 2014). To induce the 
hypoxia-like response, we ablated the VHL protein specifically from cones using the Cre-loxP 
system. We analyzed the effects of the cone-specific activation of the hypoxic response and 
validated the contribution of HIF1A to the resulting retinal pathology.  
 
Results 
Cone-specific inactivation of Vhl increased HIF1A target gene expression and induced progressive 
cone degeneration 
Photoreceptors in the all-cone R91W;Nrl-/- mouse are predominantly blue-light sensitive S-cones 
(Mears et al. 2001, Samardzija et al. 2014). Therefore, we used BP-Cre transgenic mice, which 
express functional Cre recombinase under the transcriptional control of the blue cone opsin promoter 
(BP, (Akimoto et al. 2004)) to delete floxed sequences from cones in the all-cone mice. 
BPCre;R91W;Nrl-/-;ZsGreen reporter mice verified that Cre was almost exclusively active in the ONL 
and in the majority of cones, as green fluorescence was only occasionally detected in few cells of 
the inner retina (Figure 1A). We validated Vhl excision in the BPCre;R91W;Nrl-/-;Vhlf/f (=coneΔVhl) 
mouse line by analyzing genomic DNA isolated from retinal tissues of 4-week-old coneΔVhl mice. The 
detection of a PCR product corresponding to the excised fragment suggested a successful Cre-
mediated deletion of Vhl in retinas of coneΔVhl but not of ctrl mice (=R91W;Nrl-/-;Vhlf/f, Figure 1B). 
Genomic deletion of Vhl led to the accumulation of HIF1A protein (Figure 1C) and to increased 
transcript levels of known hypoxic target genes such as adrenomedullin (Adm), egl-9 family hypoxia-
inducible factor 1 (Egln1, also known as Phd2), glucose transporter 1 (Glut1) and BCL2/adenovirus 
E1B 19-kDa interacting protein 3 (Bnip3) in normoxic coneΔVhl mice (Figure 1D, Table 2 for details 
on statistics). This suggested that cells, presumably cones, activated a hypoxia-like response in 
retinas of coneΔVhl mice. 
We observed an age-dependent decline in HIF1A protein levels and hypoxia target gene expression 
in coneΔVhl mice (Figure 1C, D). This prompted us to analyze retinal function and morphology. B-
wave amplitudes and photopic ERGs were not significantly different between coneΔVhl mice and ctrl 
mice at 6 weeks of age (Figure 2A). However, the amplitudes were strongly reduced in 12-week-old 
coneΔVhl mice as compared to age-matched ctrl mice (Figure 2B, Table 2 for details on statistics). 
This indicated an age-dependent loss of function potentially due to retinal degeneration. Indeed, we 
observed severe, progressive thinning of the outer nuclear layer (ONL) in coneΔVhl mice with most 
cones lost at 26 weeks of age (Figure 3A, B). Additionally, partial loss of the retinal pigment 
epithelium (RPE) and strong perturbations in the inner nuclear layer (INL) were detected in older 
coneΔVhl mice (Figure 3A, 12we coneΔVhl). In contrast, the ctrl mice showed only a slow age-related 
ONL thinning, as reported for the parental R91W;Nrl-/- mouse line before (Samardzija et al. 2014). 
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To gain insight into cellular mechanisms leading to cone degeneration, we analyzed expression of 
specific genes during aging in coneΔVhl and ctrl mice (Figure 3C, Table 2 for details on statistics). 
Caspase 1 (Casp1), a gene involved in retinal degeneration, was upregulated in coneΔVhl mice at 8 
weeks and peaked at 12 weeks of age. Expression of the stress signaling gene glial fibrillary acidic 
protein (Gfap) was upregulated in coneΔVhl mice already at 4 weeks and remained elevated 
throughout the observation period. Interestingly, we observed increased expression of tissue 
inhibitor of metalloproteinase 3 (Timp3) during the aging process, a gene associated with age-related 
macular degeneration (Vierkotten et al. 2011, Ardeljan et al. 2013). Similarly, expression of vascular 
endothelial growth factor (Vegf), a hypoxic response gene that is involved in neovascularization in 
wet AMD, was strongly increased in coneΔVhl mice at 4 and 6 weeks of age. 
Subretinal neovascularization and vascular leakage in coneΔVhl mice 
Increased transcription of Timp3 is potentially associated with a higher risk to develop neovascular 
AMD (Ardeljan et al. 2013) and hypoxia-regulated genes such as Vegf contribute to retinal and 
choroidal neovascularization (reviewed in (Campochiaro 2015)). Therefore, we analyzed the 
vascular network of coneΔVhl mice. All three vascular plexi were detected at 4 weeks of age (Figure 
4A, B, C). However, we observed vessels extending from the deep plexus into the normally avascular 
ONL in central retinas of coneΔVhl mice (Figure 4A, arrowheads). Vessels reached the RPE but did 
not cross Bruch’s membrane (Figure 4D, E), as we never observed retinal-choroidal anastomoses. 
This suggests that abnormal vessels originated from the retinal vasculature and not from the choroid. 
Interestingly, abnormal vessel growth was characteristic for the central but not for the peripheral 
retina (Figure 4B). To evaluate the integrity of retinal vessels we performed fluorescein angiography. 
Signs of leakage were observed in coneΔVhl mice (Figure 4F, G). Detailed analysis by 
immunofluorescent staining on retinal cross-sections revealed strong albumin (ALB) 
immunoreactivity in the ONL, RPE and inner plexiform layer (IPL) in coneΔVhl mice, as opposed to 
the signal detected in ctrl mice that was confined to retinal vessels. The choroid with its extensive 
vasculature was also strongly positive for ALB in both types of mice (Figure 4H, I). 
Microglia/macrophages detected by IBA1 staining were found within the photoreceptor and 
subretinal layer in coneΔVhl but not ctrl mice (Figure 4J, K). 
Early vascular defects in coneΔVhl mice 
S-opsin expression starts shortly before birth in mice (Roberts et al. 2006, Swaroop et al. 2010) and 
we observed Cre-activity in BPCre;R91W;Nrl-/-;ZsGreen reporter mice as early as at postnatal day 
(PND) 1 (data not shown). The primary plexus in mice develops along a central-to-peripheral 
gradient and reaches the periphery around PND8-10 (Fruttiger 2007). Vessels sprout from the 
primary plexus into the retina and turn laterally when they reach the outer and inner boundaries of 
the INL to first form the deep plexus and subsequently the intermediate plexus (Fruttiger 2007). To 
determine the onset of neovascularization in coneΔVhl mice we stained retinal flat mounts with 
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isolectin at PND7 and PND11. Using 3D-reconstruction of blood vessels, no difference in early 
vessel formation was detected between coneΔVhl and ctrl mice at PND7 (Figure 5A). However, at 
PND11, before formation of the intermediate plexus, vessels growing from the deep plexus into the 
ONL were observed in coneΔVhl mice (Figure 5B).  
Formation of the deep plexus is preceded by Vegf expression in the INL (Stone et al. 1995). We 
analyzed gene expression levels in coneΔVhl, ctrl and 129S6 (wt, rod-dominant retina) mice to test 
for different regulation of genes involved in angiogenesis and vessel guidance during and after the 
process of vessel formation (PND7, 14 and 28, Figure 5C, Table 2 for details on statistics). Vegf 
mRNA was not elevated at PND7, slightly increased by 1.3-fold at PND14 and significantly increased 
at PND28 (2-fold) in coneΔVhl mice compared to controls. Fibroblast growth factor 2 (Fgf2), a potent 
angiogenic factor that has been shown to be involved in retinal stress (Baird et al. 1985, Joly et al. 
2008, Lange et al. 2011a), was upregulated at PND28, at a time when developmental vascularization 
is completed. Recently, protective effects of semaphorin 3F (Sema3f) against subretinal 
neovascularization have been demonstrated (Sun et al. 2017). Sema3f gene expression levels in 
all-cone mice did not differ between ctrl and coneΔVhl mice (Figure 5C). Platelet derived growth factor, 
B polypeptide (Pdgfb) was upregulated in coneΔVhl mice at PND28 compared to ctrl and wt mice. 
Pdgfb expression by endothelial cells is essential for pericyte recruitment and is increased under 
hypoxia (Lindahl et al. 1997, Lindblom et al. 2003, Betsholtz 2004, Campochiaro 2013). Expression 
levels of von Willebrand factor (vWf), a marker for endothelial cells, was not increased and we did 
also not detect differences in expression of Pdgfb receptor (Pdgfrb). 
HIF1 is responsible for pathological vessel growth and progressive cone degeneration in coneΔVhl 
mice 
We hypothesized that stabilized HIF1A, and not other Vhl targets, might promote retinal 
degeneration and neovascularization in coneΔVhl mice. Therefore, we additionally deleted Hif1a in 
cone photoreceptors (BPCre;R91W;Nrl-/-;Vhlf/f;Hif1af/f=coneΔVhlHif1a). After we confirmed the presence 
of deletion alleles for both Hif1a and Vhl in genomic DNA of coneΔVhlHif1a retinas (not shown) we 
determined retinal function. At 12 weeks of age, photopic ERG traces and b-wave amplitudes were 
similar in coneΔVhlHif1a and ctrl (R91W;Nrl-/-;Vhlf/f;Hif1af/f) mice (Figure 6A, B) indicating no functional 
loss upon Hif1a inactivation in coneΔVhl mice. Similarly, retinal morphology (Figure 6C) and ONL 
thickness (Figure 6D) of coneΔVhlHif1a mice was comparable to ctrl mice, whereas the thickness of the 
ONL in coneΔVhl mice was prominently reduced (same data as in Figure 3B) at 12 weeks of age.  
Hif1a deletion also prevented pathological neovascularization into the ONL but had no effect on the 
developmental formation of the three vascular plexi (Figure 6E). No induction of the expression of 
hypoxic target genes such as Adm, Egln1, Vegf and Timp3 were detected in coneΔVhlHif1a mice, 
confirming that HIF1 was the responsible HIF isoform for regulating their expression in cones (Figure 
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6F). Altogether, these data indicate HIF1 as the causative factor for retinal degeneration and 
pathological vessel growth in coneΔVhl mice. 
 
Discussion 
Previously, it has been demonstrated that the knockdown of Vhl in rod cells causes HIF1A 
stabilization under normoxic conditions (Lange et al. 2011b). Here, we particularly investigated the 
effects of a chronic hypoxia-like response in cone photoreceptors. We show that ablation of Vhl in 
cones resulted in a chronic hypoxia-like situation with accumulation of HIF1A and induction of HIF1A 
target genes. This led to pathological vessel growth into the photoreceptor layer, reduced retinal 
function and severe, progressive cone degeneration. These consequences resemble some of the 
features of AMD pathology, particularly of a subset of neovascular AMD known as RAP. In human 
patients, HIF1A and HIF2A were detected in macrophages and endothelial cells of neovascular 
membranes associated with AMD (Inoue et al. 2007). Additionally, the correlation of drusen density 
and decreased choroidal blood flow (Berenberg et al. 2012) as well as choroidal ischemia in AMD 
patients (Ciulla et al. 1999, Grunwald et al. 2005, Coleman et al. 2013) suggest reduced oxygen 
transport from the choroid to the inner retina (Kim et al. 2013). Therefore, tissue hypoxia and HIFs 
might play an important role in disease development and/or progression.  
Expression of numerous genes involved in metabolism, stress, cell survival and angiogenesis was 
increased in cone∆Vhl mice (Figures 1D, 3C, 5C), as was Timp3 (Figure 3C). TIMP3 is an important 
regulator of extracellular matrix (ECM) remodeling through inhibition of matrix metalloproteases and 
has been suggested to be a senescence-related protein (Kamei et al. 1999) that is potentially 
regulated by HIF2 in rods (Kast et al. 2016). Importantly, TIMP3 inhibits angiogenesis by interacting 
with VEGF (Qi et al. 2003) and is relevant for Bruch’s membrane integrity (Kamei et al. 1999, 
Macgregor et al. 2009). Furthermore, mutations in Timp3 have been associated with Sorsby’s fundus 
dystrophy, an autosomal dominant maculopathy with submacular choroidal neovascularization 
(Weber et al. 1994, Lin et al. 2006). We can only speculate about the reasons for elevated Timp3 
during the aging process in cone∆Vhl mice but it seems plausible that retinas of cone∆Vhl mice require 
extensive ECM remodeling due to progressive cone degeneration (Figure 3).  
We detected early and prominent vascular defects with abnormal vessel growth into the ONL, 
subretinal space and RPE layer in cone∆Vhl mice. Increased VEGF levels in transgenic mice 
expressing Vegf under the transcriptional control of the rhodopsin promoter (rho/VEGF mice) were 
shown to cause subretinal neovascularization (Okamoto et al. 1997, Ohno-Matsui et al. 2002, Ida et 
al. 2003). In our model, Vegf was not upregulated at PND14, at a time when vessels had already 
started growing into the ONL (Figure 5). However, transient Vegf expression in the INL regulates the 
formation of the deep plexus during development (Stone et al. 1995), i.e. already minor changes in 
the local Vegf concentration gradient, which are not detectable by RT-PCR, may misguide retinal 
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vessels in cone∆Vhl mice. To date, it remains unclear which pro-angiogenic factor(s) are responsible 
for the observed neovascularization. Nonetheless, our findings demonstrate that this is a Hif1a-
mediated mechanism, as additional deletion of Hif1a fully rescued the vascular defects (Figure 6).  
Interestingly, cone-specific deletion of Hif1a did not affect formation of the three vascular plexi 
(Figure 6E), while it has been shown that knockdown of Hif1a in most cells of the retinal periphery 
prevented formation of the intermediate plexus (Caprara et al. 2011). Thus, our results suggest that 
Hif1a expression in cones, as opposed to other cells presumably in the INL, is not essential for the 
development of the intermediate plexus. 
Our data do not define whether cone degeneration in cone∆Vhl mice is due to the effects of the chronic 
intrinsic activation of the hypoxic response or to early development of vascular defects. Another 
mouse model shows, however, that a chronic hypoxia-like response in rods leads to slow 
photoreceptor degeneration in the absence of reported vascular defects (rod∆Vhl mice (Lange et al. 
2011b)). This suggests that the long-term activation of HIF1 may reduce cell survival by an intrinsic 
mechanism. During hypoxia, HIF1 regulates mitochondrial respiration and thus metabolic adaptation 
towards glycolysis (Semenza 2007) leading to reduced energy (ATP) levels and potentially 
starvation. It has been shown that starvation of cones may lead to cone cell death (Punzo et al. 
2009). Furthermore, it has been suggested that cones might be more sensitive to reduced oxygen 
and nutrient levels compared to rods, for reasons not fully understood (Punzo et al. 2012, Kurihara 
et al. 2016). This could possibly explain the progressive degeneration and the accelerated 
phenotype in cone∆Vhl compared to rod∆Vhl mice.  
It might also be possible, however, that photoreceptor degeneration is secondary to the early 
pathological vascular defects. Inactivation of Vhl in the retinal periphery during development leads 
to vessel growth into the ONL and severe retinal degeneration (Kurihara et al. 2010, Lange et al. 
2011a). Whereas the retinal periphery was strongly degenerated at 10 weeks of age, photoreceptor 
loss in the normal vascularized central retina was less pronounced (Lange et al. 2011a). We 
observed microglia activation and impaired function of the blood-retina-barrier in cone∆Vhl mice, as 
shown by IBA1 and ALB staining, respectively (Figure 4H-K). It seems likely that retinal hemorrhages 
exacerbate cone photoreceptor degeneration in our model, as suggested for other models (Zhao et 
al. 2011, Geiger et al. 2015). Photoreceptor degeneration was also observed in very low density 
lipoprotein receptor knockout mice (Vldlr-/-; (Frykman et al. 1995)) where early retinal 
neovascularization causes vessels to extend from the deep plexus into the subretinal space 
(Heckenlively et al. 2003, Hu et al. 2008). Interestingly, it has been suggested that the Vldlr-/- 
phenotype is linked to HIF1A. Joyal and colleagues proposed that starved Vldlr-/- photoreceptors 
have reduced amounts of the Krebs cycle metabolite α-ketoglutarate, which decreases PHD activity 
and thus promotes stabilization of HIF1A. Consequently, Vegf is secreted, leading to RAP-like 
neovascularization (Joyal et al. 2016). We hypothesize that the combination of early vascular defects 
and the activation of a chronic hypoxia-like response, which affects expression of genes involved in 
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cellular metabolism and retinal stress, leads to the progressive cone degeneration observed in 
coneΔVhl mice.  
Our findings identify HIF1 in cones as the factor causing cone degeneration, pathological 
neovascularization and loss of function. Similarly, chronic activation of the hypoxic response in rods 
resulted in an HIF1- and age-dependent retinal degeneration (Barben et al., submitted). Whereas 
this provides strong evidence that activation of HIF1 in rod and cone photoreceptors leads to retinal 
degeneration, the activation of HIF2 but not of HIF1 is responsible for metabolic stress in RPE upon 
RPE-specific Vhl inactivation (Kurihara et al. 2016). Thus, our data and data published by others 
suggest cell type-specific roles for HIF1A and HIF2A in retinal pathology.  
In conclusion, coneΔVhl mice serve as a model to study HIF1A-mediated degeneration and 
angiogenesis. Additionally, evidence shows that HIF1A can be safely inactivated in cones (see 
above), rods (Kast et al., 2016; Barben et al, submitted) and RPE (Kurihara et al. 2016) suggesting 
that targeting HIF transcription factors in photoreceptors and RPE may provide a potential 
therapeutic approach to rescue hypoxia-mediated retinal degeneration in patients and an alternative 
to anti-VEGF agents. 
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Material and Methods 
Mice  
All experimental procedures were performed according to ‘The Association for Research in Vision 
and Ophthalmology’ statement on animal use in ophthalmic and vision research and the regulation 
of the veterinary authorities of Zurich, Switzerland. Rpe65R91W;Nrl-/- mice were generated by crossing 
Rpe65R91W (Samardzija et al. 2008) to Nrl-/- mice (Mears et al. 2001), and were described recently 
(Samardzija et al. 2014). BPCre;R91W;Nrl-/-;Vhlf/f (=coneΔVhl) mice were generated by breeding 
Rpe65R91W;Nrl-/- mice to Vhlf/f mice (Haase et al. 2001) and mice expressing the Cre recombinase 
under the transcriptional control of the blue cone opsin (BP) promoter (Akimoto et al. 2004). To 
generate BPCre;R91W;Nrl-/-;Vhlf/f;Hif1af/f (=coneΔVhlHif1a) mice, BPCre;R91W;Nrl-/-;Vhlf/f were bred to 
Hif1af/f mice (Ryan et al. 2000). R91W;Nrl-/-;Vhlf/f and R91W;Nrl-/-;Vhlf/f;Hif1af/f littermates without Cre 
recombinase served as respective control mice (=ctrl). Genotyping was performed by PCR using 
DNA isolated from ear clips and primer pairs as described previously (Lange et al. 2011b, Kast et 
al. 2016). Presence of BPCre was tested using the following primer pair: forward (5’-
GGACATGTTCAGGGATCGCCAGGCG-3’) and reverse (5’-
GCATAACCAGTGAAACAGCATTGCTG-3’). The amplification reaction resulted in a 268 bp 
fragment in the presence of the transgene. To test for deletion of floxed sequences, genomic DNA 
was isolated from retinal tissues and tested by PCR using appropriate primer pairs as described 
(Lange et al. 2011b, Kast et al. 2016). 129S6 (Taconic, Ejby, Denmark) mice were used as wild-type 
controls. To test expression of the Cre recombinase BPCre;R91W;Nrl-/- mice were bred to a ZsGreen 
reporter line (Ai6 mice, Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze, (Madisen et al. 2010)). Mice of both sexes 
were used for experiments and were housed at the animal facility of the University Zurich under a 
14 h : 10 h light/dark cycle with lights on at 6 am and lights off at 8 pm. Food and water was provided 
ad libitum.  
Morphology/quantification 
To evaluate retinal morphology, eyes were enucleated and fixed in 2.5% glutaraldehyde in 
cacodylate buffer (pH 7.2, 0.1 M), according to the previously described procedure (Heynen et al. 
2011). By cutting through the optic nerve head, nasal and temporal halves of the eyecups were 
separated and embedded in epon plastic. Semi-thin cross sections (0.5 μm) were counterstained 
with toluidine blue and analyzed by light microscopy (Axioplan; Zeiss, Jena, Germany). Thickness 
of the outer nuclear layer was measured at indicated distances from the optic nerve head using the 
Adobe Photoshop CS6 ruler tool (Adobe Systems, Inc., San Jose, CA, USA) on reconstructed retinal 
panorama images. 
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Immunofluorescence 
After euthanasia, eyes were marked nasally, enucleated and fixed in 4% paraformaldehyde (PFA) 
in phosphate buffer for 1 h at 4°C. Cornea and lens were removed and the dissected eyecups 
postfixed for 2 h in 4% PFA. After immersion in 30% sucrose (in PBS 0.1 M) the eyecups were 
embedded in tissue freezing medium (O.C.T., Leica Biosystems Nussloch GmbH, Nussloch, 
Germany), frozen in a 2-methylbutane bath cooled by liquid nitrogen and stored at -80°C. 
Cryosections (12 μm) were blocked (3% normal goat serum (Sigma-Aldrich, St. Louis, MO, USA), 
0.3% Triton X-100 (Sigma) in PBS) and incubated with the following primary antibodies overnight at 
4°C: Isolectin GS-IB4-Alexa594 from Griffonia simplicifolia (1:300, I21413; Thermo Fisher Scientific, 
Waltham, MA, USA), rabbit anti-allograft inflammatory factor 1 (alias IBA1, 1:1000, 019-19741; 
Wako, Neuss, Germany), rabbit anti-albumin (ALB, 1:500, RARaAlb; Nordic Immunology, Tilburg, 
Netherlands). Sections were washed with PBS, incubated with secondary antibodies (Cy3-labeled, 
Jackson ImmunoResearch Laboratories, Westgrove, PA, USA) for 1 h at room temperature (RT), 
counterstained with DAPI (4',6-Diamidine-2'-phenylindole dihydrochloride, Roche, Basel, 
Switzerland) and analyzed by fluorescence microscopy (Axioplan; Zeiss). 
Analysis of retinal vasculature in whole mounted retinas 
Eyes were isolated and incubated for 5 to 10 minutes in 2% PFA in PBS as described recently 
(Caprara et al. 2011). After removal of cornea and lens, the retina was dissected and flat-mounted 
in PBS. After postfixation in 4% PFA for 1 h at RT, flat-mounts were blocked (3% normal goat serum, 
0.3% Triton X-100 in PBS, 1 h) and incubated with isolectin GS-IB4-Alexa594 (1:300, Thermo Fisher 
Scientific) at 4°C overnight. Retinas were washed in PBS, mounted on glass slides and analyzed by 
fluorescence microscopy (Axioplan/ApoTome; Zeiss). Blood vessels were reconstructed in three 
dimensions using Imaris software (Versions 7.7.2/8.3.0, Bitplane AG, Zurich, Switzerland). For better 
recognition and distinction of the vascular plexi, the z-value of the z-stacks was increased five times. 
RNA isolation and semi-quantitative real-time PCR  
Retinas were isolated through a slit in the cornea, frozen in liquid nitrogen and stored at -80°C. RNA 
was extracted using an RNA isolation kit (RNeasy; Qiagen, Hilden, Germany) including a DNAse 
treatment. 1 μg of RNA, oligo (dT) and M-MLV reverse transcriptase (Promega, Fitchburg, WI, USA) 
were used to prepare cDNA. To analyze gene expression by real-time PCR, 10 ng of cDNA template 
was amplified using a PCR polymerase ready mix (LightCycler 480 SYBR Green I Master, Roche 
Diagnostics, Rotkreuz, Switzerland), specific primer pairs (Table 1) and a thermocycler (LightCycler 
480, Roche Diagnostics). Expression levels were normalized to β-actin (Actb) and relative 
expression was calculated using the comparative threshold cycle method (∆∆CT) of the 
LightCycler480 software (Roche Diagnostics). At least 3 mice per strain and time point were used.  
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Protein isolation and Western blotting  
Proteins were isolated by homogenizing the retinas in ice-cold Tris-HCl (100 mM, pH 7.5) using 
ultrasound at 4°C. Protein concentrations were determined spectrophotometrically by using Bradford 
reagent (Bio-Rad, Hercules, CA, USA). SDS-PAGE and Western blotting were performed as 
described (Heynen et al. 2011) and proteins detected by rabbit anti-HIF1A (1:2000, NB100-479, 
Novus Biologicals, Littleton, CO, USA) and mouse anti-β-actin (1:10’000, A5441, Sigma-Aldrich) 
antibodies. HRP-conjugated secondary antibodies were applied for 1 h at RT and signals were 
visualized using Western lightning chemiluminescence reagent (PerkinElmer, Waltham, MA, USA) 
and X-ray films.  
Electroretinography (ERG)  
Mice were dark-adapted overnight and pupils were dilated under dim red light with 1% cyclogyl 
(Alcon Switzerland SA, Rotkreuz, Switzerland) and 5% neosynephrin-POS (Ursapharm Schweiz 
GmbH, Roggwil, Switzerland) 30 minutes prior to recording. Mice were anesthetized with a 
subcutaneous injection of ketamine (85 mg/kg, Pfizer PFE Switzerland GmbH, Zurich, Switzerland) 
and xylazine (Rompun 2%, 4mg/kg, Bayer, Leverkusen, Germany). To keep the cornea moist, a 
drop of mydriaticum dispersa (Omnivision AG, Neuhausen, Switzerland) was applied to each eye. 
Low background illumination for 5 min was used for light adaptation. Electroretinograms were 
recorded simultaneously from both eyes as described (Samardzija et al. 2014). Flashes of 8 different 
light intensities ranging from -10 to 25 dB (0.25–790.5694 cd*s/m2) were applied under photopic 
conditions. 10 responses were averaged per light intensity. Traces from n≥4 mice were averaged 
for each light intensity. 
Fundus imaging and fluorescein angiography 
Fundus photographs were taken with a Micron IV system (Phoenix Research Labs, Pleasanton, CA, 
USA). The pupils were dilated and the mice were anesthetized as described above. Methocel 2% 
(Omnivision) was applied to lubricate the eyes. Fluorescein images were captured 1-5 minutes after 
intraperitoneal injection of 20 μL of 2% fluorescein solution (Akorn, Lake Forest, IL, USA). 
Experimental Design and Statistical Analysis  
Two-way ANOVA with Šídák’s multiple comparison test was performed using GraphPad Prism 
(version 7.02, GraphPad Software, San Diego, CA, USA) for statistical analysis of gene expression 
levels and ERG traces. All data are shown as means ± SD. Details of statistical analyses are shown 
in Table 2. 
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Figure 1 
 
Figure 1. Knockdown of Vhl in cones of the all-cone mouse (coneΔVhl). (A) Expression of Cre 
recombinase in BPCre;R91W;Nrl-/-;ZsGreen mice. Green fluorescence (ZsGreen) indicates Cre 
activity. RPE: retinal pigment epithelium, ONL: outer nuclear layer, INL: inner nuclear layer, IPL: 
inner plexiform layer, GCL: ganglion cell layer. Scale bar 50 μm. (B) PCR of genomic DNA from 
retinas of 4-week-old ctrl and coneΔVhl mice. Floxed Vhl (fl) is detected at 460 bp and Cre-mediated 
excision (ex) results in a 260 bp fragment. (C) Western blot analysis of HIF1A in 4, 6, 8 and 12-
week-old coneΔVhl and ctrl (littermates without Cre recombinase) mice. ACTB served as loading 
control. (D) Relative expression of hypoxic target genes in retinas of ctrl (black) and coneΔVhl (orange) 
mice. Expression levels were normalized to beta-actin (Actb) and calculated relatively to 4-week-old 
ctrl mice, which were set to 1. Shown are means ± SD. Two-way ANOVA with Šídák’s multiple 
comparison test was used for statistical analysis (Adm: ****p<0.0001, *p=0.0306; Egln1: 
****p<0.0001; Glut1: ****p<0.0001; Bnip3: ****p<0.0001, **p=0.0043; n≥3 per time point, Table 2 for 
details on ANOVA). Adm: Adrenomedullin, Egln1: egl-9 family hypoxia-inducible factor 1, Glut1: 
Glucose transporter 1, Bnip3: BCL2/adenovirus E1B interacting protein 3. Cre-negative littermates 
were used as ctrl mice in all experiments unless otherwise indicated.  
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Figure 2 
 
Figure 2. Reduced retinal function in aged coneΔVhl mice. (A) Averaged traces of single-flash 
photopic ERGs and b-wave amplitudes showed no significant differences in coneΔVhl mice (orange) 
compared to ctrl mice (black) at 6 weeks of age. (B) At 12 weeks of age, photopic b-wave amplitudes 
were strongly reduced in coneΔVhl mice (orange) as compared to ctrl mice (black). b-wave amplitudes 
are shown as means ± SD. Two-way ANOVA with Šídák’s multiple comparison test was used for 
statistical analysis (6we ctrl and coneΔVhl n=5, 12we ctrl n=6 and coneΔVhl n=4, *p=0.0115, 
****p<0.0001, Table 2 for details on ANOVA). 
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Figure 3 
 
Figure 3. Progressive cone degeneration in coneΔVhl mice. (A) Inactivation of Vhl in cones led to 
progressive retinal degeneration (upper panels) as compared to ctrl mice (lower panels). ConeΔVhl 
mice displayed disturbed layering with reorganization of the INL (asterisk, 12we coneΔVhl), severe 
loss of the ONL and partial loss of the RPE (arrowhead, 12we coneΔVhl, inset) at 12 and 26 weeks 
of age. Abbreviations as in Figure 1. Scale bar 50 μm. (B) Line chart of ONL thickness in coneΔVhl 
mice (orange) as compared to ctrl mice (black) at 4 and 12 weeks of age. n≥3. (C) Relative 
expression levels of genes involved in stress signaling and degeneration. Expression levels were 
normalized to Actb and calculated relatively to 4-week-old ctrl mice, which were set to 1. Shown 
are means ± SD. Two-way ANOVA with Šídák’s multiple comparison test was used for statistical 
analysis (Casp1: **p=0.0026, ****p<0.0001, *p=0.0244, Gfap: ****p<0.0001, **p=0.0035, 
***p=0.0004, ****p<0.0001, Timp3: *p=0.0235, **p=0.0036, **p=0.0035, Vegf: ****p<0.0001, n≥3 
per time point, Table 2 for details on ANOVA). Casp1: caspase 1, Gfap: glial fibrillary acidic 
protein, Timp3: tissue inhibitor of metalloproteinase 3, Vegf: vascular endothelial growth factor.  
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Figure 4 
 
Figure 4. Subretinal neovascularization in coneΔVhl mice. (A-C) Immunostaining of cross-sections of 
the central (A) and peripheral (B) retina of 4-week-old coneΔVhl and age-matched ctrl mice (C, central 
retina) with isolectin. Arrowheads indicate vessels extending from the deep plexus into the ONL in 
central retinas of coneΔVhl mice. DP: deep plexus, IP: intermediate plexus, PP: primary plexus. Scale 
bar 50 μm. (D, E) Light microscopy of 4-week-old coneΔVhl and ctrl mice. Neovessels (arrowheads) 
reached the RPE, but did not cross Bruch’s membrane. Scale bar 20 μm. (F, G) Fundus imaging 
and fluorescein angiography of coneΔVhl mice and ctrl mice at 4 weeks of age. Signs of leakage 
(arrowhead) were detected in coneΔVhl mice. (H-K) Retinal cross-sections of ctrl (H, J) and coneΔVhl 
mice (I, K) were stained with antibodies against ALB (H, I) and IBA1 (J, K) at 4 weeks of age. 
Microglia/macrophages were found within the photoreceptor layer and RPE in coneΔVhl mice 
(arrowheads). Scale bar 50 μm. Abbreviations as in Figure 1.   
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Figure 5 
 
Figure 5. Pathological vessel growth starts around PND11 in coneΔVhl mice. (A, B) 3D-reconstruction 
of blood vessels stained with isolectin on retinal flat mounts of ctrl (left) and coneΔVhl (right) mice at 
PND7 (A) and PND 11 (B). At PND11, vessels extended from the deep plexus towards the ONL. 
The intermediate plexus has not yet been formed in both ctrl and coneΔVhl mice. For better recognition 
and distinction the z-value of the z-stacks was increased five times. DP: deep plexus, PP: primary 
plexus. Scale bar 50 μm. (C) Relative expression levels of angiogenic genes in retinas of coneΔVhl 
(orange), ctrl (black) and wt (green) mice at indicated time points. Expression levels were normalized 
to Actb and compared to ctrl mice at PND7, which were set to 1. Shown are means ± SD. Two-way 
ANOVA with Šídák’s multiple comparison test was used for statistical analysis comparing ctrl with 
coneΔVhl mice (Vegf: ****p<0.0001, Fgf2: ****p<0.0001, Pdgfb: ***p=0.0009, n=3 per time point, Table 
2 for details on ANOVA). Vegf: vascular endothelial growth factor, Fgf2: fibroblast growth factor 2, 
Sema3f: semaphorin 3F, Pdgfb: platelet derived growth factor, B polypeptide, vWf: von Willebrand 
factor, Pdgfrb: platelet derived growth factor receptor, beta polypeptide.  
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Figure 6  
 
Figure 6. Combined deletion of Hif1a and Vhl (cone∆VhlHif1a) rescues the defects in retinal function, 
morphology and vasculature observed in cone∆Vhl mice. (A, B) Average single-flash photopic ERGs 
and b-wave amplitudes showed no significant differences in cone∆VhlHif1a mice (green) compared to 
ctrl mice (R91W;Nrl-/-;Vhlf/f; Hif1af/f, black) at 12 weeks of age. n=4 per group. b-wave amplitudes are 
shown as means ± SD. (C, D) Light microscopy analysis and measurement of the ONL thickness in 
cone∆VhlHif1a (green), ctrl mice (R91W;Nrl-/-;Vhlf/f; Hif1af/f, black) and coneΔVhl mice (orange, as shown 
in Figure 3B) at indicated time points. Abbreviations as in Figure 1. Scale bar 50 μm. (E) 3D-
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reconstruction of blood vessels stained with isolectin on retinal flat mounts of ctrl (left), coneΔVhl 
(middle) and cone∆VhlHif1a mice (right). Inactivation of Hif1a (cone∆VhlHif1a) rescued the pathological 
neovascularization. Analysis at 4 weeks of age, n=3. For better recognition and distinction the z-
value of the z-stacks was increased five times. The yellow line indicates the border between the 
outer plexiform layer (OPL) and the ONL. DP: deep plexus, IP: intermediate plexus, PP: primary 
plexus. (F) Relative gene expression of hypoxic target genes in cone∆VhlHif1a mice (green) and ctrl 
mice (R91W;Nrl-/-;Vhlf/f; Hif1af/f, black) at 4we, 8we and 12we as indicated. Abbreviations as in Figure 
1 and 3. Expression levels were normalized to Actb and compared to 4-week-old ctrl mice, which 
were set to 1. Shown are means ± SD. n≥3 per time point. Scale bar 50 μm.   
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Table 1. Primers used for real-time PCR 
Gene Forward (5’-3’) Reverse (5’-3’) Product (bp) 
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 153 
Adm TCCTGGTTTCTCGGCTTCTC ATTCTGTGGCGATGCTCTGA 133 
Bnip3 CCTGTCGCAGTTGGGTTC GAAGTGCAGTTCTACCCAGGAG 93 
Casp1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC 138 
Fgf2 TGTGTCTATCAAGGGAGTGTGTGC ACCAACTGGAGTATTTCCGTGACCG 158 
Gfap CCACCAAACTGGCTGATGTCTAC TTCTCTCCAAATCCACACGAGC 240 
Glut1 CAGTGTATCCTGTTGCCCTTCTG GCCGACCCTCTTCTTTCATCTC 151 
Pdgfb GCTGCTGCAATAACCGCAAT GTGGTCCTCCAAGGTCACTG 131 
Pdgfrb CTTGCCCTTCAAAGTGGTGG CCAGGTGGAGTCGTAAGGC 199 
Egln1 GCAGCATGGACGACCTGAT CAACGTGACGGACATAGCCT 123 
Sema3f CGTCGCGCACAGGATTA GGAAAATGGCTGCATCGGTA 166 
Timp3 GCCTCAAGCTAGAAGTCAACAAA TGTACATCTTGCCTTCATACACG 69 
Vegf ACTTGTGTTGGGAGGAGGATGTC AATGGGTTTGTCGTGTTTCTGG 171 
vWF CCCTGGACAACTTGACAGCAG ACAAGCAGGCAGATCTCATACC 192 
 
Table 2. Statistical analyses: Two-way ANOVA  
Figure Number of mice Experiment F-values P-value 
1D 
4we: n=3, 6we: n=3, 8we: n=4, 
12we: ctrl n=4; cone∆Vhl n=3, 
26we: n=3 
Adm 
Interaction: F (4, 23) = 14.63 
Strain: F (1, 23) = 183.2 
P<0.0001 
P<0.0001 
Egln1 
Interaction: F (4, 23) = 60.19 
Strain: F (1, 23) = 259.4 
P<0.0001 
P<0.0001 
Glut1 
Interaction: F (4, 23) = 17.28 
Strain: F (1, 23) = 92.58 
P<0.0001 
P<0.0001 
Bnip3 
Interaction: F (4, 23) = 61.1 
Strain: F (1, 23) = 535 
P<0.0001 
P<0.0001 
2B ctrl n=6, cone∆Vhl n=4 12we 
Interaction: F (7, 64) = 5.76 
Strain: F (1, 64) = 59.33 
P<0.0001 
P<0.0001 
3C 
4we: n=3, 6we: n=3, 8we: ctrl 
n=4; cone∆Vhl n=4 and n=3 for 
Timp3, 12we: ctrl n=4; cone∆Vhl 
n=3, 26we: n=3 
Casp1 
Interaction: F (4, 23) = 27.6 
Strain: F (1, 23) = 100.9 
P<0.0001 
P<0.0001 
Gfap 
Interaction: F (4, 23) = 4.392 
Strain: F (1, 23) = 130 
P=0.0088 
P<0.0001 
Timp3 
Interaction: F (4, 22) = 1.846  
Strain: F (1, 22) = 37.12 
P=0.1561 
P<0.0001 
Vegf 
Interaction: F (4, 23) = 26.52 
Strain: F (1, 23) = 81.18 
P<0.0001 
P<0.0001 
5C n=3 
Vegf 
Interaction: F (4, 18) = 6.041 
Strain: F (2, 18) = 17.4 
P=0.0029 
P<0.0001 
Fgf2 
Interaction: F (4, 18) = 19.52 
Strain: F (2, 18) = 20.16 
P<0.0001 
P<0.0001 
Pdgfb 
Interaction: F (4, 18) = 3.333 
Strain: F (2, 18) = 8.26 
P=0.0329 
P=0.0028 
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Abstract  
Reduced choroidal blood flow and tissue changes in the ageing human eye impairs oxygen 
delivery to photoreceptors and the retinal pigment epithelium. As a consequence, mild but chronic 
hypoxia may develop and disturb cell metabolism, function and ultimately survival, potentially 
contributing to retinal pathologies such as age-related macular degeneration (AMD). Here, we show 
that several hypoxia-inducible genes were expressed at higher levels in the aged human retina 
suggesting increased activity of hypoxia-inducible transcription factors (HIFs) during the 
physiological ageing process. To model chronically elevated HIF activity and investigate ensuing 
consequences for photoreceptors, we generated mice lacking von Hippel Lindau (VHL) protein in 
rods. This activated HIF transcription factors and led to a slowly progressing retinal degeneration in 
the ageing mouse retina. Importantly, this process depended on HIF1 but not on HIF2. A gene 
therapy approach using AAV-mediated RNA interference through an anti-Hif1a shRNA significantly 
mitigated the degeneration suggesting a potential intervention strategy that may be applicable to 
human patients. 
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Introduction 
Several blinding conditions of the retina are characterized by the progressive loss of 
photoreceptors and retinal pigment epithelium (RPE) cells. Underlying causes are manifold and 
include gene mutations, age-related tissue changes, systemic alterations and environmental factors. 
A relevant condition that can lead to retinal pathology is hypoxia. Reduced tissue oxygenation is 
causative for the production of vascular endothelial growth factor (VEGF), a main factor involved in 
the development of diabetic macular edema and neovascularization in age-related macular 
degeneration (AMD) (Caprara and Grimm, 2012; Simó et al., 2014; Campochiaro, 2015). However, 
tissue hypoxia may also be of significance for retinal pathologies not associated with abnormal 
vessel growth such as the highly prevalent non-exudative form of AMD (Arjamaa et al., 2009; Feigl, 
2009; Stefánsson et al., 2011). Reduced choroidal blood flow in the ageing eye (Dallinger et al., 
1998; Lam et al., 2003) and in the foveolar region of AMD patients (Grunwald et al., 2005), choroidal 
ischemia in dry AMD (Ciulla et al., 1999; Grunwald et al., 2005; Coleman et al., 2013) and the 
correlation between drusen accumulation and decreased choroidal blood volume in AMD (Berenberg 
et al., 2012) has led to the hypothesis that reduced oxygen availability to retinal cells might be a 
significant factor that contributes – likely together with other factors – to disease development and 
progression (Arjamaa et al., 2009; Kent, 2014). Since both rods and cones have an extraordinarily 
high demand for energy (Okawa et al., 2008), their function and survival might be especially sensitive 
to reduced tissue oxygenation.  
Hypoxia-inducible transcription factors (HIFs) are the major regulators of the cellular response 
to reduced oxygen levels (Webb et al., 2009). They are composed of a constitutively expressed β− 
(HIFB) and an oxygen-labile α−subunit (HIFA). In the presence of O2, prolyl hydroxylases 
hydroxylate the α−subunit that is then recognized by the von Hippel Lindau (VHL) protein complex. 
An E3 ligase in this complex adds ubiquitins to the hydroxylated HIFAs targeting them for rapid 
proteasomal degradation. In hypoxia, HIFAs are less hydroxylated, escape recognition by VHL, 
ubiquitination and degradation, and can thus function as transcription factors (Maxwell et al., 1999; 
Jaakkola et al., 2001). Probably the most prominent HIF target genes are VEGF and erythropoietin 
(EPO). Both play eminent roles in the response to hypoxia and are key factors for neovascularization 
and the increase in haematocrit, respectively. Although HIF1 and HIF2 share several common 
targets, they may also have their own set of genes for specific regulation (Loboda et al., 2010).  
Inactivation of VHL prevents degradation of HIF-alpha subunits and leads to increased HIF1 
and HIF2 activity. It is an experimental way to model a major part of the molecular response to 
hypoxia in normoxic conditions. When the Vhl gene is inactivated in retinal cells already during 
development, a severe vessel phenotype develops and the retina degenerates (Kurihara et al., 2010; 
Lange et al., 2011a). Recently, Kurihara and colleagues inactivated Vhl also in the RPE and showed 
that the ensuing molecular response in these cells leads to severe alterations in RPE morphology 
and metabolism causing cell death (Kurihara et al., 2016). This phenotype was rescued by the 
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additional inactivation of Hif2a suggesting that HIF2 may be responsible for RPE degeneration in 
conditions of reduced tissue oxygenation. The importance of a tightly controlled VHL/HIF system 
within the retina is further underlined by the observation that a rod-specific inactivation of Vhl after 
postnatal development leads to a late onset and age-dependent loss of photoreceptors and retinal 
function (Lange et al., 2011b). Here, we show that the ageing human retina may indeed experience 
increased hypoxic stress. We also identify HIF1 as the factor being responsible for photoreceptor 
degeneration in a model of chronic hypoxia-like conditions and demonstrate that AAV-mediated 
expression of an shRNA targeting Hif1a mitigates the degenerative phenotype.  
 
Results 
Increased expression of hypoxia-related genes in the aged human retina 
Reduced choroidal blood flow and tissue changes may reduce oxygen availability for 
photoreceptors in the aged neuronal retina (see introduction). To test this hypothesis, we analysed 
expression of hypoxia-related genes in the central and peripheral retina from 10 human donors 
between the age of 17 and 92 years without diagnosed retinal pathology (Table 1). The central retina 
samples included the macular region whereas peripheral tissue was isolated from the mid periphery 
of the nasal retina. Although post-mortem times differed considerably (Table 1), Ct-values of the 
housekeeping genes glyceraldehyde 3-phosphate dehydrogenase (GAPDH), ribosomal protein L28 
(RPL28) and beta-actin (ACTB) were relatively similar in the samples (Fig. 1A,B). Expression levels 
of genes of interest, however, varied strongly between donor eyes. Although R2 values were low (not 
shown), linear regression indicated a tendency of an age-dependent increased expression of the 
classic hypoxia-regulated HIF-target genes adrenomedullin (ADM), VEGFA and to a lower extent 
also of pyruvate dehydrogenase kinase 1 (PDK1) and glucose transporter type 1 (GLUT1) in both 
the central and the peripheral retina (Fig. 1C,D). In contrast, rod and cone-specific genes involved 
in phototransduction including rhodopsin (RHO), G protein subunit alpha transducin 2 (cone 
transducin, GNAT2) and rod phosphodiesterase 6A (PDE6A) showed the opposite trend and 
seemed to be expressed at reduced levels in the aged retina. The only exception was cone 
phosphodiesterase 6C (PDE6C) in the central retina that followed expression of the reference gene 
RPL28 (Fig. 1E,F). Thus, the aged human retina may upregulate expression of hypoxia-related 
factors and reduce expression of photoreceptor-specific genes. Given that photoreceptors receive 
their oxygen largely from the choroidal blood with its reduced flow in older eyes, it is plausible to 
assume that photoreceptors contribute to the upregulation of hypoxia-induced HIF target genes in 
response to a mild but chronic hypoxia that may develop during ageing. 
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Rod photoreceptor degeneration induced by a chronic hypoxia-like response is controlled by HIF1 
To model a state of chronically activated HIF transcription factors in photoreceptors as it may 
be found in the aged human retina, we inactivated Vhl in adult rods using the opsin-Cre mouse 
(LMOPC1; (Le et al., 2006)). We have chosen rods as target cells because they are among the first 
cells to die in AMD (Curcio et al., 1996). The additional rod-specific inactivation of Hif1a and/or Hif2a 
allowed to test the contribution of each transcription factor to the phenotype. Opsin-Cre-mediated 
excision of floxed sequences occurs postnatally in about 50% of rods and reaches its maximal extent 
at around 6 weeks of age (Le et al., 2006; Lange et al., 2011a). Genomic excision was verified by 
PCR (Fig. 2A) and normoxic stabilization of HIF1A and HIF2A confirmed in retinas of 11 weeks old 
rodΔVhl mice by Western blotting (Fig. 2B) as reported earlier (Lange et al., 2011b). Additional 
inactivation of Hif1a and/or Hif2a resulted in increased levels of only HIF2A in rodΔVhl;Hif1a or of HIF1A 
in rodΔVhl;Hif2a, or in unchanged levels of both HIFA transcription factors in rodΔVhl;Hif1a;Hif2a mice (Fig. 
2B). Rod-specific inactivation of Vhl (rodΔVhl) resulted in a late onset and slowly progressing retinal 
degeneration reaching its maximal extent (loss of about 50% of photoreceptors) around 6 months of 
age. Since only about 50% of rods express Cre (Le et al., 2006; Lange et al., 2011a), it is likely that 
surviving photoreceptors were without Cre and may thus not have activated HIF transcription factors. 
Although an earlier cohort of rodΔVhl mice showed no functional loss or degeneration at 17 weeks of 
age (Lange et al., 2011b), we detected photoreceptor degeneration already at 4 months in the cohort 
presented here (Fig. 3). The reason for the slightly accelerated degeneration is unclear, but may be 
based on changed environmental conditions in the new animal facility of the University of Zurich with 
a prolonged light period (14 h instead of 12 h) and slightly increased light levels. Importantly, 
however, the new cohort also showed a slowly progressing, age-dependent photoreceptor 
degeneration similar to the cohort used before. The degenerative phenotype of rodΔVhl mice was 
completely rescued by the additional inactivation of Hif1a or of Hif1a and Hif2a together, but not of 
Hif2a alone. This was also reflected by the retinal stress marker glial fibrillary acidic protein (GFAP) 
that was elevated in rodΔVhl and rodΔVhl;Hif2a retinas that were prone to degeneration, but remained at 
basal levels when Hif1a was inactivated (see below, Fig. 7). Surprisingly, rodΔVhl mice showed also 
an RPE phenotype, albeit with variable severity and only in isolated areas. Fundus imaging detected 
few pale flecks that appeared in the OCT scans as thick, hyperreflective regions in or close to the 
RPE layer at 4 months of age (Fig. 4A). Unevenly distributed fundus flecks that correspond to 
hyperreflective OCT signals close to the RPE are also described for human retinal degenerative 
diseases such as Stargardt dystrophy (Sparrow et al., 2015). Thus, even in the presence of causative 
gene mutations for instance in ABCA4, degeneration of retinal cells and fundus appearance may not 
always be uniform across the retina. Cross sections of rodΔVhl retinas showed that the RPE was 
thicker and multi-layered in focused regions that may correspond to the flecks detected by fundus 
imaging and OCT. RPE cells appeared more heavily pigmented, partially vesiculated and enlarged 
(Fig. 4B,C). This was confirmed in flatmounts where phalloidin staining indicated that some RPE 
cells had a less regular shape and contact to an unusually high number of neighbouring cells (Fig. 
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4D). Photoreceptors below affected RPE regions seemed less viable as many pyknotic nuclei were 
detectable in the ONL (Fig. 4B, arrows). Since this RPE phenotype was never observed in rodΔVhl;Hif1a 
mice we conclude that chronic activation of HIF1 in rods not only caused cell death in cis but also 
affected neighbouring RPE cells in some parts of the retina.  
The tissue phenotype was mirrored by retinal function. At 6 months of age, rodΔVhl and 
rodΔVhl;Hif2a mice had significantly reduced scotopic a- and b-wave amplitudes at higher flash 
intensities compared to their respective control littermates. Mice lacking Hif1a in addition to Vhl 
(rodΔVhl;Hif1a and rodΔVhl;Hif1a;Hif2a mice), however, retained normal function (Fig. 5). This is of 
significance since it shows that adult photoreceptors do not require HIF1 for function or survival. 
Although Vhl inactivation was rod-specific, the cone-driven photopic b-wave amplitudes at higher 
light intensities were also reduced in rodΔVhl mice suggesting that loss of VHL in rods affected cone 
function or survival. Interestingly, the reduction in cone-driven ERG responses was prevented by the 
additional inactivation of Hif1a and/or Hif2a (Fig. S1). The reason for this is unclear but may point to 
mechanisms in rods that can affect cone function in a HIF1- and HIF2-dependent manner. However, 
this needs further testing. 
 
The transcriptomic response  
Increased expression of the HIF1 targets Adm, Vegf, Glut1, Pdk1 and Egl-9 family hypoxia 
inducible factor 1 (Egln1) in rodΔVhl and rodΔVhl;Hif2a mice at 11 weeks of age verified that HIF1 was 
transcriptionally active (Fig. 6). Normal expression levels of these genes in rodΔVhl;Hif1a and 
rodΔVhl;Hif1a;Hif2a mice confirmed their dependency on HIF1. Expression of these HIF1-target genes 
was less increased at 6 months, probably because most rods lacking Vhl have already degenerated 
at this age (Fig. 3). BCL2 interacting protein 3 (Bnip3), caspase-1 (Casp1), leukemia inhibitory factor 
(Lif), endothelin-2 (Edn2), fibroblast growth factor-2 (Fgf2), signal transducer and activator of 
transcription-3 (Stat3) and Gfap are upregulated in the degenerating retina and connected to cell 
death or cell survival (Guo et al., 2001; Samardzija et al., 2006a; Samardzija et al., 2006b; Joly et 
al., 2008). These genes were activated exclusively in the degenerating retinas of rodΔVhl (Lange et 
al., 2011b) and rodΔVhl;Hif2a mice. It is noteworthy that LIF and to a lesser extent also EDN2 and 
CASP1 showed a trend of increased expression in the aged human retina (Fig. 8) pointing to a stress 
response that is more likely to be activated in the senescent retina. 
It is important to note that in addition to HIF1A and HIF2A also levels of pSTAT3 were 
increased in rodΔVhl and rodΔVhl;Hif2a mice (Fig. 7). It has been reported that HIF1 may cooperate with 
STAT3 to regulate HIF1-specific gene expression (Pawlus et al., 2013). It has also been shown that 
HIF1 increases STAT3 activity through decreasing the levels of suppressor of cytokine signalling 3 
(SOCS3) (Yokogami et al., 2013) and that constitutively active STAT3 directly interacts with the C-
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terminal domain of HIF1A (Jung et al., 2008). Thus, regulation of individual genes in rodΔVhl and 
rodΔVhl;Hif2a mice may be attributable to HIF1, STAT3 or to both transcription factors.  
To detect novel genes that were differentially regulated by chronically active HIF in rods, we 
determined the retinal transcriptomes of rodΔVhl, rodΔVhl;Hif1a and of Vhlflox/flox;Hif1aflox/flox controls at 11 
weeks of age. Tables S1-S3 show the top 20 up- and downregulated genes of the individual 
comparisons. Table S1 lists genes that may be regulated by HIF1, HIF2 or STAT3, or by a 
combination of those, Table S2 shows genes that may be controlled by HIF1, STAT3 or by both of 
them, and genes in Table S3 may be regulated mostly by HIF2. Complete gene lists are available 
on request. Venn-diagrams summarized overlaps between the individual comparisons (Fig. S2). For 
a detailed description of the transcriptomic data, see the supplemental information.  
Among the top 20 upregulated genes in rodΔVhl mice were Adm and Edn2 that were already 
verified by real-time PCR in Figure 6, and many genes with less well known function. Among those, 
we verified the expression pattern of lysyl oxidase like 4 (Loxl4), ladinin 1 (Lad1) and smoothelin like 
2 (Smtnl2) by real-time PCR (Fig. 6) establishing them as HIF-responsive genes in mouse rods.  
 
Gene expression in the human retina 
The gene expression pattern in the mouse retina may also be relevant to understand ageing 
processes in human eyes. LIF that was strongly induced in the stressed (degenerating) mouse retina 
(Fig. 6) was also expressed at higher levels in the aged central and peripheral human retina. EDN2, 
another gene of the LIF-signalling pathway in mice (Joly et al., 2008), also showed a slight tendency 
of an age-dependent increase in expression both in the central and peripheral human retina. 
Similarly, CASP1, a proinflammatory protein (Sun and Scott, 2016) that has been implicated in 
inflammasome-triggered pyroptosis (Miao et al., 2011) revealed a trend of increased expression in 
aged human retinas (Fig. 8A,B) providing some evidence of potential inflammatory processes in the 
old eye. 
Although LAD1 was detected in only 5 out of 10 samples of the central retina and in 8 out of 9 
samples of the peripheral retina, it showed a clear tendency of increased expression with age. 
Expression of LOXL4 and SMTNL2 was also detected, but expression of these genes followed a 
similar trend as observed for RPL28 and was thus without apparent regulation during ageing (Fig. 
8C,D). LAD1 encodes an anchoring filament protein that has been associated with basement 
membranes (Klobučar et al., 2016). Its function in rods has not been determined but as a HIF1 target 
gene, LAD1 might be involved in a structural adaptation to reduced oxygen levels. The HIF target 
LOXL4 encodes a lysyl oxidase-like protein that has been implicated in collagen remodelling and 
metastasis formation in cancer (Semenza, 2012). Its expression in the retina has not yet been 
described but it might be involved in extracellular matrix remodelling during hypoxic periods. Even 
less is known about SMTNL2 and its function, except that it may be a target gene of c-Jun N-terminal 
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kinase (Gordon et al., 2013). It will be of interest to localize these proteins in the normal and hypoxic 
retina and to elucidate their functions. 
 
Anti-Hif1a gene therapy  
Our genetic experiments showed that chronically active HIF1 was responsible for retinal 
degeneration in rodΔVhl mice (Fig. 3). To establish a therapeutic approach aiming at the reduction of 
toxic HIF1 levels in photoreceptors, we used RNA interference through the AAV-mediated 
expression of an shRNA against Hif1a. A scrambled sequence served as control. Test of the shRNA 
and corresponding siRNA in NIH3T3 cells showed a highly efficient downregulation of HIF1A 
whereas STAT3 was not affected (Fig. 9A). AAV2/8(Y733F) viral particles carrying the sh-Hif1a or a 
scrambled sequence (sh-ctrl) as well as an Egfp expression cassette were injected into the subretinal 
space of rodΔVhl mice at 5 weeks of age. sh-Hif1a and Egfp expression was driven by the ubiquitous 
U6 and CMV promoters, respectively (Fig. S3). Fundus fluorescence imaging at 6 months of age 
showed widespread expression of EGFP in both sh-ctrl and sh-Hif1a injected mice (Fig. 9B). The 
EGFP-positive retinal areas were surprisingly large in most injected mice. Possibly, retinal damage 
inflicted by the injection allowed the virus to diffuse and reach cells also peripheral to the injection 
site. OCT scans suggested that retinal architecture and layering in the ONL was more regular in 
retinas of sh-Hif1a injected eyes. Dorsoventral sections showed widespread expression of EGFP 
that was predominantly localized in the ONL and RPE (Fig. 9C). Treatment with sh-Hif1a resulted in 
a significantly increased ONL thickness that was most pronounced in the ventral retina and the dorsal 
retina close to the optic nerve head (Fig. 9D, E). These data strongly support the hypothesis that an 
anti-Hif1a approach may be developed as a therapy to protect photoreceptors in a situation of 
chronic tissue hypoxia.  
 
Discussion 
Tissue hypoxia is relevant for many pathologies that affect the retinal and choroidal vasculature 
in diseases such as diabetic retinopathy and neovascular AMD. The HIF-regulated growth factor 
VEGF for example is central for the development of choroidal neovascularization and anti-VEGF 
therapies show great benefit for patients suffering from wet AMD. However, chronic hypoxia may 
also slowly develop in the normal retina during ageing as indicated by the increased expression of 
HIF target genes in retinas of older donors (Fig. 1). Since chronic HIF activity led to age-dependent 
photoreceptor degeneration in mice, we and others hypothesize that chronically increased HIF 
activity in aged human retinas may be involved in AMD pathogenesis in at least some patients 
(Arjamaa et al., 2009; Kent, 2014). The hypothesis, however, does not imply that elevated HIF 
activity is toxic per se but that it may be one of several factors that contribute to multifactorial 
pathologies found in diseases such as dry AMD. Thus, reducing HIF levels may be a potential 
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strategy to eliminate one of the disease-contributing factors. This may lessen the burden for cells 
and potentially result in delaying or even preventing onset and/or progression of the disease.  
Earlier we showed that a short 6-hour period of acute systemic hypoxic preconditioning 
activates HIF transcription factors in the retina and induces a response that protects photoreceptors 
(Grimm et al., 2002). This protective response depends either on HIF-independent mechanisms or 
on HIF activity in cells other than photoreceptors (Thiersch et al., 2009; Kast et al., 2016). Also, after 
mice are released from acute hypoxia retinal HIF1A returns to basal levels in less than one hour 
allowing the cells to quickly recover and re-establish a normoxic gene expression profile (Grimm et 
al., 2002; Thiersch et al., 2008). This is in contrast to the degeneration-inducing chronic activation 
of HIF1 in rods. Here, increased HIF1 activity over weeks or months may induce lasting changes in 
the cellular metabolism, which may lead to deficits such as reduced energy production and finally to 
cell death. Indeed, increased expression of Pdk1 and Glut1 in rodΔVhl mice indicated a metabolic shift 
that may have resulted in reduced oxidative phosphorylation and thus reduced production of ATP in 
rods. If long-lasting, such a shift may curtail metabolic support and weaken the cells ability to survive 
periods of stress. Gene expression profiling revealed that HIF1-induced degeneration in rodΔVhl mice 
followed similar signalling mechanisms as detected in other models of retinal degeneration. This 
included activation of the Lif - Edn2 - Fgf2 pathway (Samardzija et al., 2006a; Joly et al., 2008; Bürgi 
et al., 2009) with a late increase in Casp1 expression (Samardzija et al., 2006b). In addition, we 
detected a variety of differentially expressed HIF1 target genes in retinas of rodΔVhl mice, even before 
the onset of extensive degeneration. Among those, LAD1, LOXL4 and SMTNL2 were also detected 
in the human retina, with LAD1 showing a tendency of increased expression with age. 
The individual or combined genetic inactivation of the two HIFA transcription factors clearly 
showed that chronic activation of intrinsic HIF1 but not of HIF2 caused rod cells to die. This is of 
relevance and in marked contrast to RPE cells where chronically active HIF2, but not HIF1, leads to 
RPE loss (Kurihara et al., 2016). Intriguingly, the changes in cellular metabolism resulting from 
chronically active HIF1 in rods or HIF2 in RPE not only caused cell death in cis but also affected 
neighbouring cells (Fig. 4 and (Kurihara et al., 2016)) either through secreted factors, accumulation 
of toxic debris from degenerated cells or reduced metabolic support. The differential toxicity of 
chronically active HIF1 and HIF2 for rods and RPE, respectively, may reflect the highly divergent 
function of these two cell types and indicates that different aspects of the hypoxic response can be 
toxic. These might be altered lipid handling for RPE cells (Kurihara et al., 2016) and affected energy 
metabolism (see above) or other factors for rods.  
Although it will be important to define the individual processes and hypoxia-related 
mechanisms that lead to HIF1-dependent cell death of rods and to HIF2-dependent degeneration of 
RPE cells, their detailed knowledge might not be essential to establish and test therapeutic 
approaches. Our genetic experiments showed that inactivation of Hif1a at the beginning of the 
hypoxic response rescued photoreceptor cells. Patients, however, may seek medical advice only 
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once pathological processes are ongoing. Thus, it is important to establish an interventional therapy. 
We tested RNA interference through the AAV-based delivery of an sh-RNA against Hif1a and 
showed that this may be an applicable strategy to protect photoreceptors in conditions of chronic 
HIF activity. However, from our data and data published by Kurihara and colleagues (Kurihara et al., 
2016) it seems clear that a therapy targeting solely Hif1a in photoreceptors will not be sufficient for 
patients. Since reduced choroidal blood flow in the ageing eye causes tissue hypoxia affecting 
photoreceptors as well as the RPE, a combination therapy that targets both cell types and both HIF1 
and HIF2 transcription factors may be needed. For the success of such a therapy it is mandatory 
that inactivation of HIF1 and HIF2 in adult photoreceptors and RPE does not lead to toxic effects. 
We recently showed that Hif1a and Hif2a can be safely inactivated in adult rods (Kast et al., 2016). 
Similarly, inactivation of Hif1 alone in RPE cells had no obvious consequences (Lin et al., 2012) and 
we have collected preliminary evidence that simultaneous inactivation of both Hif1a and Hif2a did 
not adversely affect RPE function or survival (not shown). This is further supported by the normal 
appearance of the retina and RPE in mice lacking Vhl, Hif1a and Hif2a in the RPE (Kurihara et al., 
2016). However, since a beneficial effect of Hif1a in retinal detachment has been suggested (Shelby 
et al., 2015), it may be advisable not to inhibit HIF completely but to merely reduce its expression or 
activity. In conclusion, our data show that a chronic activation of HIF transcription factors in 
photoreceptors induces retinal degeneration in a HIF1-dependent manner. Since several hypoxia-
related genes may be expressed at higher levels in the retina of older donors, hypoxia-related 
mechanism may be relevant in the ageing human retina and may contribute to retinal diseases such 
as AMD. As HIF transcription factors do not seem essential for adult photoreceptors and RPE, anti-
HIF therapies may prove beneficial for patients. 
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Material and Methods 
Mice, genotyping and excision of floxed sequences 
All mice were maintained as breeding colonies at the Laboratory Animal Services Center 
(LASC) of the University of Zurich in a 14 h : 10 h light-dark cycle with lights on a 6 am and lights off 
at 8 pm. Mice had access to food and water ad libitum. Average light intensity at cage levels was 60 
-150 lux, depending on the position in the rack. 
Vhlflox/flox (Haase et al., 2001), Hif1aflox/flox (Ryan et al., 2000), Hif2aflox/flox (Gruber et al., 2007) 
and OpsinCre (LMOPC1; (Le et al., 2006)) mice were intercrossed to obtain rodΔVhl 
(Vhlflox/flox;OpsinCre), rodΔVhl;Hif1a (Vhlflox/flox;Hif1aflox/flox; OpsinCre), rodΔVhl;Hif2a (Vhlflox/flox; 
Hif2aflox/flox;OpsinCre) and rodΔVhl;Hif1a;Hif2a (Vhlflox/flox; Hif1aflox/flox;Hif2aflox/flox;OpsinCre) mice. Breeding 
pairs were always heterozygous for OpsinCre and pups without OpsinCre served as littermate 
controls. Rod-specific Cre expression in OpsinCre mice starts around postnatal day 7 and increases 
up to 6 weeks of age (Le et al., 2006). All mice were homozygous for the Rpe65450Leu variant 
(Danciger et al., 2000). Genotyping was performed by conventional PCR using DNA isolated from 
ear clips and primer pairs as specified in Table 2. To detect alleles carrying CRE-mediated deletions 
of the floxed sequences, genomic DNA was isolated from retinal tissue and amplified by PCR using 
the primer pairs shown in Table 3. All PCR products were run on agarose gels and visualized using 
ethidium bromide. 
 
Human retina samples 
Peripheral nasal retina and central retina including the macula were isolated and frozen 
separately. RNA was isolated using the RNeasy kit (Qiagen, Hilden, Germany). cDNA synthesis and 
real-time PCR were performed as described for the mouse samples (see below) using human-
specific primer pairs (Table 4). 
 
Western blotting 
Isolated retinas were sonicated in 200 µl of 100 mM Tris/HCl (pH 8,0). After centrifugation 
(1000 x g; 3 min) protein concentrations were determined in the supernatants using Bradford reagent 
(BioRad, Hercules, CA, USA). Standard SDS-PAGE and Western blotting were performed using the 
following primary antibodies: rabbit anti-HIF1A (1:2,000 – 1:4,000, NB100-479, Novus Biologicals, 
Cambridge, UK); rabbit anti-HIF2A (1:1,000, PAB12124, Abnova, Aachen, Germany); rabbit anti-
pSTAT3Tyr705 (1:500, #913L, Cell Signaling Technology, Danvers, MA, USA); rabbit anti-STAT3 
(1:1,000, D3Z2G, Cell Signaling Technology); mouse anti-GFAP (1:1,000, G3893-Clone G-A-5, 
Sigma, Buchs, Switzerland); mouse anti-ACTB (1:10,000, A5441, Sigma). Primary antibodies were 
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diluted in 5% non-fat blocking milk (BioRad, Cressier, Switzerland) in TBST, added to the membrane 
and incubated over night at 4°C with gentle agitation. Appropriate HRP-conjugated secondary 
antibodies were added and signals detected using the Western lightning chemiluminescence 
reagent (PerkinElmer, Waltham, MA, USA). Signals were analysed using X-ray films. 
 
Morphology, RPE flatmounts and immunofluorescence 
Eyes were marked at the dorsal limbus, enucleated, fixed in glutaraldehyde (2.5% in 
cacodylate buffer) for 12 – 24 h at 4°C, trimmed, post-fixed in 1% osmium tetroxide and embedded 
in Epon 812 as described (Samardzija et al., 2006a). Tempero-nasal cross-sections of 0.5 µm were 
cut through the optic nerve head, stained with toluidine blue and analysed by light microscopy (Zeiss, 
Axioplan, Jena, Germany). RPE flatmounts were prepared and stained as described elsewhere 
(Oczos et al., 2014). Briefly, eyes were enucleated and incubated in 2% paraformaldehyde for 5 min. 
After removal of cornea and lens and incubation in phosphate buffer containing 140 mM NaCl and 
2.7 mM KCl for 20 min, the detached retina was gently removed and the eyecup prepared for flat 
mounting by making four incisions. The resulting clover-leafed eyecup was post-fixed in 4% PFA for 
1 hour. Alexa Fluor 488-phalloidin (1:100, A12379, Thermo Fischer Scientific, Waltham, MA, USA) 
was applied for 2 hours and nuclei stained with DAPI for 30 minutes. Flatmounts were analysed 
using a fluorescent microscope (Axioplan 2, Zeiss, Switzerland). 
 
Electroretinography, fundus imaging and OCT 
Pupils of dark-adapted mice were dilated with Cyclogyl 1% (Alcon Pharmaceuticals, Fribourg, 
Switzerland) and Neosynephrine 5% (Ursapharm Schweiz GmbH, Roggwil, Switzerland). Mice were 
anesthetized by a subcutaneous injection of ketamine (85 mg/kg, Parke-Davis, Berlin, Germany) 
and xylazine (4 mg/kg, Bayer AG, Leverkusen, Germany). A drop of atropin 0.5% (Thea Pharma, 
Schaffhausen, Switzerland) was applied to each cornea just prior to placing gold ring electrodes onto 
each cornea. Recordings were done with an LKC UTAS Bigshot unit (LKC Technologies, Inc. 
Gaithersburg, MD, USA) using flash intensities from -50 db (0.000025 cd*s/m2) to 15 db (79 cd*s/m2) 
for scotopic and from -10 db (25 cd*s/m2) to 25 db (790 cd*s/m2) for photopic responses. Before 
photopic responses were recorded, mice were light-adapted for 5 minutes. Ten recordings were 
averaged per light intensity. 
For fundus imaging and OCT scans, pupils were dilated and mice anesthetized as described 
above. A drop of 2% methocel (OmniVision AG, Neuhausen, Switzerland) was applied to keep eyes 
moist. Fundus images and OCT scans were acquired using the Micron IV system (Phoenix Research 
Labs, Pleasanton, CA, USA) as described (Geiger et al., 2015). 
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RNA isolation, gene chip analysis and semi-quantitative real-time PCR 
Total RNA was purified from retinas using RNA isolation kits (RNeasy, Qiagen, Hilden, 
Germany; Machery-Nagel, Düren, Germany) according to the manufacturer’s instructions with an 
on-column DNAse treatment to digest residual genomic DNA. RNA concentrations were measured 
using a Nanodrop spectrophotometer (Thermo Fisher Scientific). The retinal transcriptomes of 11 
weeks old rodΔVhl, rodΔVhl;Hif1a, and Vhlflox/flox;Hif1aflox/flox (controls, ctrl) mice were determined at the 
Functional Genomics Center of the University of Zurich using ‘Agilent Mouse 4x44k V2’ gene chips. 
RNA isolates from 4 individual mice per genotype were analysed.  
For real-time PCR, cDNA was prepared from total RNA using oligo(dT) and M-MLV reverse 
transcriptase (Promega, Dübendorf, Switzerland). 10 ng cDNA was amplified in a LightCycler480 
instrument with SYBR Green I master mix (Roche Diagnostics). Primer pairs (Table 4) avoided 
known SNPs and were designed to span large intronic regions. Levels were normalized to Actb as 
reference gene and relative expression was calculated using the comparative threshold cycle 
method (ΔΔCT). At least 3 mice per strain were used for each time point and strain. Deletion strains 
were compared to their respective control strain, which expression was set to 1 for each time point. 
 
siRNA and shRNA-mediated gene silencing in NIH3T3 cells 
NIH3T3 cells (ATCC® CRL-1658™) were plated on 6-well plates and grown in DMEM + 10% 
heat-inactivated fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific) and 1% penicillin-
streptomycin (Gibco) at 37°C and 5% CO2 for 24 h. Cells were transfected with 80 pmol anti-Hif1a 
siRNA (5’-GUGGAUAGCGAUAUGGUCAUU-3’) using lipofectamine RNAiMAX (Invitrogen, Thermo 
Fisher Scientific) and Opti-MEM (Gibco). A scrambled sequence (AllStars negative control siRNA; 
Qiagen) served as control. 24 h after transfection, cells were or were not exposed to hypoxia (0.2% 
O2, 5% CO2) at 37°C for 6 hours. After washing with pre-warmed PBS, cells were collected with 
sample buffer and Western blotting was performed as described above. 
To test the efficiency of the corresponding anti-Hif1a shRNA, we used lentivirus-pseudotyped 
particles that were produced using HEK293T cells (ATCC® CRL-3216). Briefly, cells were plated in 
75 cm2 culture flasks and co-transfected with anti-Hif1a shRNA or non-target shRNA (Sigma) using 
the Vira-Power lentiviral expression vector system and lipofectamine 3000 (Invitrogen, Thermo 
Fisher Scientific). The following day, the medium was replaced with fresh medium containing 10% 
FBS and 1% penicillin-streptomycin. The supernatant was collected 72 h post transfection, 
centrifuged to pellet large particles and debris, and filtered through a 0.45 μm filter (Merck&Cie, 
Schaffhausen, Switzerland). The filtrate was used to transduce NIH3T3 cells with lentiviral particles 
containing sh-Hif1a or sh-ctrl and 6 μg/mL polybrene, followed by selection with 2 μg/mL puromycin. 
To test shHif1a-mediated downregulation of HIF1A in hypoxia, cells were exposed to 0.2% O2 for 6 
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h and harvested immediately thereafter. Protein homogenates were used for Western blotting as 
described above. 
 
AAV–mediated shRNA expression and analysis 
pAAV2.1-U6-shHif1a-CMV-EGFP (3x1011 vector genomes (vg)/μL) and pAAV2.1-U6-sh-
control-CMV-EGFP (3x1010 vg/μL) (Fig. S3) were packaged as AAV2/8Y733F and produced as 
described recently (Becirovic et al., 2016). For subretinal injections, the pupils were dilated and mice 
were anesthetized as described above. Viscotears (Bausch & Lomb Swiss AG, Zug, Switzerland) 
were applied to keep the eyes moist. 1.5x1010 total vg were injected into the subretinal space using 
the NanoFil Intraocular Injection Kit (WPI, Berlin, Germany). To visualize and control the injection, 
we added a small amount of fluorescein (0.1 mg/mL, Akorn Inc., IL, USA) to the AAV solution. Mice 
were injected at 5 weeks of age and analysed at 6 months of age. After euthanasia, eyes were 
marked nasally, enucleated and fixed in 4% paraformaldehyde for 1 h at 4°C as described (Heynen 
et al., 2011). Dorsoventral cryosections (12 μm) were cut, counterstained with DAPI (4',6-Diamidine-
2'-phenylindole dihydrochloride, Roche, Basel, Switzerland) and analysed by fluorescence 
microscopy (Axioplan; Zeiss, Jena, Germany). The thickness of the outer nuclear layer was 
measured at indicated distances from the optic nerve head using the Adobe Photoshop CS6 ruler 
tool (Adobe Systems, Inc., San Jose, CA, USA). Areas of tissue that was damaged due to injections 
were excluded from measurements. The average ONL thickness, excluding the optic nerve head, 
was calculated and compared (Lewin et al., 1998) after treatment with sh-Hif1a (115 measurements) 
and sh-ctrl (99 measurements) viruses. 
 
Statistical analysis 
a- and b-wave amplitudes of ERG recordings were tested using 2-way ANOVA with Sidak’s 
multiple comparison test. Gene expression in deletion strains was compared to their respective 
control strains at each time point individually and evaluated by Student’s t-test (GraphPad Prism, 
San Diego, CA, USA). Student’s t-test was also used to compare the overall ONL thickness of sh-
Hif1a and sh-crl treated mice. P-values < 0.05 were considered to show significant differences. 
Linear regression of gene expression in human samples was calculated using Prism software 
(GraphPad). 
 
Study approval 
Mouse experiments were performed in accordance with the regulations of the Veterinary 
Authority of Zurich (ZH109/2013; ZH219/2012; ZH216/2015; ZH141/2016) and with the statement 
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of ‘The Association for Research in Vision and Ophthalmology’ for the use of animals in research. 
Human retinas were collected from donor eyes that were enucleated post-mortem at the University 
Hospital Zurich, Switzerland. Collection of retinas was approved by the ethics committee of Zurich, 
Switzerland (KEK-ZH-Nr: 2015-0489) and adhered to the tenets of the Declaration of Helsinki. 
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Figure 1 
 
Fig 1. Expression of HIF controlled genes in the human retina.  
A,B) Ct-values of housekeeping genes GAPDH, RPL28 and ACTB in the central and peripheral 
retina of 10 donor eyes. 10 ng cDNA were used as template. C,D) Expression of HIF regulated  
genes in the central and peripheral retina of 10 donor eyes relative to the expression level in a 17 
year old donor. E,F) Expression of rod- and cone-specific genes in the central and peripheral retina 
of 10 donor eyes relative to the expression level in a 17 year old donor. Expression of genes was 
normalized to ACTB and the housekeeping gene RPL28 served as control (C-F). Dots: individual 
values. Lines: linear regression through all values. Note the tendency of hypoxia-regulated genes to 
be expressed at higher levels and photoreceptor-specific genes to be expressed at lower levels in 
aged human retinas. 
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Figure 2 
 
 
Fig 2. Characterization of mouse strains.  
A) Cre-positive (+) and Cre-negative (-) strains carrying floxed (f/f) alleles of Vhl, Hif1a and Hif2a 
were tested for excision of floxed sequences from genomic DNA of the retina by conventional PCR. 
2-loxP: not excised; 1-loxP: excised; NA: not applicable. Note that genomic DNA was isolated from 
total retina that included cells without CRE expression. Thus, the 2-loxP band was expected in all 
samples. B) Western blots for HIF1A and HIF2A in retinal homogenates of strains with genotypes 
as indicated. ACTB was used as control. Mice were 10-11 weeks of age. Retinal homogenates of 
wild type mice exposed to 6 h of hypoxia (7% O2) were used as positive controls. Homogenates of 
normoxic wild type mice served as negative controls. N = 3. 
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Figure 3 
 
Fig 3. Retinal morphology of mice with chronically activated HIF transcription factors in rods. 
Retinal morphology was tested at 11 weeks, 4 months, 6 months and 1 year of age as indicated. 
Cre-negative Vhlflox/flox mice served as controls. RPE: retinal pigment epithelium; POS: photoreceptor 
outer segments; PIS: photoreceptor inner segments; ONL: outer nuclear layer; INL: inner nuclear 
layer. Scale bar: 50 µm. N ≥ 3. 
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Figure 4 
 
 
Fig 4. RPE phenotype in rodΔVhl mice at 4 months of age.  
A) Fundus imaging and OCT scans of rodΔVhl;Hif1a mice (left, served as controls) and rodΔVhl mice 
(right) at 4 months of age. Red lines indicate the positions of the OCT scans. White arrows point to 
RPE irregularities in rodΔVhl mice. B) Morphology of a control and three different rodΔVhl mice at 4 
months of age. Shown are the focused regions where RPE irrgularities were detected. Arrows: 
examples of pyknotic nuclei. C) Higher magnifications of the RPE of a control and a rodΔVhl mouse. 
Red lines indicate borders of the RPE. D) RPE flatmounts of rodΔVhl;Hif1a and rodΔVhl mice as indicated. 
Green: F-actin stained with phalloidin. Blue: nuclei stained with DAPI. RPE: retinal pigment 
epithelium; POS: photoreceptor outer segments; PIS: photoreceptor inner segments; ONL: outer 
nuclear layer; INL: inner nuclear layer. Scale bars: 100 μm (A) and 50 µm (B-D). 
  
 
 
  
  Results 
87 
Figure 5 
 
 
 
Fig 5. Scotopic retinal function of rodΔVhl, rodΔVhl;Hif1a, rodΔVhl;Hif2a, and rodΔVhl;Hif1a;Hif2a mice at 6 months 
of age.  
A) Scotopic ERG traces were recorded after light stimuli of increasing light intensities. Shown are 
representative traces. Cre-negative Vhlflox/flox mice served as controls. B) Scotopic a- and b-wave 
amplitudes plotted as a function of stimulus intensity. Control mice were Cre-negative littermates of 
the respective strains. Shown are averages ± SD. N = 6 eyes (3 mice), except for controls of 
rodΔVhl;Hif2a (N = 5) and of rodΔVhl;Hif2a  (N = 7), and for rodΔVhl;Hif1a;Hif2a (N = 4). *: P < 0.05. 2-way ANOVA 
with Sidak’s multiple comparison test. 
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Figure 6 
 
 
 
Fig 6. Retinal gene expression.  
Retinal expression of indicated genes was tested in retinas of rodΔVhl (V), rodΔVhl;Hif1a (VH1), rodΔVhl;Hif2a 
(VH2), and rodΔVhl;Hif1a;Hif2a (VH1H2) mice at 11 weeks, 4 months and 6 months of age. Expression 
levels were calculated relative to their respective Cre-negative controls (set to 1; dotted line). Shown 
are means ± SD of N = 3-4. *: P < 0.05; **: P < 0.01; ***: P < 0.001. Individual comparisons between 
Cre-positive and Cre-negative mice of each genotype were done using Student’s t-test. 
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Figure 7 
 
  
 
Fig 7. Protein levels in retinal homogenates.  
Western blot for indicated proteins in mice at 10-11 weeks of age. Retinal homogenates of wild type 
mice exposed to 6 h of hypoxia (7% O2) were used as positive controls. Homogenates of normoxic 
wild type mice served as negative controls. Note that homogenates were the same as those used 
for Fig. 2B and the same ACTB control is shown. N = 3. 
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Figure 8 
 
 
Fig 8. Age-dependent gene expression in the human retina.  
A,B) Expression of LIF, CASP1, FGF2 and EDN2 in the central and peripheral human retina. C,D) 
Expression of LOXL4, LAD1 and SMTNL2 in the central and peripheral human retina. Expression 
levels were normalized to ACTB and are shown relative to the levels in the retina of a 17 year old 
donor. The housekeeping gene RLP28 served as control. Dots: individual values. Lines: linear 
regression through all values. 
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Figure 9 
 
Fig 9. Efficacy of RNA interference and anti-Hif1a gene therapy.  
A) NIH3T3 cells were transiently transfected with si-Hif1a RNA or stably transfected with shHif1a, or 
treated with the respective scrambled controls as indicated, followed by exposure to 0.2% oxygen 
(hypoxia) or normoxia. Not transfected cells (nt) exposed to hypoxia served as controls. Levels of 
HIF1A, STAT3 and ACTB were detected by Western blotting. B) Fluorescent fundus imaging (upper 
panels) and OCT scans (lower panels) of eyes that received a subretinal injection of AAV2/8(Y733F) 
particles expressing either the control sh-RNA sequence (left, sh-ctrl) or the sh-Hif1a sequence (sh-
Hif1a, right) together with EGFP. The red line in the fundus image indicates the position of the OCT 
scan. C) Retinal cross sections of mice injected with the control (left, sh-ctrl) or the sh-Hif1a virus 
(right, sh-Hif1a). Lower panels are higher magnifications of retinal areas marked with a white square 
in the upper panels. White arrow: damage due to injection. Scale bar: 50 µm. D) Spidergram of the 
ONL thickness 5 months after injection of the control (black line, sh-ctrl) or the sh-Hif1a virus (blue 
line, sh-Hif1a). All mice were injected at 5 weeks and analysed at 6 months of age. Areas of obvious 
injection-inflicted damage (see white arrow in (C) as an example) were excluded from quantification. 
Shown are means ± SEM. N = 6. E) Quantification of the ONL thickness of sh-Hif1a (blue bar) and 
sh-ctrl (black bar) virus injected mice at 6 months of age. All data points (115 for sh-Hif1a; 99 for sh-
ctrl) shown in (D) were included. Shown are means ± SEM. **: P < 0.01. ONL: outer nuclear layer. 
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Table 1. Human retina samples used in the study 
Nr Age Gender Post mortem-time Cause of death 
HE19 17 male 30 h Accident 
HE4 24 male 21 h Heart failure 
HE6 57 male 13 h Multiorgan failure 
HE11 58 male 31 h Accident / brain trauma 
HE1 72 male 13 h Cardiogenic shock 
HE16 74 male 35 h Prostata adenocarcinoma 
HE17 78 male 27 h Heart failure 
HE13 80 female 15 h Cerebral ischemia 
HE15 91 female 23 h Aortic stenosis 
HE3 92 male 36 h Gastrointestinal bleeding 
 
Table 2. Primers used for genotyping 
Gene Primer sequence (5’ – 3’) Products [bp] 
Vhl forward:  TGAGTATGGGATAACGGGTTGAAC wt: 125 floxed: 317 
 reverse:  AGAACTGACTGACTTCCACTGATGC   
Hif1a forward:  GGAGCTATCTCTCTAGACC wt: 215 floxed: 260 
 reverse:  GCAGTTAAGAGCACTAGTTG   
Hif2a forward:  TGTAGGCAAGGAAACCAAGG wt: 182 floxed: 220 
 reverse:  GAGAGCAGCTTCTCCTGGAA   
OpsinCre forward:  AGGTGTAGAGAAGGCACTTAGC wt: – cre: 441 
 reverse:  CTAATCGCCATCTTCCAGCAGG   
 
Table 3. Primers used to test for genomic excision 
Gene Primer sequence (5’ – 3’) 
Product [bp] 
wt 1-loxP 2-loxP 
Vhl forward-1 CTGGTACCCACGAAACTGTC 286 ~260 ~460 
 forward-2 CTAGGCACCGAGCTTAGAGGTTTGCG    
 reverse-1+2: CTGACTTCCACTGATGCTTGTCACAG    
Hif1a forward-1: TTGGGGATGAAAACATCTGC 215 ~270 ~260 
 forward-2 GGAGCTATCTCTCTAGACC    
 reverse-1+2: GCAGTTAAGAGCACTAGTTG    
Hif2a forward-1: GCTAACACTGTACTGTCTGAAAGAGTAGC 457 ~300 ~550 
 forward-2 CTTCTTCCATCATCTGGGATCTGGGACT    
 reverse-1+2: CAGGCAGTATGCCTGGCTAATTCCAGTT    
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Table 4. Primers used for real-time PCR 
 
 
 
 
 
 
  
Gene Forward 5’ – 3’ Reverse 5’ – 3’ Product [bp] 
Human-specific primers 
ACTB CCTGGCACCCAGCACAAT GGGCCGGACTCGTCATAC 144 
GAPDH CTTCGCTCTCTGCTCCTCCT ATCCGTTGACTCCGACCTTC 111 
RPL28 GCAATTCCTTCCGCTACAAC TGTTCTTGCGGATCATGTGT 198 
ADM ATCACTCTCTTAGCAGGGTCT CCACTTATTCCACTTCTTTCG 148 
VEGFA GTGGACATCTTCCAGGAGTACC TGTTGTGCTGTAGGAAGCTCAT 205 
GLUT1 ACTGTCGTGTCGCTGTTTG CCAGGACCCACTTCAAAGAA 191 
PDK1 CACGCTGGGTAATGAGGATT GGAGGTCTCAACACGAGGT 127 
RHO ATCATGGTCATCGCTTTCCT CTTGGACACGGTAGCAGAG 252 
GNAT2 CTGCTACTGCTGGGTGCT TGGTGAATAGCCATCCTGGT 84 
PDE6A CTACCAGATGAAATCCCAGAAC CTTGAAATACAGGGCGAGGT 202 
PDE6C AACTGTTTCAAACTGCCGCT TATTTTGGAGAGGCACCACC 100 
LOXL4 AACTGCCTCTCCAAGTCTGC AGGAGGTCGTAGTGGGTGAA 191 
LAD1 CCTTTCGGATGAAACCCAAGA CCCACAGGAGCCACGAATA 187 
SMTNL2 AACTTCGAGCTGGCTTTCA CATCACCATCATGTCCTCCA 81 
LIF TGCCAATGCCCTCTTTATTC AGGTGCCAAGGTACACGACT 170 
EDN2 TGTGCCACCTTCTGCCTTC TGGAAATGTCCCTCAGCCTT 139 
FGF2 AGAAGAGCGACCCTCACATCAAG TCATCCGTAACACATTTAGAAGCCAG 139 
CASP1 CCACAATGGGCTCTGTTTTT GCTCTACCATCTGGCTGCTC 124 
    
Mouse-specific primers 
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 153 
Adm TCCTGGTTTCTCGGCTTCTC ATTCTGTGGCGATGCTCTGA 133 
Vegf ACTTGTGTTGGGAGGAGGATGTC AATGGGTTTGTCGTGTTTCTGG 171 
Bnip3 CCTGTCGCAGTTGGGTTC GAAGTGCAGTTCTACCCAGGAG 93 
Egln1 CATTGTTGGCAGAAGGTGTG CAAAGGACTACAGGGTCTCCA 70 
Lif AATGCCACCTGTGCCATACG CAACTTGGTCTTCTCTGTCCCG 216 
Edn2 AGACCTCCTCCGAAAGCTG CTGGCTGTAGCTGGCAAAG 64 
Fgf2 TGTGTCTATCAAGGGAGTGTGTGC ACCAACTGGAGTATTTCCGTGACCG 158 
Casp1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC 138 
Pdk1 GTTGAAACGTCCCGTGCT AGTCTCTCGACGGATTCTGT 170 
Glut1 CAGTGTATCCTGTTGCCCTTCTG GCCGACCCTCTTCTTTCATCTC 151 
Stat3 CAAAACCCTCAAGAGCCAAGG TCACTCACAATGCTTCTCCGC 132 
Gfap CCACCAAACTGGCTGATGTCTAC TTCTCTCCAAATCCACACGAGC 240 
Smtnl2 GCATCTTGGAGAACGGACA CAGAGAATTTCTCGGAGACTCG 168 
Lad1 CACCCAGAATGGAGCTCAG CACCTGCCGCCTCTGTCTCCG 154 
Loxl4 GTTGCACAACTGCCACACA GGAGTGCAGTAATGGCTTC 108 
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Supplemental Information 
 
Deletion of Vhl in rods may affect function in cones 
Photopic ERG recordings of rodΔVhl mice at 6 months of age showed reduced b-wave amplitudes 
suggesting that cones were affected by the hypoxic response in rods. After the additional rod-specific 
deletion of Hif1a, of Hif2a or of both Hif1a and Hif2a photopic b-wave amplitudes of deletion strains 
were not distinguishable from their respective controls (Fig. S1). Importantly, photopic ERGs were 
recorded in the same mice and during the same experimental session used to determine the scotopic 
ERGs shown in Fig. 5. The reduced photopic response in rodΔVhl mice may not have been caused 
by a significant loss of cones since expression of cone specific transducin (Gnat2) was not affected 
at 6 months of age (Fig. 6), the timepoint of the functional tests. Thus, the hypoxic response of rods 
between 10 weeks and 6 months of age may have induced a lasting effect on cone function by 
unknown mechanisms. These putative mechanisms may depend on both HIF1 and HIF2 
transcription factors as additional deletion of either factor in rodΔVhl mice prevented the effect. 
 
Transcriptomic analysis 
To detect genes that may be under transcriptional control of HIF1 and/or HIF2 in rods and that may 
contribute to the degenerative phenotype in rodΔVhl mice, we determined the retinal transcriptome of 
rodΔVhl, rodΔVhl;Hif1a and Vhlflox/flox;Hif1aflox/flox control mice and compared them to each other. Tables 
S1 – S3 show the top 20 up- and down regulated genes of each individual comparison. The full lists 
of genes analysed can be found in Files S1 – S3. Inactivation of Vhl in rods had a strong impact on 
the retinal transcriptome with 657 and 245 genes that were more than 2-fold (P < 0.05) up- or down-
regulated, respectively. In contrast, only 30 genes were more than 2-fold (P < 0.05) up- and 29 genes 
down-regulated in rodΔVhl;Hif1a mice when compared to controls. Whereas the differentially regulated 
genes in rodΔVhl mice may be mostly controlled by HIF1, HIF2 and/or STAT3, the genes found in 
rodΔVhl;Hif1a mice may be primarily regulated by HIF2. When we compared differentially regulated 
genes in rodΔVhl to those in rodΔVhl;Hif1a mice we identified 493 genes that were expressed at least 2-
fold higher than in rodΔVhl mice and 246 genes that were down regulated. These genes may be 
primarily regulated by HIF1 and/or STAT3, but not by HIF2. Venn diagrams of up- and down-
regulated genes showed that genes differentially regulated in rodΔVhl mice were largely overlapping 
with those regulated in rodΔVhl when compared to rodΔVhl;Hif1a mice. But both had only little overlap to 
the differentially regulated genes rodΔVhl;Hif1a mice (Fig. S2A). RodΔVhl;Hif1a mice had overlaps only with 
rodΔVhl mice since both mice had HIF2 activated. This was not the case in the list of genes that 
resulted from the comparison of rodΔVhl mice with rodΔVhl;Hif1a mice as already stated above. The gene 
that was commonly downregulated in all three gene lists was Igh-VJ558, a gene that has been 
implicated in the immune response, leukocyte migration and apoptosis (1, 2). The strongly different 
retinal transcriptome of rodΔVhl mice and the similarity of rodΔVhl;Hif1a to controls is also obvious from 
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the cluster heat map (Fig. S2B). Thus, inactivating Hif1a in mice lacking Vhl results in only few 
transcriptomic changes that may be attributable to HIF2. 
To evaluate the regulation of the genes in more detail, we cross-compared the top regulated genes 
of all three lists. Table S4 uses the top 20 up- and down regulated genes in rodΔVhl mice (see Table 
S1) as reference list. Fold-changes of these genes as detected in the other lists are shown for direct 
comparison. The same was done using the 20 top regulated genes in rodΔVhl when compared to 
rodΔVhl;Hif1a (see Table S2) as reference list (Table S5); and using the 20 top regulated in genes in 
rodΔVhl;Hif1a (see Table S3) as reference list (Table S6). It is apparent that the transcriptome of 
rodΔVhl;Hif1a mice differs strongly from rodΔVhl mice. Genes that were differentially regulated in 
rodΔVhl;Hif1a and rodΔVhl mice compared to their respective controls, but not in rodΔVhl mice when 
compared to rodΔVhl;Hif1a are good candidates to be regulated by HIF2 in rod photoreceptors. These 
genes included five (Prim2, Gadl1, Xlrb4, Slurp1, Mybph) up- and eight (Mns1, Lmod1, Lce1i, Lce1d, 
Lce1f, Cd27, Ak7, Calm4) down-regulated genes that were not defined as HIF2 targets so far. 
Clearly, however, HIF2-regulated expression of these genes needs to be verified by additional tests 
in future experiments.  
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Figure S1 
 
Fig. S1. Retinal function. Photopic retinal function was tested in 6 months old rodΔVhl, rodΔVhl;Hif1a, 
rodΔVhl;Hif2a, and rodΔVhl;Hif1a;Hif2a mice. Cre-negative Vhlflos/flox mice served as controls. A) 
Representative photopic ERG traces recorded after light stimuli of increasing light intensities. B) 
Photopic b-wave amplitudes plotted as a function of stimulus intensity. Control mice were Cre-
negative littermates of the respective strains. Shown are averages ± SD. N = 6 eyes (3 mice), except 
for controls of rodΔVhl;Hif2a (N = 5), rodΔVhl;Hif2a  (N = 7) and rodΔVhl;Hif1a;Hif2a (N = 4). *: P < 0.05. 2-way 
ANOVA with Sidak’s multiple comparison test. 
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Figure S2 
 
Fig. S2. Differentially regulated genes. A) Venn diagrams of genes differentially regulated in rodΔVhl 
(compared to controls; green), rodΔVhl;Hif1a (compared to controls; blue) and rodΔVhl (compared to 
rodΔVhl;Hif1a; orange). Controls were Vhlflox/flox;Hif1aflox/flox mice. Genes with a fold change of ≥ 2 and a 
P-value < 0.05 were included in the analysis. B) Cluster heat map of the transcriptomic data. Note 
the close relationship between rodΔVhl;Hif1a and control mice. 
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Figure S3 
 
Fig. S3. Schematic representation of viral construct. Expression of sh-Hif1a is controlled by the U6 
promoter. Expression of EGFP is driven by the CMV enhancer and CMV promoter. A woodchuck 
hepatitis post-transcriptional regulatory element (WPRE) is added before the bovine growth hormone 
(bGH) poly(A) signal. ITR: inverted terminal repeat. The entire cassette is 3001 bp in length. 
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Table S1. Top regulated genes in retinas of rodΔVhl mice, relative to Vhlflox/flox;Hif1aflox/flox ctrl 
mice 
Top 20 genes upregulated in retinas of rodΔVhl mice 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue Description 
71957 Ints11 162.9 4.09E-07 integrator complex subunit 11 
76487 Ppp1r3g 79.7 8.93E-10 protein phosphatase 1, regulatory (inhibitor) subunit 3G 
223780 Adm2 71.9 9.09E-08 adrenomedullin 2 
13615 Edn2 62.7 4.30E-08 endothelin 2 
67573 Loxl4 33.9 1.83E-05 lysyl oxidase-like 4 
240913 Adamts4 31.9 1.61E-04 
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin 
type 1 motif, 4 
16763 Lad1 30.3 6.58E-07 ladinin 
14663 Glycam1 25.2 3.39E-05 glycosylation dependent cell adhesion molecule 1 
11535 Adm 23.7 1.12E-07 adrenomedullin 
17339 Mip 22.9 8.08E-03 major intrinsic protein of eye lens fiber 
214301 Crygn 22.3 6.26E-03 crystallin, gamma N 
192199 Rspo1 21.7 7.82E-03 R-spondin homolog (Xenopus laevis) 
233187 Lim2 21.6 4.19E-03 lens intrinsic membrane protein 2 
12954 Cryaa 20.9 7.34E-03 crystallin, alpha A 
20856 Stc2 20.7 1.13E-06 stanniocalcin 2 
77998 Grifin 19.8 3.58E-03 galectin-related inter-fiber protein 
12051 Bcl3 19.5 1.62E-06 B-cell leukemia/lymphoma 3 
276829 Smtnl2 17.0 9.83E-08 smoothelin-like 2 
381359 Prdm12 16.2 1.72E-05 PR domain containing 12 
100039660 Ect2l 15.5 1.72E-05 epithelial cell transforming sequence 2 oncogene-like 
     
Top 20 genes downregulated in retinas of rodΔVhl mice 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue Description 
258198 Olfr224 0.015 2.21E-06 olfactory receptor 224 
80509 Med8 0.015 3.21E-07 mediator of RNA polymerase II transcription, subunit 8 homolog (yeast) 
76681 Trim12a 0.024 2.23E-08 tripartite motif-containing 12A 
30939 Pttg1 0.026 1.03E-09 pituitary tumor-transforming gene 1 
54631 Nphs1 0.032 1.02E-07 nephrosis 1 homolog, nephrin (human) 
14537 Gcnt1 0.039 1.14E-09 glucosaminyl (N-acetyl) transferase 1, core 2 
75764 Slx1b 0.051 2.71E-09 SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae) 
72154 Zfp157 0.058 4.90E-07 zinc finger protein 157 
269209 Stk36 0.091 4.27E-06 serine/threonine kinase 36 (fused homolog, Drosophila) 
214523 Tmprss4 0.095 2.39E-08 transmembrane protease, serine 4 
17427 Mns1 0.100 1.01E-06 meiosis-specific nuclear structural protein 1 
72461 Prcp 0.115 1.35E-08 prolylcarboxypeptidase (angiotensinase C) 
16061 Igh-VJ558 0.117 4.18E-04 immunoglobulin heavy chain (J558 family) 
140709 Emid2 0.120 1.01E-06 EMI domain containing 2 
17921 Myo7a 0.124 1.77E-07 myosin VIIA 
94216 Col4a6 0.129 3.29E-04 collagen, type IV, alpha 6 
69611 Lce1d 0.148 1.60E-02 late cornified envelope 1D 
71687 Tmem25 0.154 6.43E-08 transmembrane protein 25 
12769 Ccr9 0.163 5.52E-03 chemokine (C-C motif) receptor 9 
66442 Spc25 0.168 7.49E-05 SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) 
 
Genes with P > 0.05 were excluded from the analysis, as were ‘Rik’ sequences, ‘expressed 
sequences’, ‘predicted genes’ and ‘hypothetical proteins’. Also excluded was ‘Xist’ as this gene is X-
linked and the number of females and males in the gene chip analyses were not balanced. 
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Table S2. Top regulated genes in retinas of rodΔVhl mice, relative to rodΔVhl;Hif1a mice  
Top 20 genes upregulated in retinas of rodΔVhl mice 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue Description 
71957 Ints11 282.8 5.20E-09 integrator complex subunit 11 
223780 Adm2 70.9 1.19E-06 adrenomedullin 2 
13615 Edn2 65.8 3.12E-08 endothelin 2 
76487 Ppp1r3g 59.2 5.15E-06 protein phosphatase 1, regulatory (inhibitor) subunit 3G 
240913 Adamts4 24.7 2.89E-04 
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin 
type 1 motif, 4 
11535 Adm 23.5 6.34E-08 adrenomedullin 
16763 Lad1 23.3 3.38E-05 ladinin 
67573 Loxl4 22.4 2.51E-04 lysyl oxidase-like 4 
381359 Prdm12 19.5 1.37E-05 PR domain containing 12 
12051 Bcl3 18.7 4.52E-06 B-cell leukemia/lymphoma 3 
233187 Lim2 17.0 2.37E-02 lens intrinsic membrane protein 2 
17339 Mip 16.3 2.49E-02 major intrinsic protein of eye lens fiber 
21818 Tgm3 15.6 4.76E-04 transglutaminase 3, E polypeptide 
20856 Stc2 13.8 5.69E-07 stanniocalcin 2 
276829 Smtnl2 13.2 2.79E-07 smoothelin-like 2 
14663 Glycam1 13.0 1.27E-03 glycosylation dependent cell adhesion molecule 1 
15006 H2-Q1 12.2 9.49E-06 histocompatibility 2, Q region locus 1 
14173 Fgf2 11.6 7.27E-06 fibroblast growth factor 2 
192199 Rspo1 11.3 2.04E-02 R-spondin homolog (Xenopus laevis) 
12954 Cryaa 10.9 1.64E-02 crystallin, alpha A 
     
Top 20 genes downregulated in retinas of rodΔVhl mice 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue Description 
76681 Trim12a 0.014 8.54E-09 tripartite motif-containing 12A 
80509 Med8 0.025 1.54E-06 mediator of RNA polymerase II transcription, subunit 8 homolog (yeast) 
30939 Pttg1 0.026 1.81E-10 pituitary tumor-transforming gene 1 
258198 Olfr224 0.027 2.80E-05 olfactory receptor 224 
54631 Nphs1 0.028 4.80E-07 nephrosis 1 homolog, nephrin (human) 
75764 Slx1b 0.034 4.22E-09 SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae) 
14537 Gcnt1 0.035 3.59E-11 glucosaminyl (N-acetyl) transferase 1, core 2 
109685 Hyal3 0.052 3.57E-06 hyaluronoglucosaminidase 3 
72154 Zfp157 0.053 2.11E-07 zinc finger protein 157 
17921 Myo7a 0.074 3.64E-08 myosin VIIA 
214523 Tmprss4 0.084 2.07E-08 transmembrane protease, serine 4 
72461 Prcp 0.101 9.91E-09 prolylcarboxypeptidase (angiotensinase C) 
269209 Stk36 0.103 4.68E-06 serine/threonine kinase 36 (fused homolog, Drosophila) 
94216 Col4a6 0.112 3.70E-04 collagen, type IV, alpha 6 
140709 Emid2 0.112 9.73E-07 EMI domain containing 2 
209760 Tmc7 0.129 1.24E-05 transmembrane channel-like gene family 7 
68668 Klk5 0.134 1.22E-02 kallikrein related-peptidase 5 
71687 Tmem25 0.156 7.66E-08 transmembrane protein 25 
19223 Ptgis 0.167 2.71E-06 prostaglandin I2 (prostacyclin) synthase 
18261 Ocm 0.175 1.41E-05 oncomodulin 
 
Genes with P > 0.05 were excluded from the analysis, as were ‘Rik’ sequences, ‘expressed 
sequences’, ‘predicted genes’ and ‘hypothetical proteins’. Also excluded was ‘Xist’ as this gene is X-
linked and the number of females and males in the gene chip analyses were not balanced. 
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Table S3. Top regulated genes in retinas of rodΔVhl;Hif1a mice, relative to Vhlflox/flox;Hif1aflox/flox 
control mice 
Top 20 genes upregulated in retinas of rodΔVhl;Hif1a mice 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue Description 
109685 Hyal3 7.0 1.26E-02 hyaluronoglucosaminidase 3 
19076 Prim2 5.3 7.60E-09 DNA primase, p58 subunit 
77044 Arid2 4.8 3.88E-02 AT rich interactive domain 2 (ARID, RFX-like) 
434794 Xlr4a 4.5 8.59E-03 X-linked lymphocyte-regulated 4A 
628171 Olfr936 3.4 5.31E-03 olfactory receptor 936 
73748 Gadl1 3.3 1.48E-02 glutamate decarboxylase-like 1 
545548 Lce3a 2.9 3.65E-03 late cornified envelope 3A 
12534 Cdk1 2.9 8.44E-03 cyclin-dependent kinase 1 
27083 Xlr4b 2.9 3.77E-02 X-linked lymphocyte-regulated 4B 
57277 Slurp1 2.8 2.82E-02 secreted Ly6/Plaur domain containing 1 
17748 Mt1 2.7 6.82E-08 metallothionein 1 
53311 Mybph 2.7 3.58E-02 myosin binding protein H 
67652 Spaca1 2.7 8.29E-05 sperm acrosome associated 1 
194597 Tmprss11a 2.5 4.75E-03 transmembrane protease, serine 11a 
230678 Tmem125 2.4 1.02E-03 transmembrane protein 125 
244332 Defb14 2.3 5.00E-03 defensin beta 14 
14428 Galr2 2.3 1.65E-02 galanin receptor 2 
238393 Serpina3f 2.3 2.42E-05 serine (or cysteine) peptidase inhibitor, clade A, member 3F 
22326 Vax1 2.2 3.28E-02 ventral anterior homeobox containing gene 1 
69930 Zfp715 2.2 2.04E-02 zinc finger protein 715 
     
Top 20 genes downregulated in retinas of rodΔVhl;Hif1a mice 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue Description 
353371 Oxct2b 0.183 1.24E-02 3-oxoacid CoA transferase 2B 
17427 Mns1 0.254 1.58E-02 meiosis-specific nuclear structural protein 1 
51925 D2Ertd640e 0.260 2.78E-04 DNA segment, Chr 2, ERATO Doi 640, expressed 
93689 Lmod1 0.324 3.44E-02 leiomodin 1 (smooth muscle) 
76585 Lce1i 0.335 5.87E-03 late cornified envelope 1I 
69611 Lce1d 0.338 2.88E-02 late cornified envelope 1D 
56057 Btg4 0.356 4.73E-02 B-cell translocation gene 4 
16061 Igh-VJ558 0.357 7.34E-03 immunoglobulin heavy chain (J558 family) 
236904 Klhl15 0.375 1.83E-02 kelch-like 15 (Drosophila) 
67828 Lce1f 0.376 1.43E-02 late cornified envelope 1F 
20521 Slc22a12 0.377 3.41E-04 solute carrier family 22 (organic anion/cation transporter), member 12 
21940 Cd27 0.380 1.84E-02 CD27 antigen 
78801 Ak7 0.385 4.67E-04 adenylate kinase 7 
68694 Lce1e 0.394 2.09E-02 late cornified envelope 1E 
258692 Olfr1442 0.395 1.93E-02 olfactory receptor 1442 
76117 Arhgap15 0.397 2.29E-03 Rho GTPase activating protein 15 
246746 Cd300lf 0.398 4.89E-02 CD300 antigen like family member F 
96875 Prg4 0.400 1.36E-04 
proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone 
protein) 
15130 Hbb-b2 0.402 2.54E-02 hemoglobin, beta adult minor chain 
80796 Calm4 0.402 2.60E-02 calmodulin 4 
 
Genes with P > 0.05 were excluded from the analysis, as were ‘Rik’ sequences, ‘expressed 
sequences’, ‘predicted genes’ and ‘hypothetical proteins’. Also excluded was ‘Xist’ as this gene is X-
linked and the number of females and males in the gene chip analyses were not balanced. 
 
 
  
  Results 
102 
Table S4. Comparison to top 20 genes that were differentially regulated in rodΔVhl mice 
relative to Vhlflox/flox;Hif1aflox/flox control mice 
Reference list: Table S1: rodΔVhl vs ctrl 
Upregulated genes  
Potential targets of: HIF1; HIF2; pSTAT3 
rodΔVhl vs rodΔVhl;Hif1a rodΔVhl;Hif1a vs ctrl 
potential targets of:  
HIF1; pSTAT3 
potential targets of:  
HIF2 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue ratio pValue ratio pValue 
71957 Ints11 162.9 4.09E-07 282.8 5.20E-09 – – 
76487 Ppp1r3g 79.7 8.93E-10 59.2 5.15E-06 – – 
223780 Adm2 71.9 9.09E-08 70.9 1.19E-06 – – 
13615 Edn2 62.7 4.30E-08 65.8 3.12E-08 – – 
67573 Loxl4 33.9 1.83E-05 22.4 2.51E-04 – – 
240913 Adamts4 31.9 1.61E-04 24.7 2.89E-04 – – 
16763 Lad1 30.3 6.58E-07 23.3 3.38E-05 – – 
14663 Glycam1 25.2 3.39E-05 13.0 1.27E-03 – – 
11535 Adm 23.7 1.12E-07 23.5 6.34E-08 – – 
17339 Mip 22.9 8.08E-03 16.3 2.49E-02 – – 
214301 Crygn 22.3 6.26E-03 † 10.3 † 1.19E-02 – – 
192199 Rspo1 21.7 7.82E-03 11.3 2.04E-02 – – 
233187 Lim2 21.6 4.19E-03 17.0 2.37E-02 – – 
12954 Cryaa 20.9 7.34E-03 10.9 1.64E-02 – – 
20856 Stc2 20.7 1.13E-06 13.8 5.69E-07 – – 
77998 Grifin 19.8 3.58E-03 † 10.7 † 1.75E-02 – – 
12051 Bcl3 19.5 1.62E-06 18.7 4.52E-06 – – 
276829 Smtnl2 17.0 9.83E-08 13.2 2.79E-07 † 1.3 † 1.34E-02 
381359 Prdm12 16.2 1.72E-05 19.5 1.37E-05 – – 
100039660 Ect2l 15.5 1.72E-05 † 10.8 † 3.46E-05 – – 
     
Reference list: Table S1: rodΔVhl vs ctrl 
Downregulated genes  
Potential targets of: HIF1; HIF2; pSTAT3  
rodΔVhl vs rodΔVhl;Hif1a rodΔVhl;Hif1a vs ctrl 
potential targets of:  
HIF1; pSTAT3 
potential targets of:  
HIF2 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue ratio pValue ratio pValue 
258198 Olfr224 0.015 2.21E-06 0.027 2.80E-05 – – 
80509 Med8 0.015 3.21E-07 0.025 1.54E-06 – – 
76681 Trim12a 0.024 2.23E-08 0.014 8.54E-09 † 1.68 † 3.77E-03 
30939 Pttg1 0.026 1.03E-09 0.026 1.81E-10 – – 
54631 Nphs1 0.032 1.02E-07 0.028 4.80E-07 – – 
14537 Gcnt1 0.039 1.14E-09 0.035 3.59E-11 – – 
75764 Slx1b 0.051 2.71E-09 0.034 4.22E-09 † 1.49 † 9.70E-03 
72154 Zfp157 0.058 4.90E-07 0.053 2.11E-07 – – 
269209 Stk36 0.091 4.27E-06 0.103 4.68E-06 – – 
214523 Tmprss4 0.095 2.39E-08 0.084 2.07E-08 – – 
17427 Mns1 0.100 1.01E-06 – – † 0.25 † 1.58E-02 
72461 Prcp 0.115 1.35E-08 0.101 9.91E-09 † 1.14 † 2.83E-02 
16061 Igh-VJ558 0.117 4.18E-04 † 0.313 † 2.28E-02 † 0.37 † 1.28E-02 
140709 Emid2 0.120 1.01E-06 0.112 9.73E-07 – – 
17921 Myo7a 0.124 1.77E-07 0.074 3.64E-08 † 1.75 † 1.24E-04 
94216 Col4a6 0.129 3.29E-04 0.112 3.70E-04 – – 
69611 Lce1d 0.148 1.60E-02 – – † 0.34 † 2.88E-02 
71687 Tmem25 0.154 6.43E-08 0.156 7.66E-08 – – 
12769 Ccr9 0.163 5.52E-03 – – – – 
66442 Spc25 0.168 7.49E-05 † 0.183 † 1.35E-04 – – 
 
Genes with P > 0.05 were excluded from the analysis, as were ‘Rik’ sequences, ‘expressed 
sequences’, ‘predicted genes’ and ‘hypothetical proteins’. Also excluded was ‘Xist’ as this gene is X-
linked and the number of females and males in the gene chip analyses were not balanced. 
† : not present in the top 20 regulated genes of the respective list 
– : not present in the respective list of genes, or P > 0.05  
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Table S5. Comparison to top 20 genes that were differentially regulated in rodΔVhl relative to 
rodΔrod;Hif1a mice  
Reference list: Table S2: rodΔVhl vs rodΔVhl;Hif1a 
Upregulated genes  
Potential targets of: HIF1; pSTAT3  
rodΔVhl;Hif1a vs ctrl rodΔVhl vs ctrl 
potential targets of:  
HIF2 
potential targets of: 
HIF1; HIF2; pSTAT3 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue ratio pValue ratio pValue 
71957 Ints11 282.8 5.20E-09 – – 162.9 4.09E-07 
223780 Adm2 70.9 1.19E-06 – – 71.9 9.09E-08 
13615 Edn2 65.8 3.12E-08 – – 62.7 4.30E-08 
76487 Ppp1r3g 59.2 5.15E-06 – – 79.7 8.93E-10 
240913 Adamts4 24.7 2.89E-04 – – 31.9 1.61E-04 
11535 Adm 23.5 6.34E-08 – – 23.7 1.12E-07 
16763 Lad1 23.3 3.38E-05 – – 30.3 6.58E-07 
67573 Loxl4 22.4 2.51E-04 – – 33.9 1.83E-05 
381359 Prdm12 19.5 1.37E-05 – – 16.2 1.72E-05 
12051 Bcl3 18.7 4.52E-06 – – 19.5 1.62E-06 
233187 Lim2 17.0 2.37E-02 – – 21.6 4.19E-03 
17339 Mip 16.3 2.49E-02 – – 22.9 8.08E-03 
21818 Tgm3 15.6 4.76E-04 – – † 14.5 † 2.99E-05 
20856 Stc2 13.8 5.69E-07 – – 20.7 1.13E-06 
276829 Smtnl2 13.2 2.79E-07 † 1.3 † 1.34E-02 17.0 9.83E-08 
14663 Glycam1 13.0 1.27E-03 – – 25.2 3.39E-05 
15006 H2-Q1 12.2 9.49E-06 – – † 10.3 † 2.26E-06 
14173 Fgf2 11.6 7.27E-06 – – † 9.86 † 1.01E-05 
192199 Rspo1 11.3 2.04E-02 – – 21.7 7.82E-03 
12954 Cryaa 10.9 1.64E-02 – – 20.9 7.34E-03 
     
Reference list: Table S2: rodΔVhl vs rodΔVhl;Hif1a 
Downregulated genes  
Potential targets of: HIF1; pSTAT3  
rodΔVhl;Hif1a vs ctrl rodΔVhl vs ctrl 
potential targets of:  
HIF2 
potential targets of:  
HIF1; HIF2; pSTAT3 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue ratio pValue ratio pValue 
76681 Trim12a 0.014 8.54E-09 † 1.68 † 3.77E-03 0.024 2.23E-08 
80509 Med8 0.025 1.54E-06 – – 0.015 3.21E-07 
30939 Pttg1 0.026 1.81E-10 – – 0.026 1.03E-09 
258198 Olfr224 0.027 2.80E-05 – – 0.015 2.21E-06 
54631 Nphs1 0.028 4.80E-07 – – 0.032 1.02E-07 
75764 Slx1b 0.034 4.22E-09 † 1.49 † 9.70E-03 0.051 2.71E-09 
14537 Gcnt1 0.035 3.59E-11 – – 0.039 1.14E-09 
109685 Hyal3 0.052 3.57E-06 6.96 1.26E-02 – – 
72154 Zfp157 0.053 2.11E-07 – – 0.058 4.90E-07 
17921 Myo7a 0.074 3.64E-08 † 1.75 † 1.24E-04 0.124 1.77E-07 
214523 Tmprss4 0.084 2.07E-08 – – 0.095 2.39E-08 
72461 Prcp 0.101 9.91E-09 † 1.14 † 2.83E-02 0.115 1.35E-08 
269209 Stk36 0.103 4.68E-06 – – 0.091 4.27E-06 
94216 Col4a6 0.112 3.70E-04 – – 0.129 3.29E-04 
140709 Emid2 0.112 9.73E-07 – – 0.120 1.01E-06 
209760 Tmc7 0.129 1.24E-05 † 1.45 † 2.99E-03 † 0.187 † 4.51E-05 
68668 Klk5 0.134 1.22E-02 – – – – 
71687 Tmem25 0.156 7.66E-08 – – 0.154 6.43E-08 
19223 Ptgis 0.167 2.71E-06 † 1.49 † 9.72E-03 † 0.249 † 1.39E-06 
18261 Ocm 0.175 1.41E-05 † 1.42 † 3.63E-02 † 0.403 † 4.41E-06 
 
Genes with P > 0.05 were excluded from the analysis, as were ‘Rik’ sequences, ‘expressed 
sequences’, ‘predicted genes’ and ‘hypothetical proteins’. Also excluded was ‘Xist’ as this gene is X-
linked and the number of females and males in the gene chip analyses were not balanced. 
† : not present in the top 20 regulated genes of the respective list 
– : not present in the respective list of genes, or P > 0.05 
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Table S6. Comparison to top 20 genes that were differentially regulated in rodΔVhl;Hif1a 
relative to Vhlflox/flox;Hif1aflox/flox control mice 
Reference list: Table S3: rodΔVhl;Hif1a vs ctrl 
Upregulated genes  
Potential targets of: HIF2  
rodΔVhl vs rodΔVhl;Hif1a rodΔVhl vs ctrl 
potential targets of: HIF1; 
pSTAT3 
potential targets of:  
HIF1; HIF2; pSTAT3 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue ratio pValue ratio pValue 
109685 Hyal3 7.0 1.26E-02 0.05 3.57E-06 – – 
19076 Prim2 5.3 7.60E-09 – – † 4.7 † 3.02E-05 
77044 Arid2 4.8 3.88E-02 – – – – 
434794 Xlr4a 4.5 8.59E-03 – – – – 
628171 Olfr936 3.4 5.31E-03 – – – – 
73748 Gadl1 3.3 1.48E-02 – – † 5.0 † 9.08E-04 
545548 Lce3a 2.9 3.65E-03 † 0.2 † 2.17E-03 – – 
12534 Cdk1 2.9 8.44E-03 – – – – 
27083 Xlr4b 2.9 3.77E-02 – – † 2.6 † 5.27E-03 
57277 Slurp1 2.8 2.82E-02 – – † 2.5 † 8.05E-03 
17748 Mt1 2.7 6.82E-08 † 0.8 † 9.22E-03 † 2.0 † 4.22E-05 
53311 Mybph 2.7 3.58E-02 – – † 1.9 † 3.72E-02 
67652 Spaca1 2.7 8.29E-05 – – – – 
194597 Tmprss11a 2.5 4.75E-03 – – – – 
230678 Tmem125 2.4 1.02E-03 – – – – 
244332 Defb14 2.3 5.00E-03 – – – – 
14428 Galr2 2.3 1.65E-02 † 0.3 † 1.33E-02 – – 
238393 Serpina3f 2.3 2.42E-05 † 1.44 † 2.38E-03 † 3.3 † 2.46E-07 
22326 Vax1 2.2 3.28E-02 – – – – 
69930 Zfp715 2.2 2.04E-02 † 0.4 † 1.87E-02 † 0.8 † 9.99E-03 
     
Reference list: Table S3: rodΔVhl;Hif1a vs ctrl 
Downregulated genes  
Potential targets of: HIF2  
rodΔVhl vs rodΔVhl;Hif1a rodΔVhl vs ctrl 
potential targets of:  
HIF1; pSTAT3 
potential targets of:  
HIF1; HIF2; pSTAT3 
Entrez 
Gene ID 
Gene 
Symbol ratio pValue ratio pValue ratio pValue 
353371 Oxct2b 0.183 1.24E-02 – – – – 
17427 Mns1 0.254 1.58E-02 – – 0.100 1.01E-06 
51925 D2Ertd640e 0.260 2.78E-04 – – – – 
93689 Lmod1 0.324 3.44E-02 – – † 0.322 † 3.25E-02 
76585 Lce1i 0.335 5.87E-03 – – † 0.207 † 1.09E-02 
69611 Lce1d 0.338 2.88E-02 – – 0.148 1.60E-02 
56057 Btg4 0.356 4.73E-02 – – – – 
16061 Igh-VJ558 0.357 7.34E-03 † 0.31 † 2.28E-02 0.117 4.18E-04 
236904 Klhl15 0.375 1.83E-02 – – – – 
67828 Lce1f 0.376 1.43E-02 – – † 0.175 † 4.43E-03 
20521 Slc22a12 0.377 3.41E-04 – – – – 
21940 Cd27 0.380 1.84E-02 – – † 0.329 † 3.02E-02 
78801 Ak7 0.385 4.67E-04 – – – – 
68694 Lce1e 0.394 2.09E-02 – – † 0.180 † 3.60E-03 
258692 Olfr1442 0.395 1.93E-02 † 4.50 † 4.86E-02 – – 
76117 Arhgap15 0.397 2.29E-03 † 0.68 † 8.86E-04 – – 
246746 Cd300lf 0.398 4.89E-02 † 0.74 † 4.34E-03 – – 
96875 Prg4 0.400 1.36E-04 – – – – 
15130 Hbb-b2 0.402 2.54E-02 † 2.29 † 1.86E-02 – – 
80796 Calm4 0.402 2.60E-02 – – † 0.239 † 1.79E-02 
 
Genes with P > 0.05, were excluded from the analysis, as were ‘Rik’ sequences, ‘expressed 
sequences’, ‘predicted genes’ and ‘hypothetical proteins’. Also excluded was ‘Xist’ as this gene is X-
linked and the number of females and males in the gene chip analyses were not balanced. 
† : not present in the top 20 regulated genes of the respective list 
– : not present in the respective list of genes, or P > 0.05  
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3.3 Article 3: Blue light-induced retinal lesions, intraretinal vascular 
leakage and edema formation in the all-cone mouse retina  
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4 DISCUSSION 
Our knowledge about cone cell death is still limited. Using different experimental mouse models, we 
analyzed and compared the effects of a chronically activated hypoxic response in cones and rods. 
Additionally, we analyzed retinal degenerative processes in R91W;Nrl-/- mice which were exposed 
to blue light.  
4.1 The effects of a chronic hypoxia-like response on photoreceptors 
Accumulating evidence suggests a role for reduced tissue oxygenation in the pathogenesis of 
several retinal diseases. Hypoxia is not only relevant for neovascular diseases such as diabetic 
retinopathy and retinopathy of prematurity, but it might also play an important role in the aging retina 
and contribute to the development of age-related diseases such as AMD. In the first part of this 
thesis, we analyzed the effects of a chronic hypoxia-like situation on photoreceptors. To assess the 
significance of hypoxia in the aged human retina (see 3.2), we analyzed gene expression levels in 
retinas of human donors. We observed an age-dependent tendency of increased expression of 
hypoxia-regulated genes, supporting our hypothesis that oxygen delivery in older eyes is reduced 
and may lead to mild but chronic hypoxia during the aging process. 
To model such a chronic hypoxic response related to the human situation, we generated 
BPCre;R91W;Nrl-/-;Vhlf/f (coneΔVhl, all-cone retina) and OpsinCre;Vhlf/f (rod∆Vhl, rod-dominant retina) 
mice. We showed that cone-specific deletion of Vhl in coneΔVhl mice caused pathological vessel 
growth into the photoreceptor layer and severe, progressive cone degeneration (see 3.1). 
Additionally, we found increased expression of Timp3, an important regulator of extracellular matrix 
remodeling associated with Sorsby’s fundus dystrophy and neovascular AMD (Weber et al. 1994, 
Lin et al. 2006, Ardeljan et al. 2013). We clearly demonstrated that the observed neovascularization 
in coneΔVhl mice is Hif1-dependent, as additional deletion of Hif1a (BPCre;R91W;Nrl-/-;Vhlf/f;Hif1af/f 
(coneΔVhlHif1a) mice) fully rescued the phenotype. ConeΔVhl mice recapitulate some of the features of 
AMD pathology, particularly of a distinct form of neovascular AMD known as RAP. In RAP, vessels 
grow from the deep retinal plexus into the photoreceptor layer and subretinal space (see 1.3.2; 
(Hartnett et al. 1996, Yannuzzi et al. 2008)). By using rod∆Vhl mice, we showed that a chronic hypoxia-
like response induced photoreceptor degeneration, which was dependent on chronic activation of 
HIF1 but not of HIF2 (see 3.2). Rod∆Vhl mice represent some features of dry AMD such as age-
related photoreceptor degeneration and RPE defects. Although both coneΔVhl and rod∆Vhl mice may 
not recapitulate all the features of the disease, as for example drusen accumulation, they provide 
suitable models to study hypoxia-related degeneration and test potential treatments. 
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4.1.1 Similarities and differences between coneΔVhl and rod∆Vhl mouse models 
ConeΔVhl and rod∆Vhl mice are used as models to simulate a chronic hypoxia-like situation in cones 
and rods, respectively. Even though the hypoxic response is triggered in different types of 
photoreceptors, the two models share similar aspects. As expected, in both models chronic 
activation of the hypoxic response led to increased expression of hypoxia-regulated genes. 
Increased expression of hypoxic target genes associated with glycolysis (e.g. Glut1, Pdk1) indicated 
a metabolic shift that may result in reduced oxidative phosphorylation and thus reduced ATP 
production. Affected energy metabolism might have detrimental consequences for photoreceptor 
survival. Indeed, we observed progressive photoreceptor degeneration in both coneΔVhl and rod∆Vhl 
mice. Although the individual mechanisms leading to cell death and the contribution of a metabolic 
shift are still elusive, we provide evidence for a HIF1A-regulated process: the degenerative 
phenotype was rescued by genetic inactivation of HIF1A in both models. Consequently, we identify 
HIF1A as a therapeutic target to rescue hypoxia-mediated photoreceptor loss in patients. 
Interestingly, recently published work by Kurihara and colleagues suggests that another HIF isoform, 
HIF2A, affects survival of RPE cells and photoreceptors in a different mouse model of chronic 
hypoxia (Kurihara et al. 2016). In their study, they used VMD2-Cre to delete Vhl in the RPE and 
showed that chronic HIF2A-mediated metabolic stress (i.e. altered glucose and lipid metabolism) in 
RPE cells induced photoreceptor dysfunction and degeneration. Given the different impact of 
chronically active HIF1A and HIF2A in photoreceptor cells and the RPE, cell type-specific targeting 
of both HIF1A and HIF2A might be required to develop a successful therapy for AMD. 
Additionally, in both coneΔVhl and rod∆Vhl mice we observed RPE changes, albeit with variable 
severity. RPE damage was more pronounced in coneΔVhl mice as compared to rod∆Vhl mice. Thicker 
RPE and/or partial loss of the RPE indicated RPE stress, which could be explained by several 
possible causes. At first, unspecific Cre expression could activate a hypoxic response in the RPE. 
However, since in both models Cre expression was found predominantly in the ONL and no sign of 
Cre activity was detected in the RPE (analyzed by using reporter mouse lines) this option can be 
ruled out. Secondly, RPE stress could be secondary to photoreceptor cell death due to increased 
amounts of phagocytic material. However, debris of degenerated rods in rod∆Vhl mice should not 
represent a major problem for the RPE, as progression of degeneration in rod∆Vhl mice is rather slow. 
Nevertheless, ingestion and accumulation of toxic byproducts resulting from activated HIF1A in 
photoreceptors may cause RPE stress. Additionally, secreted factors or reduced metabolic support 
may result in RPE damage. Clearly, more research is required to define these mechanisms. 
In both coneΔVhl and rod∆Vhl mice, we observed activation of the Lif/Edn2/Fgf2 pathway (coneΔVhl mice 
not shown, rod∆Vhl mice see 3.2 and (Lange et al. 2011b)). Expression of leukemia inhibitory factor 
(Lif) by a subset of Müller cells is strongly induced upon photoreceptor cell death (Joly et al. 2008). 
Different models for inherited and light-induced degeneration may activate LIF and an endogenous 
rescue defense system that involves the Janus kinase/signal transducer and activator of 
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transcription (Jak/STAT) signaling pathway (Samardzija et al. 2006, Burgi et al. 2009). Additionally, 
Lif has been shown to be involved in retinal neuroprotective signaling (Samardzija et al. 2006, Joly 
et al. 2008, Burgi et al. 2009, Leibinger et al. 2009). Despite the documented neuroprotective role of 
LIF in the retina, the regulation of Lif signaling and LIF target molecules are still under debate (Agca 
et al. 2013). In addition, it remains to be elucidated if modulating Lif could activate neuroprotective 
signaling and reduce degeneration in coneΔVhl and rod∆Vhl mice. 
Despite the similar aspects observed in coneΔVhl and rod∆Vhl mice, the two models differ in some 
features. While coneΔVhl and rod∆Vhl mice both represent some aspects of dry AMD such as age-
related photoreceptor degeneration and RPE defects, the phenotype of coneΔVhl mice additionally 
recapitulates features of a distinct form of neovascular AMD known as RAP, including vascular 
defects with vessels extending from the deep plexus into the ONL/subretinal space. Although 
photoreceptor degeneration was evident in both models, the progression of the degenerative 
process varied. While we observed severe cone degeneration in coneΔVhl mice already at early time 
points, rod cell death in rod∆Vhl was milder and progressed more slowly. A possible explanation for 
the different pathological phenotypes in the two mouse lines could arise from the different 
characteristics of rods and cones. Several studies suggest that cones are particularly sensitive to 
reduced oxygen and nutrient levels compared to rods. RPE-specific Vegfa ablation (VMD2-
Cre;Vegfaf/f mice) leads to severe choriocapillaris deficits that in turn induce hypoxia in the RPE and 
promote photoreceptor degeneration. While dysfunction of cone photoreceptors was deteced 
already within one week after Vegfa deletion, defects in rod function were not detected until 11 
months post deletion. Thus, cones seem to be more sensitive to oxygen deprivation than rods 
(Kurihara et al. 2012, Kurihara et al. 2016). Additionally, metabolic dysregulation has been 
associated with cone cell death in retinitis pigmentosa, a genetic disorder that causes severe vision 
impairment due to loss of rods and secondary loss of cones (Punzo et al. 2009, Punzo et al. 2012). 
Although the reasons for secondary cone cell death are still elusive, one hypothesis by Punzo and 
colleagues suggested that upon rod cell loss cones die, at least in part, as a result of starvation and 
nutritional imbalance (Punzo et al. 2009). Although the higher sensitivity of cones may contribute to 
the stronger phenotype observed in coneΔVhl compared to rod∆Vhl mice, for a precise interpretation of 
the observed phenotypes we need to emphasize the different timing to trigger the hypoxic response 
in the two models. In coneΔVhl mice, BPCre drives strong Cre expression in almost all cells of the 
ONL and is already active at PND1 (not shown). In rod∆Vhl mice, rod-specific Cre expression is patchy 
and evident in 50-70% of rod photoreceptors (Le et al. 2006, Lange et al. 2011b). OpsinCre 
expression starts around PND7 and increases up to 6 weeks of age (Le et al. 2006). Thus, based 
on Cre expression, the hypoxic response in coneΔVhl mice should be triggered at an earlier time point 
and in an increased number of photoreceptors as compared to rodΔVhl mice. The early hypoxic 
response in coneΔVhl mice interferes with the development of the retinal vasculature and causes 
vessel growth from the deep plexus into the photoreceptor layer and subretinal space. It remains 
unclear which angiogenic factor(s) are misguiding the vessels to extend into the ONL and subretinal 
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space. However, a prominent candidate factor responsible for neovascularization is VEGF, as Vegf 
overexpression has been shown to cause abnormal vessel growth (Okamoto et al. 1997, Ohno-
Matsui et al. 2002, Ida et al. 2003). We also observed increased Vegf gene expression levels in 
rodΔVhl mice (tested at 11 weeks of age, see 3.2). However, given the crucial role of a VEGF gradient 
during vascular development (see 1.2.3), timing of increased Vegf expression might be the key factor 
for misguiding the vessels to the ONL in coneΔVhl mice. The observed pathological vascular defects 
and retinal hemorrhages (as shown by albumin immunostaining) in coneΔVhl mice may exacerbate 
cone photoreceptor degeneration, as suggested for other models ((Zhao et al. 2011) and see 3.3, 
4.3).  
Collectively, our results suggest that timing and dosage (i.e. the amount of cells with active Cre 
recombinase) are decisive factors for neovascularization, which, subsequently, may accelerate 
neurodegeneration in response to an activated hypoxic response. This, together with stronger Cre 
activity in coneΔVhl mice, might explain the different progression of the degenerative process in 
coneΔVhl and rodΔVhl mice.  
4.1.2 Future directions: cone degeneration and a hypoxia-like response in 
coneΔVhl mice 
To date, it remains unclear whether cones in coneΔVhl mice degenerate due to chronic activation of 
the hypoxic response, due to vascular defects or due to a combination of the two. In coneΔVhl mice, 
early Cre activity triggered a hypoxic response that caused vessel growth from the deep plexus into 
the photoreceptor layer and subretinal space. To further clarify the impact of a chronic hypoxia-like 
response on mature photoreceptors, a delayed trigger of Cre expression, at the time when 
developmental vascularization is completed, should be pursued. For this purpose, an AAV 
expressing Cre under the transcriptional control of a photoreceptor-specific promoter (e.g. G protein-
coupled receptor kinase 1 (GRK1), a component of phototransduction expressed in rods and cones) 
can be delivered to adult R91W;Nrl-/-;Vhlf/f mice by subretinal injections. Testing of this approach is 
currently ongoing and may assist in elucidating the influence of chronic hypoxia on cone 
photoreceptors in the adult all-cone retina. However, separating a potential degenerative phenotype 
triggered by Vhl excision and injection-inflicted damage will be challenging. Furthermore, we 
generated BPCre;Vhlf/f mice (rod-dominant retina) to assess the effects of Vhl ablation on cones in 
retinas with normal photoreceptor ratio (3% cones, 97% rods). Based on preliminary results, retinal 
vasculature is normal in these mice. Further analysis will focus on cell death mediated by the lack of 
Vhl in cones in the rod-dominant retina. With this model, we will be able to study hypoxia-mediated 
cone cell death in a normally vascularized retina with a mixed rod/cone composition. However, due 
to the low number of cones in the rod-dominant retina, cone cell death analysis will be challenging 
as potential differences between Vhl knockout and control mice are expected to be small.  
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To further elucidate the contribution of VEGF on vascular defects in coneΔVhl mice, VEGF could be 
targeted. FLT1-Fc is a VEGF receptor-1/Fc chimeric protein that binds VEGF and decreases its 
activity. Intraocular injections of FLT1-Fc have been proven to prevent vascular defects in distal-
retina-specific α-Cre;Vhlf/f mice that express Cre under the α-element of the Pax6-promotor (Kurihara 
et al. 2010). Apart from the vessel phenotype such as abnormal vessel growth into the ONL in the 
retinal periphery, reduced vascular density as well as persistent hyaloid vasculature, the α-Cre;Vhlf/f 
mice show also photoreceptor degeneration (Kurihara et al. 2010, Lange et al. 2011a). FLT1-Fc or 
AAV-sFLT1 injections were used in mouse models and subsequently in clinical trials to treat 
neovascular AMD (see 1.3.5). Such an approach, applied early (PND4/PND7), could be considered 
to address the neovascular phenotype in coneΔVhl mice and evaluate the impact of Vegf on the cone 
pathology. Another strategy to study the role of Vegf would be a genetic approach: crossing 
BPCre;R91W;Nrl-/-;Vhlf/f and Vegfaf/f (Gerber et al. 1999) mice would allow analyzing the phenotype 
in absence of cone-specific Vegf expression.  
With the above discussed strategies, the effects of chronic hypoxia on cones and the role of Vegf on 
vascular defects in coneΔVhl mice should be further clarified. 
4.1.3 Future directions: optimization of gene therapy approach in rod∆Vhl mice 
Currently, no treatment is available for patients suffering from AMD, apart from repeated intravitreal 
anti-VEGF injections for the less common neovascular form of AMD. First clinical trials using different 
AAVs to treat AMD were initiated (see 1.3.5), however these studies reported limited success of the 
treatment in patients. Therefore, new therapeutic approaches are urgently needed. In an attempt to 
establish an interventional therapy, we aimed at targeting HIF1A in the adult retina of rod∆Vhl mice. 
To reduce toxic HIF1A levels, we used RNA interference through expression of an shRNA against 
HIF1A. First, we tested our shHif1a in NIH3t3 cells and showed an efficient downregulation of HIF1A 
in shHif1a-transfected cells following exposure to 0.2% oxygen (hypoxia). In a next step, viral 
particles carrying the shHif1a sequence (AAV2/8Y733F-shHif1a) were injected into the subretinal 
space of rod∆Vhl mice. We provided evidence that anti-Hif1a gene therapy reduced the degenerative 
phenotype in mice (see 3.2), which supports the hypothesis of targeting Hif1a to protect 
photoreceptors in hypoxia-related diseases such as AMD. To achieve robust shRNA expression, we 
used the ubiquitous polymerase III promoter U6 to drive shHif1a. We observed widespread 
expression, predominantly localized in the ONL and RPE but we also detected weak expression in 
some other retinal cells. HIF1A can be safely inactivated in adult cones (see 3.1), rods (Thiersch et 
al. 2009), and 3.2) and RPE (Kurihara et al. 2012, Kurihara et al. 2016). However, the consequences 
of HIF1A inactivation in other adult retinal cell types is unknown. As we did not observe AAV-shHif1a-
mediated toxicity in other cells, our data suggest that Hif1a inactivation does not have adverse 
effects. Nevertheless, further thorough analysis is required to make that conclusion.  
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Clearly, far more research is needed to further test and improve our gene therapy approach. Besides 
the above-mentioned specificity of our AAV vector, an open question that needs to be addressed is 
the route of delivery. We delivered AAV-shHif1a by subretinal injections, which is currently the 
preferred route to target photoreceptor cells. However, injection-inflicted damage was unavoidable 
due to the small size of the mouse eye. Recently, successful transduction of the outer retina following 
intravitreal injection has been reported. Vitreous aspiration prior to intravitreal injections results in 
retina-wide AAV transduction, but occasionally leads to side effects such as cataracts or retinal 
remodeling due to retinal detachment (see 5.2.3, (Da Costa et al. 2016)). Intravitreal administration 
of a newly engineered AAV capsid (AAV2-7m8) may provide a less invasive alternative to target 
photoreceptors (Dalkara et al. 2013). The AAV2-7m8 vector has a capsid-displayed peptide-insertion 
of 10 amino acids (referred to as 7m8) which leads to increased efficacy of cellular entry and allows 
transduction of the outer retina after non-invasive injection into the vitreous (Khabou et al. 2016). 
However, in contrast to subretinal injections, intravitreal injections were shown to trigger an immune 
response. Although both the intravitreal and subretinal space possess immune privilege, apparently 
they respond to AAV-injection differently (Li et al. 2008). Even though the precise mechanisms still 
need to be determined, anatomical characteristics might partially explain the difference in humoral 
immune response. The vitreous is located in close proximity to the vasculature system, which offers 
the potential to present capsid antigens to the immune system. The subsequent humoral immune 
response may reduce the therapeutical dose by decreasing transgene expression upon re-
administration and limit the therapeutical benefit if sequential treatment is needed (Li et al. 2008). In 
contrast, the subretinal space is separated from blood vessels of the choriocapillaris by RPE cells, 
which form the outer BRB. In addition, RPE cells secrete anti-inflammatory and immune-suppressive 
molecules which contribute to ocular immune privilege (Li et al. 2008). Therefore, injections into the 
subretinal space might not induce a humoral immune response.  
Taken together, packaging of our shHif1a in an optimized AAV capsid (e.g. AAV2-7m8) would 
possibly allow targeting of photoreceptors by intravitreal injection, a technique that is 
methodologically less complicated and less invasive. However, for a potential future application in 
clinical trials, subretinal injections may be the safer route regarding the activation of the immune 
response. Additionally, as discussed earlier, development and testing of a an AAV-mediated cell 
type-specific targeting of HIF1A and HIF2A should be considered in future experiments (see above, 
and results from 3.2 and (Kurihara et al. 2016)). 
4.2 Light-induced retinal degeneration in the all-cone R91W;Nrl-/- mouse 
To further understand the underlying mechanisms of cone cell death, we analyzed retinal 
degenerative processes in R91W;Nrl-/- mice which were exposed to blue light. Interestingly, 
exposure to light may act as co-factor in retinal diseases (Taylor et al. 1990, Margrain et al. 2004). 
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In our study, we exposed wild-type (wt, 129S6) and all-cone R91W;Nrl-/- mice to toxic levels of blue 
light. Our data suggest significant differences between rod- and cone-dominant retinas, regarding 
not only photoreceptor degeneration but also BRB integrity. Interestingly, although cones seem to 
be more sensitive to reduced oxygen and nutrient levels compared to rods (Punzo et al. 2012, 
Kurihara et al. 2016), they are more resistant to light-induced damage (Cicerone 1976, Okano et al. 
2012). In line with these results, cone photoreceptors of R91W;Nrl-/- mice were more resistant to 
blue-light damage compared to rods of wt mice (see 3.3). Although cones in R91W;Nrl-/- mice 
survived the toxic insult to a higher extent, we identified dying cells in the INL in R91W;Nrl-/- mice but 
not in wt mice. In wt mice, blue light exposure led to the disruption of the outer BRB, which is 
maintained by the RPE. In contrast, cell death in the INL of R91W;Nrl-/- mice was accompanied by 
retinal hemorrhages, suggesting vessel leakage and breakdown of the inner BRB which is formed 
by tight junctions between retinal capillary endothelial cells. As a result, retinal swelling and edema 
formation was more pronounced in R91W;Nrl-/- than in wt mice. This resulted in neuroinflammation 
and increased expression levels of the proinflammatory cytokines Tnf and Il1b in R91W;Nrl-/- mice. 
Similarly, increased levels of TNFa and IL1B were found in aqueous humor of patients suffering from 
proliferative diabetic retinopathy (Demircan et al. 2006), a disease affecting retinal blood vessels 
that ultimately leads to dysfunction of the BRB, vascular leakage and vision loss (see 1.3.1). In 
patients, macular edema is often associated with DR, but a wide variety of pathologic conditions may 
cause its formation. Compromised retinal blood barrier function has also been suggested to play an 
important role in several other retinal diseases including AMD and other chronic retinal diseases 
(Klaassen et al. 2013).  
Blue light damage in R91W;Nrl-/- mice can be used to study mechanisms leading to edema formation 
in a cone-exclusive environment, resembling partially the human rod-free central macula. 
Additionally, our model allows testing of potential therapeutic agents that may prevent edema 
formation and restore proper vessel function. Besides anti-inflammatory therapy (Das et al. 2015), 
purinergic receptor activation improving the retinal water transport may be a promising research area 
to test therapeutic agents for prevention of cell death in degenerative and proliferative retinopathies 
(Reichenbach et al. 2016).  
4.3 Vascular leakage: a common feature of coneΔVhl and blue-light 
damaged all-cone R91W;Nrl-/- mice  
We investigated photoreceptor degeneration based on a chronic hypoxic response or on toxic levels 
of blue light exposure. Certainly, the experimental setup including stimuli (hypoxia versus light) and 
timing (acute versus chronic) varies greatly. Nevertheless, in both blue-light damaged all-cone 
R91W;Nrl-/- and coneΔVhl mice, we observed breakdown of the inner BRB and vascular leakage 
(see 3.1, 3.3 and discussion above). The molecular mechanisms underlying vascular leakage 
possibly differ in the two models. While Vegf is a prominent candidate factor responsible for vascular 
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pathology in coneΔVhl mice, we did not find upregulation of Vegf expression in R91W;Nrl-/- mice 
following blue light damage (not shown). However, leakage may have detrimental consequences in 
both coneΔVhl and blue-light damaged all-cone R91W;Nrl-/- mice. Extravasated blood components 
such as hemoglobin and iron can have toxic effects on surrounding cells (Regan et al. 1993, Gelfand 
et al. 2015). Although iron is essential for retinal function, excess iron has been associated with 
retinal degeneration (Hahn et al. 2004, Dunaief 2006, Song et al. 2013). Besides inducing oxidative 
damage, iron accumulation has been shown to activate the NLRP3 inflammasome and promote RPE 
degeneration (Gelfand et al. 2015). Another report by Zhao and colleagues supports the involvement 
of an inflammatory reaction to extravasated blood components, as blood constituents have been 
shown to cause an inflammatory response that causes photoreceptor degeneration (Zhao et al. 
2011). Blood leakage and BRB disruption may have additional adverse effects by impairing the influx 
of nutrients and oxygen supply to the retina. The inner retina is nourished by the retinal vasculature 
and diffusion of molecules is controlled by the inner BRB. The outer retina including photoreceptors 
is supplied mainly by the choroidal vasculature and diffusion of solutes is regulated by the outer BRB 
(see 1.2.1). Thus, it is conceivable that while dysfunctional blood vessels and inner BRB disruption 
might impair oxygen supply for the inner retina, outer BRB disruption may affect oxygen supply for 
photoreceptors. However, experiments substantiating this hypothesis would be required.  
Clearly, more experiments are needed to clarify the exact mechanisms and consequences of 
vascular leakage in blue-light damaged all-cone R91W;Nrl-/- and coneΔVhl mice. Further testing 
should investigate the impact of extravasated blood components and the effects of BRB disruption 
on nutrient and oxygen supply.  
4.4 Concluding Remarks 
In our work, we analyzed the retinal response to toxic levels of light and chronic hypoxia-like 
conditions, two important features of retinal degenerative diseases. Our research revealed different 
responses of rod- and cone-dominant retinas: cone photoreceptors are not only resistant to light 
damage induced by white light, even strong blue light affected cones less severely than rods. Our 
data confirmed the previous notion that rod photoreceptors are more susceptible than cones in a 
light-damage paradigm used to study retinal degenerations. However, cone degeneration induced 
by blue light in the all-cone R91W;Nrl-/- mice was accompanied by vascular leakage and edema. 
Thus, our blue light damaged R91W;Nrl-/- mouse model can be used to study edema-based 
complications in different macular degenerations and may serve as a platform to test therapeutic 
agents. 
Vascular leakage was also a prominent feature of all-cone R91W;Nrl-/- mice with a cone-specific 
activation of the molecular hypoxic response. Chronic activation of HIF transcription factors caused 
severe early-onset cone degeneration and neovascularization – features that are central to a distinct 
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form of neovascular AMD known as retinal angiomatous proliferation (RAP). The phenotype of mice 
with a rod-specific activation of the molecular hypoxic response in a rod-dominant retina 
recapitulates features of dry AMD such as slow, age-dependent photoreceptor death and loss of 
vision. We identified HIF1A as causative factor and showed that targeting HIF1A might be an 
applicable strategy to rescue vision in hypoxia-mediated retinal degenerative diseases. However, 
many open questions remain to be answered. An important point that needs to be addressed is 
whether it is safe to inactivate a protein with pleiotropic effects such as HIF1A. Our data and data 
from others suggest that HIF1A can be safely inactivated in adult photoreceptors and RPE. Future 
experiments will assist in elucidating safety and effectiveness of our gene therapy approach. 
Additionally, a cell type-specific targeting of HIF1A and HIF2A may further increase treatment 
success. With our research, we hope to contribute to the development of therapeutic strategies to 
protect invaluable high-acuity vision.  
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5 APPENDIX 
5.1 List of Abbreviations 
AAV adeno-associated virus  
ABCA4 ATP binding cassette subfamily A member 4 
Adm adrenomedullin 
AMD age-related macular degeneration 
AMPA α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid 
ARMS2 age-related maculopathy susceptibility 2 
ARNT aryl hydrocarbon receptor nuclear translocator 
ARNTL ARNT-like 
ATP adenosine triphosphate 
bHLH basic-helix-loop-helix 
BMAL1 brain and muscle Arnt-like protein 1 
Bnip3 BCL2/adenovirus E1B interacting protein 3 
BRB blood-retinal barrier 
C-TAD C-terminal transactivation domain 
C2 complement 2 
C3 complement 3 
cap capsid 
CBP  CREB-binding protein 
CEP carboxyethylpyrrole  
CFB complement factor B 
CFH complement factor H  
cGMP cyclic guanosine monophosphate 
CNTF ciliary neurotrophic factor 
CNV  choroidal neovascularization 
cpfl1 cone photoreceptor function loss 1 
CRALBP cellular retinaldehyde-binding protein 
CRBP cellular retinol binding protein  
CREB  cAMP-response element-binding protein 
DR diabetic retinopathy 
EIAV Equine Infectious Anemia Virus  
EPAS1 endothelial PAS domain protein 1 
Epo erythropoietin 
FIH factor inhibiting HIF1 
FLT1 fms related tyrosine kinase 1 
GCL ganglion cell layer 
GDP guanosine diphosphate 
Glut1 glucose transporter 1 
GRK1 G protein-coupled receptor kinase 1 
GTP guanosine triphosphate 
hESC human embryonic stem cell 
HIF hypoxia-inducible factor 
HLA human leukocyte antigen  
Hmox1 heme oxygenase (decycling) 1 
HRE hypoxia response element 
Htra1 HtrA serine peptidase 1 
INL inner nuclear layer 
IPL inner plexiform layer 
iPSCs induced pluripotent stem cells 
IRBP interphotoreceptor retinol binding protein 
ITR inverted terminal repeats 
Jak/STAT Janus kinase / signal transducer and activator 
of transcription 
Ldha lactate dehydrogenase A 
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Lif leukemia inhibitory factor 
LRAT lecithin retinol acyltransferase  
mGluR6 G protein-coupled metabotropic glutamate 
receptor 6 
MNU N-methyl-N-nitrosourea 
Nrl neural retina leucine zipper 
OCT optical coherence tomography  
ONL outer nuclear layer 
OPL outer plexiform layer 
PAS Per/ARNT/Sim 
PCR  polymerase chain reaction 
PDE phosphodiesterase 
PDGF platelet-derived growth factor 
PEDF pigment epithelium-derived factor 
Phd  prolyl hydroxylase domain  
PND postnatal day 
RAP retinal angiomatous proliferation 
Rd retinal degeneration 
rep replication 
RPE retinal pigment epithelium 
RPE65 RPE-specific 65kDa protein 
sFLT1 soluble fms related tyrosine kinase 1  
shRNA short hairpin RNA 
siRNA small interfering RNA 
Timp3 tissue inhibitor of metalloproteinase 3  
Vegf vascular endothelial growth factor 
VHL von Hippel Lindau 
VLDLR very low density lipoprotein receptor  
wt wild-type 
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Abstract  
In industrialized countries, age-related macular degeneration (AMD) is the leading cause of 
blindness in elderly people. Hallmarks of the non-neovascular (dry) form of AMD are the formation 
of drusen and geographic atrophy, whereas the exudative (wet) form of the disease is characterized 
by invading blood vessels. In retinal angiomatous proliferation (RAP), a special form of wet AMD, 
intraretinal vessels grow from the deep plexus into the subretinal space. Little is known about the 
mechanisms leading to intraretinal neovascularization but age-related changes such as reduction of 
choroidal blood flow, accumulation of drusen and thickening of the Bruch’s membrane may lead to 
reduced oxygen availability in photoreceptors. Such a chronic hypoxic situation may induce several 
cellular response pathways including the stabilization of hypoxia-inducible factors (HIFs) and the 
production of angiogenic factors, such as vascular endothelial growth factor (VEGF). Here, we 
discuss the potential contribution of hypoxia and HIFs in RAP disease pathology and in some mouse 
models for subretinal neovascularization. 
 
XX.1 Introduction 
Retinal function can be affected by three variants of neovascularization (Grossniklaus et al. 2010). 
In retinal neovascular diseases such as diabetic retinopathy, central retinal vein occlusion and 
retinopathy of prematurity, retinal vessels grow along the inner retinal surface and/or extend into the 
vitreous (Grossniklaus et al. 2010) due to retinal ischemia and increased concentrations of vascular 
endothelial growth factor (VEGF) (Aiello et al. 1994, Lashkari et al. 2000). In choroidal 
neovascularization (CNV) new vessels originate in the choroid and grow towards the retina, 
characteristic for wet age-related macular degeneration (AMD) (Bressler et al. 1988, Spaide 2013). 
Additionally, retinal angiomatous proliferation (RAP), also known as deep retinal vascular anomalous 
complexes, has been described (Yannuzzi et al. 2001). RAP is a distinct form of neovascular AMD, 
characterized by the growth of vessels that invade the subretinal space not from the choroid but from 
the retina. In RAP, vessels originate from the deep retinal plexus and cause intraretinal 
neovascularization mainly in the photoreceptor layer resulting in an abnormal communication 
between retinal and choroidal vasculatures (Hartnett et al. 1996, Yannuzzi et al. 2008, Atmani et al. 
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2010). However, since vessels originating from the choroid in CNV of late stage neovascular AMD 
can form connections with the retinal vasculature known as retinal-choroidal anastomosis, the 
distinction between a retinal or choroidal origin of vessel growth is sometimes difficult (Slakter et al. 
2000, Scott et al. 2010). Therefore, the more general term “type 3 neovascularization” has been 
suggested (Freund et al. 2008) but RAP is still the most frequently used designation. RAP has a 
poor clinical prognosis and treatment of RAP remains difficult (Bottoni et al. 2005, Gross et al. 2005). 
The prevalence of RAP is estimated at 15-20% of neovascular AMD (Cohen et al. 2007, Massacesi 
et al. 2008).  
XX.2 Hypoxia and Hypoxia-Inducible Factors 
The exact cause for neovascular AMD and particularly RAP is still unclear. Although VEGF plays a 
critical role in neovascularization the triggering factor is still largely unknown. Hypoxia activates 
regulatory systems in the body with hypoxia-inducible factor 1 (HIF1) playing a central role. HIF1 
heterodimers are composed of an oxygen-labile α-subunit and a constitutively expressed β-subunit. 
Under normal oxygen levels, the HIF1A protein is rapidly degraded, which is mediated by 
hydroxylation of HIF1A by prolyl hydroxylases promoting its interaction with the von-Hippel-Lindau 
ubiquitin E3 ligase complex. As a result, the HIF1A protein is degraded via the proteosomal pathway. 
Under hypoxia, hydroxylation does not occur and hence, HIF1A gets stabilized, translocates into the 
nucleus and enables transcription of target genes such as VEGF (Jaakkola et al. 2001, Grimm et al. 
2002, Caprara et al. 2012). This can trigger neovascularization in an attempt to resolve the long-
term tissue hypoxia. Besides hypoxia, other factors such as oxidative stress, inflammation and 
disturbance in energy metabolism may also be involved in HIF1A stabilization (Cash et al. 2007, 
Dehne et al. 2009, Joyal et al. 2016). Since a chronic hypoxic situation has been suggested to play 
an important role in RAP and AMD pathology (Arjamaa et al. 2009, Kent 2014) we discuss the 
potential contribution of tissue hypoxia and HIF1A stabilization for disease development. 
XX.3 Hypoxia and HIF in Neovascular AMD and RAP Pathology 
In AMD patients, abnormalities in choroidal perfusion and vascular defects were described (reviewed 
in (Harris et al. 1999)), suggesting tissue hypoxia. In effect, strong VEGF protein immunoreactivity 
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has been shown in surgically excised CNV membranes and transdifferentiated retinal pigment 
epithelial (RPE) cells of AMD patients (Kvanta et al. 1996, Lopez et al. 1996). Additionally, stabilized 
HIF1A and HIF2A were detected in the endothelium and macrophages of human choroidal 
neovascular membranes associated with AMD (Inoue et al. 2007).  
In human patients with RAP, vitreous VEGF levels determined by ELISA are higher compared to 
control subjects (Joyal et al. 2016). Intravitreally injected anti-VEGF agents have been shown to be 
effective in blocking vessel growth and improving vision in neovascular AMD (Solomon et al. 2014) 
and in RAP (Engelbert et al. 2009, Atmani et al. 2010). Evidence indicates that hypoxia and HIF 
transcription factors are important driving forces in RAP disease development. For example, Hartnett 
and colleagues hypothesized that large drusen and Bruch’s membrane deposits observed in RAP 
could decrease retinal oxygenation and create a hypoxic microenvironment in the outer retina which 
may stimulate angiogenic growth factor release, vessel growth and retinal degeneration (Hartnett et 
al. 1996). A thinner choroid and greater density of drusen has been observed in RAP patients 
compared to typical neovascular AMD patients, two factors that may cause ischemia and/or restrict 
oxygen availability for photoreceptors (Kim et al. 2013). Additionally, RPE detachment could intensify 
the hypoxic challenge by increasing the distance between the photoreceptors and the choroid 
(Hartnett et al. 1996). Shimada et al. reported HIF1A and HIF2A expression in the surroundings of 
VEGF-positive retinal neovascular areas in RAP specimens (Shimada et al. 2007). This suggests a 
hypoxia-mediated mechanism leading to VEGF expression in RAP.  
In summary, hypoxic factors such as VEGF and HIF1 may be involved in both typical neovascular 
AMD and RAP disease pathology. However, RAP does not require perturbation of Bruch’s 
membrane and/or RPE, unlike CNV (Campochiaro 2013).  
XX.4 Rho/VEGF and Vldlr-/- Mice: Two Animal Models for RAP 
Transgenic mice expressing VEGF driven by the rhodopsin promoter (rho/VEGF) develop vessels 
that originate in the deep capillary bed of the retina and extend through the outer nuclear layer into 
the subretinal space (Okamoto et al. 1997). CNV has not been observed in these mice (Tobe et al. 
1998). In addition, VEGF overexpression caused retinal neovascularization even in adult mice with 
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completely developed retinal vasculature (Ohno-Matsui et al. 2002). Less neovascularization has 
been observed in mice with ischemic retinopathy lacking the hypoxia response element in the Vegf 
promoter compared to control mice (Vinores et al. 2006), suggesting an important role for HIF1 in 
the regulation of VEGF-mediated neovascularization. 
Mice with a partial deletion of exon 5 of the very low density lipoprotein receptor gene lack functional 
VLDLR (Vldlr-/-) (Frykman et al. 1995) and show a retinal phenotype resembling RAP lesions 
(Heckenlively et al. 2003). Due to increased VEGF levels (see below) Vldlr-/- mice exhibit retinal 
neovascularization with vessels originating within the outer plexiform layer. Vessels start to grow at 
postnatal day (PND) 15, reach the subretinal space by PND20, and anastomoses with the 
choriocapillaries are observed at 3 months of age. This is accompanied by photoreceptor 
degeneration affecting predominantly cone cells (Hu et al. 2008, Dorrell et al. 2009). The increased 
VEGF levels observed in Vldlr-/- mice were initially suggested to be linked to the negative regulatory 
role of VLDLR on Wnt signaling, which targets VEGF (Dorrell et al. 2009). However, since VLDLR 
has important functions in cholesterol homeostasis, lipid metabolism and transport (Tiebel et al. 
1999), Joyal and colleagues demonstrated that impaired fatty acid uptake in Vldlr-/- mice results in a 
reduction of α-ketoglutarate, which decreases prolyl hydroxylase dehydrogenase activity and 
promotes the stabilization of HIF1A. Subsequently, VEGF levels are increased, leading to a RAP-
like neovascular phenotype (Joyal et al. 2016). Thus, dysregulated energy metabolism might drive 
pathological neovascularization by stabilizing HIF1A.  
XX.5 Concluding Remarks and Future Therapeutic Perspectives 
Pathological vessel growth in wet AMD and RAP are both associated with increased VEGF 
levels and are currently treated by frequent intraocular injections of anti-VEGF agents. However, 
such treatment should not downregulate VEGF below basal concentrations since physiological 
levels of VEGF are needed for proper visual function. It has been shown for example that an RPE-
specific Vegf deletion leads to atrophy of the choriocapillaris and cone degeneration (Kurihara et al. 
2012, Kurihara et al. 2016). Its hypoxia-specific regulator Hif1a, however, can be safely inactivated 
in RPE (Kurihara et al. 2012), adult rods (Thiersch et al. 2009) and cones (author’s unpublished 
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data). Therefore, tissue-specific targeting HIF1A may provide a valid and safe therapeutical 
approach to treat RAP and potentially AMD. Animal models such as rho/VEGF and Vldlr-/- mice are 
clearly important to test and improve such treatment strategies. However, considering that these 
mice lack a cone-rich region resembling the human macular region, more research is needed to 
determine the influence of hypoxia, HIF1A and VEGF on cone survival and function.   
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